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vSummary
The cells making up all living organisms integrate external and internal signals to carry
out the functions of life. Dysregulation of signaling can lead to a variety of grave dis-
eases, including cancer [Slamon et al., 1987]. In order to understand signal transduc-
tion, one has to identify and characterize the main constituents of cellular signaling
cascades. Proteins are involved in most cellular processes and form the major class
of biomolecules responsible for signal transduction. Post-translational modifications
(PTMs) of proteins can modulate their enzymatic activity and their protein-protein
interactions (PPIs) which in turn can ultimately lead to changes in protein expres-
sion. Classical biochemistry has approached the study of proteins, PTMs and inter-
action from a reductionist view. The abundance, stability and localization of proteins
was studied one protein at a time, following the one gene-one protein-one function
paradigm [Beadle and Tatum, 1941]. Pathways were considered to be linear, where sig-
nals would be transmitted from a gene to proteins, eventually resulting in a specific
phenotype. Establishing the crucial link between genotype and phenotype remains
challenging despite great advances in omics technologies, such as liquid chromatog-
raphy (LC)-mass spectrometry (MS) that allow for the system-wide interrogation of
proteins.
Systems and network biology [Barabási and Oltvai, 2004, Bensimon et al., 2012,
Jørgensen and Locard-Paulet, 2012, Choudhary and Mann, 2010] aims to transform
modern biology by utilizing omics technologies to understand and uncover the var-
ious complex networks that govern the cell. The first detected large-scale biologi-
cal networks have been found to be highly structured and non-random [Albert and
Barabási, 2002]. Furthermore, these are assembled from functional and topological
modules. The smallest topological modules are formed by the direct physical interac-
tions within protein-protein and protein-RNA complexes. These molecular machines
are able to perform a diverse array of cellular functions, such as transcription and
degradation [Alberts, 1998]. Members of functional modules are not required to have a
direct physical interaction. Instead, such modules also include proteins with temporal
co-regulation throughout the cell cycle [Olsen et al., 2010], or following the circadian
day-night rhythm [Robles et al., 2014]. The signaling pathways that make up the cellu-
lar network [Jordan et al., 2000] are assembled from a hierarchy of these smaller mod-
ules [Barabási and Oltvai, 2004]. The regulation of these modules through dynamic
vi
rewiring enables the cell to respond to internal an external stimuli.
The main challenge in network biology is to develop techniques to probe the topol-
ogy of various biological networks, to identify topological and functional modules, and
to understand their assembly and dynamic rewiring. LC-MS has become a powerful ex-
perimental platform that addresses all these challenges directly [Bensimon et al., 2012],
and has long been used to study a wide range of biomolecules that participate in the
cellular network. The field of proteomics in particular, which is concerned with the
identification and characterization of the proteins in the cell, has been revolutionized
by recent technological advances in MS. Proteomics experiments are used not only to
quantify peptides and proteins, but also to uncover the edges of the cellular network,
by screening for physical PPIs in a global [Hein et al., 2015] or condition specific man-
ner [Kloet et al., 2016]. Crucial for the interpretation of the large-scale data generated by
MS experiments is the development of software tools that aid researchers in translating
raw measurements into biological insights. The MaxQuant and Perseus platforms were
designed for this exact purpose.
The aim of this thesis was to develop software tools for the analysis of MS-based
proteomics data with a focus on network biology and apply the developed tools to
study cellular signaling. The first step was the extension of the Perseus software with
network data structures and activities. The new network module allows for the side-
by-side analysis of matrices and networks inside an interactive workflow and is de-
scribed in article 1. We subsequently apply the newly developed software to study the
circadian phosphoproteome of cortical synapses (see article 2). In parallel we aimed
to improve the analysis of large datasets by adapting the previously Windows-only
MaxQuant software to the Linux operating system, which is more prevalent in high
performance computing environments (see article 3).
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Chapter 1
Introduction
1.1 Mass spectrometry-based proteomics
The shotgun (bottom-up) approach has been established as a generic and flexible work-
flow for MS-based proteomics. By measuring peptides instead of intact proteins, chal-
lenges in the analysis of intact proteins are circumvented [Zhang et al., 2013]. A typical
workflow begins by sample preparation, optional protein or peptide fractionation and
enrichment (see Figure 1.2), high performance liquid chromatography (HPLC), and MS
acquisition (see Figure 1.1). Finally, a computational analysis of the acquired data is re-
quired to identify and quantify the peptides, the proteins and their PTMs in the sample.
1.1.1 Sample preparation
The first step of the workflow is the extraction of protein material from the sample by
cell or tissue lysis, followed by the enzymatic digestion of the proteins into peptides
(see Figure 1.2). The most popular restriction enzyme is trypsin, which specifically
cleaves C-terminal after arginine and lysine. Tryptic peptides have a convenient length
distribution and favorable charge for MS. Historically, proteins where digested ’in-gel’
after separating them on a SDS polyacrylamide gel [Shevchenko et al., 1996]. More
recently, ’in-solution’ digestion became the method of choice, especially in combination
with HPLC [Wis´niewski et al., 2009, Kulak et al., 2014].
In order to reduce the sample complexity a number of different offline and online
fractionation techniques can be employed prior to MS analysis. One-dimensional poly-
acrylamide gel electrophoresis (1D-PAGE) can be used to separate peptides according
1
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ESI
HPLC
time mass spectrometer
Cycles of full MS followed
by fragment MS²
Full MS
MS² MS² ... MS²
Figure 1.1: Overview over a typical LC-MS workflow. The sample elutes from the
HPLC and is injected into the mass spectrometer after ESI. The machine follows a pre-
defined acquisition strategy along its duty cycle, which combines scanning the injected
ions and their fragment products by MS and MS2 scans. Adapted from [Hein et al.,
2013].
Figure 1.2: In the shotgun proteomics workflow proteins are extracted from the sample
of interest and digested into peptides prior to MS analysis. Adapted from [Hein et al.,
2013].
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to their mass, and is easily combined with ’in-gel’ digestion. Samples which are ’in-
solution’ are analyzed by HPLC. In HPLC systems the peptides differentially interact
with the stationary phase of strong cation exchange (SCX) or reversed-phase (RP) chro-
matography columns due to their different physiochemical properties [Wolters et al.,
2001]. RP chromatography is based on the hydrophobic interaction between the pep-
tide and the C18-silica of the column. By applying a pH gradient to the mobile phase
all peptides can be eluted from the column over the course of a MS run. Optimal chro-
matographic resolution can be obtained by increasing the length of the column and
reducing its diameter. However, these alterations lead to increased backpressure on the
HPLC system and reduced ionization efficiency [Jorgenson, 2010].
1.1.2 The mass spectrometer
The three central parts that make up the mass spectrometer and define its main char-
acteristics are the ion source, the mass analyzer, and the detector. An ion source is
required for the production of ionized particles which subsequently enter the high vac-
uum of the mass spectrometer. The soft-ionization technique ESI [Fenn et al., 1989]
enables the analysis of intact proteins and peptides from solution, which makes it at-
tractive for LC-MS analysis. Alternative approaches, such as matrix-assisted laser des-
orption/ionization (MALDI) [Karas and Hillenkamp, 1988] create ions by pulsing the
sample loaded onto a solid matrix with a laser.
The mass-to-charge ratio m/z of the injected ions is measured in the mass analyzer
(see Table 1.1). Beam-type analyzers include the quadrupole, in which the ions are
guided through two pairs of electrodes, and the time-of-flight (TOF) analyzer, where
the ions fly through a drift region that separates them according to their mass. Beam-
type analyzers are characterized by their simplicity and dynamic range while hav-
ing lower resolution and mass accuracy. Trapping mass analyzers include linear ion
traps, Fourier transform ion cyclotrons (FTICRs) and the Orbitrap. The transients of
ions oscillating inside the trapping analyzer are recorded and transformed into m/z val-
ues using Fourier analysis [Scigelova et al., 2011]. The Orbitrap has many favourable
characteristics for lower-mass peptide analytes, such as very high resolution and mass
accuracy [Zubarev and Makarov, 2013]. Many modern mass spectrometers, such as
the Q-Exactive HF [Scheltema et al., 2014] operate multiple mass analyzers in tandem.
Quadrupoles are used for the selection of ions within a specified m/z range and traps
4 CHAPTER 1. INTRODUCTION
Quadrupole TOF Ion trap FTICR Orbitrap
Resolution medium high medium very high very high
Accuracy low high low very high very high
Sensitivity very high medium very high medium very high
Dynamic range very high very high medium high high
Speed medium very high very high medium very high
Simplicity very high high very high low medium
Table 1.1: Characteristics of mass analyzers commonly used in MS
are often utilized for the accumulation of ions prior to mass analysis (see Figure 1.3).
Finally, the ions reach the detector which counts the number of ions observed at each
m/z value.
Mass spectrometers can be operated in a number of different acquisition modes
which determine the succession of full (MS1) and fragment (MS2) scans during a mea-
surement run (see Figure 1.1). In targeted mode, the mass spectrometer is configured to
target a predefined set of masses, aiming for the highest possible quantitative accuracy
and reproducibility [Marx, 2013]. In contrast, data-dependent acquisision (DDA) relies
on the observed peaks on the MS1-level to decide which ions will be subsequently iso-
lated, fragmented and sent for MS2 analysis. The goal of the MS2 analysis is to sequence
the peptide by measuring the fragment ion series. To this end, fragmentation energies
are optimized to induce a single peptide backbone breakage that gives rise to a set of
complementary fragment ions. Time constraints do not allow for the exhaustive se-
quencing of peptides. Instead, a common strategy is the selection of the n most intense
peaks for MS2 [Mann et al., 2001]. With advances in instrumentation and software,
data-independent acquisition (DIA) [Gillet et al., 2012] has emerged as an alternative
to DDA for proteomic analysis. After acquiring the MS1 scan, the entire mass range is
segmented into overlapping windows. Subsequently, each mass window is fragmented
and a fragment scan is obtained, regardless of the measured MS1 information.
1.1.3 Quantitative Proteomics
While historically the mass spectrometer was mainly used for protein identification, the
development of quantitative MS enabled a wide range of analytical techniques for MS-
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S-lens
Quadrupole
HCD
cell
Orbitrap
C-trap
Figure 1.3: Component layout of the Q Exactive HF mass spectrometer. Ions entering
the machine are focussed and filtered in the S-lens and the consecutive optics. The Q
Exactive HF then combines a quadrupole for ion selection, C-trap for ion accumulation,
HCD cell for fragmentation and Orbitrap for mass analysis.
based proteomics. MS is not inherently quantitative due to the effect that the different
physiochemical properties of the peptides have on their behavior in the mass spectrom-
eter. For example, differences in ionization efficiency are reflected in the measured in-
tensities, thus making direct comparisons difficult. Label-free approaches therefore rely
on computational schemes for accurate quantification of the observed intensities [Cox
et al., 2014]. By labeling peptides metabolically or chemically, the introduced mass shift
adds a directly measurable quantitative dimension to the experiment. Stable isotope
labeling by amino acids in cell culture (SILAC) [Ong et al., 2002, Blagoev et al., 2004]
exploits the incorporation of heavy or medium lysine and arginine into the proteome.
The digested tryptic peptides will contain at least one labeled amino acid and are there-
fore distinguishable from their unlabeled counterparts. In MS analysis, SILAC triplets
can be detected and their intensities compared. Alternatively, isobaric chemical label-
ing reagents such as tandem mass tag (TMT) [Thompson et al., 2003]. The isobaric
label is constructed of up to 11 reporters with distinct mass and a corresponding bal-
ancer [Werner et al., 2014]. While isobarically labeled peptides are indistinguishable
on the MS1 level, on the MS2 level a reporter ion fragment can be observed for each
channel.
6 CHAPTER 1. INTRODUCTION
SILAC labeling provides the highest quantification accuracy but is limited in the
number of channels. With up to 11 channels, TMT has increased multiplexing ca-
pabilities but an accurate MS2 quantification without ratio compression introduced
by co-eluting peptides requires specialized mass spectrometers [Savitski et al., 2013].
Compared to the label-free approach, TMT showed higher precision and fewer missing
values [O’Connell et al., 2018], however, only the label-free approach can scale to an
arbitrary number of samples
1.2 Computational mass spectrometry
In the following review a broad introduction to the computational aspects of MS-based
proteomics is presented. It covers the identification and quantification of peptides, pro-
teins and PTMs, as well the statistical downstream data analysis of quantitative pro-
teomics data. The main problems arising at each step of the analysis are discussed con-
ceptually and instead of presenting all methods developed by the community, MaxQuant [Cox
and Mann, 2008] and Perseus [Tyanova et al., 2016] often serve as examples on how
these problems could be addressed. The manuscript was written with Jürgen Cox and
Pavel Sinitcyn. Furthermore, I contributed figures and to the writing of the peptide
identification and the statistical downstream analysis sections.
Pavel Sinitcyn, Jan Daniel Rudolph, and Jürgen Cox. Computational Methods for Un-
derstanding Mass Spectrometry–Based Shotgun Proteomics Data. Annual Review of
Biomedical Data Science, 1(1):annurev–biodatasci–080917–013516, July 2018a. ISSN 2574-
3414. doi: 10.1146/annurev-biodatasci-080917-013516
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Abstract
Computational proteomics is the data science concerned with the identi-
fication and quantification of proteins from high-throughput data and the
biological interpretation of their concentration changes, posttranslational
modifications, interactions, and subcellular localizations. Today, these data
most often originate frommass spectrometry–based shotgun proteomics ex-
periments. In this review, we survey computational methods for the analysis
of such proteomics data, focusing on the explanation of the key concepts.
Starting with mass spectrometric feature detection, we then cover methods
for the identification of peptides. Subsequently, protein inference and the
control of false discovery rates are highly important topics covered.We then
discuss methods for the quantification of peptides and proteins. A section
on downstream data analysis covers exploratory statistics, network analy-
sis, machine learning, and multiomics data integration. Finally, we discuss
current developments and provide an outlook on what the near future of
computational proteomics might bear.
207
A
nn
u.
 R
ev
. B
io
m
ed
. D
at
a 
Sc
i. 
20
18
.1
:2
07
-2
34
. D
ow
nl
oa
de
d 
fro
m
 w
w
w
.a
nn
ua
lre
vi
ew
s.o
rg
 
A
cc
es
s p
ro
vi
de
d 
by
 W
IB
64
17
 - 
M
ax
-P
la
nc
k-
G
es
el
lsc
ha
ft 
on
 1
1/
07
/1
8.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
8 CHAPTER 1. INTRODUCTION
BD01CH10_Cox ARI 25 May 2018 9:23
INTRODUCTION
Proteins perform nearly all the work in a cell and are the key players in the structure, function, and
regulation of cells, tissues, and organs. Collectively they form the proteome (1), a highly dynamic
and diverse molecular omics space comprising interactions among proteins and other types of
biomolecules. The proteome can be studied comprehensively with mass spectrometry (MS)-based
technologies (2–4). Thousands of proteins and posttranslational modifications (PTMs) can be
studied quantitatively over a multitude of samples in complex experimental designs. Describing
all applications of proteomics is beyond the scope of this review, but among its applications are
diverse topics such as cancer immunotherapy (5) and the evolution of extinct species (6).
Computational MS-based proteomics can be roughly subdivided into two main areas: (a) the
identification and quantification of peptides, proteins, and PTMs and (b) downstream analysis,
aiming at the biological interpretation of the quantitative results obtained in area a. This review fol-
lows this subdivision. Computational proteomics is a highly multidisciplinary endeavor attracting
scientists frommany fields and incorporates other disciplines like statistics, machine learning, effi-
cient scientific programming, and network and time series analysis. Furthermore, the integration
of proteomics data with other biological high-throughput data is increasingly gaining importance.
Peptide-based shotgun proteomics, also called bottom-up proteomics (7), needs to be dis-
tinguished from top-down proteomics (8–10), in which whole proteins are studied in the mass
spectrometer. Data analysis tools and approaches exist for top-down methods (11–13) in which
feature deconvolution plays an important part. In targeted proteomics (14–17) (Figure 1), a set
of key peptides from a target list, which is informative for a set of proteins or PTMs of interest,
is quantitatively monitored over many samples using dedicated software (18). Data-independent
acquisition (19), as exemplified by the SWATH-MS method, comes with its own computational
challenges for which solutions are provided in the literature (20–23). Imaging MS (24) is also a
400 800 1,200 1,600
m/z m/z m/z
0
40
80
120
Re
te
nt
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n 
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e 
(m
in
)
a  Data-dependent acquisition
400 800 1,200 1,600
c  Targeted
400 800 1,200 1,600
b  Data-independent acquisition
Figure 1
Main formats of mass spectrometry (MS)-based proteomics. Peptide-based bottom-up proteomics is most often done in the
data-dependent acquisition mode (a). MS2 (second-stage MS) scans are triggered depending on the MS1 (first-stage MS) data features
seen in real time. Typically, at a given retention time, the n most intense peptide features are selected for fragmentation, dynamically
excluding masses that have just been previously selected. In data-independent acquisition (b), a set of constant mass ranges, which do
not depend on the peptides being analyzed, is isolated for fragmentation. In targeted proteomics (c), a list of peptides is targeted based
on a list of mass and retention time ranges corresponding to peptides of interest, which are particularly informative of a set of proteins
or posttranslational modifications that are the focus of the investigation.
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Figure 2
Bottom-up shotgun proteomics workflow. () Proteins are extracted from a sample of interest. Enrichment of organelles or affinity
purification may be performed. Proteins are digested to peptides that are optionally enriched for modifications. () After HPLC
separation, peptides are ionized (181, 182) and () injected into a high-resolution mass spectrometer (e.g., 183, 184). MS1 spectra
containing peptide isotope patterns are recorded in a cycle with a timescale of about one second. () Peptide precursors are selected for
fragmentation and fragment (MS2) spectra are recorded. () BothMS1 andMS2 spectra are written to disk, typically resulting in several
gigabytes of data per LC-MS run, and then analyzed by computational proteomics software. Abbreviations: HPLC, high-performance
liquid chromatography; LC, liquid chromatography; MS, mass spectrometry; MS1, first-stage MS; MS2, second-stage MS.
fruitful area of research that will not be covered here. This review focuses on data-dependent
bottom-up or shotgun proteomics (Figure 2), which currently is the format most frequently used
in proteomics.
It is not the aim of this review to present an exhaustive list of all available software tools. Instead,
we focus on explaining concepts and key applications. In several places, we use theMaxQuant (25–
27) and Perseus (28) software as concrete examples for the implementation of certain concepts.
Alternative software platforms developed in academia (29–31) or offered by mass spectrometer
vendors can provide similar functionality.Wepropose that robustness, ease of use, parallelizability,
www.annualreviews.org • Computational Methods for Understanding Proteomics Data 209
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and automation of all computational aspects are the key factors to consider in the selection of
software tools.
Proteomics research is supported by community tools such as repositories, databases, and an-
notation sources (32). There are public repositories for the storage and dissemination ofMS-based
proteomics data (33–39), and submission of raw data is highly recommended for every proteomics
publication (34). Protein and peptide sequences are essential for the interpretation of proteomics
data. For this purpose, UniProt (universal protein resource) (40) is a comprehensive, high qual-
ity, and freely accessible resource of protein sequences and functional information. Since most
amino acid sequence identifications can be put into the context of coding nucleic acid sequences—
exceptions prove the rule (41)—genome-centric sequence repositories like Ensembl (42) are of
high importance as well. Data sharing and dissemination of publicly available proteomics data are
facilitated by dedicated software tools for the reanalysis of community data (43, 44).
This review consists of two main parts, the first dealing with the data analysis steps performed
on the spectral data itself, going up to the identification and quantification of peptides, proteins,
and PTMs. This part is organized in a problem-centric way, where in each subsection, a particular
challenge in theMSworkflow is described. The second part is about the downstream data analysis.
Here, the sections are organized by methodologies rather than application areas, which is a more
approachable organization scheme, since the number of different applications is enormous, while
the methodologies overlap. The downstream analysis of proteomics data is still an art, and there is
not always only one correct way to arrive at biologically meaningful conclusions. Hence, we give
a comprehensive overview of the available methods that can be used along the way.
IDENTIFICATION AND QUANTIFICATION OF PEPTIDES, PROTEINS,
AND POSTTRANSLATIONAL MODIFICATIONS
Liquid Chromatography-Mass Spectrometry Features
Since the early days of MS, the detection of peaks in a mass spectrum, corresponding to molecular
features, played a central role (45). Nowadays, the mass resolution is sufficiently high in general
that the isotope pattern of peptides is resolvable (Figure 3a). On the molecular level, a single
peak corresponds to an isotopic species with fixed elemental composition and several nucleons.
In case of ultrahigh mass resolution, the isotopic fine structure of peptides in the low-mass range
can be resolved (46) (Figure 3a), resulting in increased information about the atomic constituents
of the peptide. While obtaining isotopic resolution is standard nowadays for peptides, the same
is still technically challenging for whole proteins in top-down proteomics. For instance, for each
charge state of an antibody, usually only an envelope is detected, while the isotopic peaks remain
unresolved.
In proteomics, the mass spectrometer is typically coupled on-line to additional continuous
separation dimensions like liquid chromatography (LC) (47) or ion mobility separation (48). MS
features can therefore be viewed as higher-dimensional objects. In case of LC-MS, peaks become
three-dimensional (3D) objects in the m/z–retention time–intensity space (Figure 3b). Using
ion mobility adds another dimension, turning features into 4D objects. Technically, due to its
dimensionality, the problem of MS feature detection is equivalent to general-purpose 2D image
feature detection or voxel assembly to 3D volume elements (49), respectively. However, since MS
data often have additional regularities that can be exploited, the problem is often simpler than
generic object recognition. Simplifying assumptions specific to mass spectrometer types should be
exploited to apply faster algorithms to the multidimensional feature detection problem. (Readers
are referred to the supplement of Reference 25.)
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Figure 3
MS1 feature–based computational tasks in a proteomics workflow. (a) Theoretical spectrum of an MS1 feature measured in three
different resolutions. The lowest resolution (1,000 FWHM) does not resolve the isotope pattern. The ultrahigh resolution (1,000,000)
reveals the natural isotopic fine structure. (b) A three-dimensional isotope pattern in m/z–retention time–intensity space. (c) Peptide
mass errors as a function of retention time and peptide m/z before and after nonlinear recalibration. Clearly, nonlinear systematic
errors were present and were then removed by recalibration. (d) Mass error distribution before and after recalibration. A large increase
in mass accuracy was achieved through nonlinear recalibration. (e) Retention time alignment curve between two LC-MS runs.
( f ) Matching between runs. Peptide identities are transferred between LC-MS runs fromMS2-identified MS1 features to nonidentified
MS1 features in other similar LC-MS runs based on accurate mass and retention time. Abbreviations: FWHM, full width at half
maximum; LC, liquid chromatography; MS, mass spectrometry; MS1, first-stage MS; MS2, second-stage MS; ppm, parts per million.
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Once features corresponding to isotopic peaks are detected, they are assembled to isotope
patterns, effectively deisotoping the spectrum. Different models exist (50–52), one of them being
the Averaginemodel (50), which can be used to explore spectral properties, since nearly all peptides
with a given approximate molecular mass have a similar elemental composition. In the model, it is
assumed that a peptide is made up of the average number of the 20 amino acids according to their
natural occurrence. The model then predicts the mass differences between isotopic peaks in an
isotope pattern, as well as their relative heights. This approach is usually sufficient when dealing
with data with unresolved isotopic fine structure. When the isotopic fine structure is resolved,
one will have to employ the true atomic compositions of the peptide candidates to utilize this
information. In the approaches using higher-dimensional features, the exact coelution of isotopic
peaks can also be utilized to increase the specificity of assignment of isotope patterns. While in
most cases, the spectral information is not sufficient to determine the elemental composition,
one will obtain the charge state and a highly precise estimate of the monoisotopic mass from the
information contained in the higher-dimensional features.
One can find labeling n-plexes of isotope patterns in the MS1 (first-stage MS) data prior to
peptide identification, similar to how features are assembled to isotope patterns. This applies
to nonradioactive differential isotopic sample labeling techniques (53, 54) like SILAC (stable
isotope labeling by amino acids in cell culture) (55) or dimethyl labeling (56, 57). Analogous to the
deisotoping step, specific mass differences between the isotope patterns participating in a labeling
n-plex are expected. This is not the case for 15N labeling (58, 59) in which all nitrogen atoms are
completely exchanged with the stable heavy isotope. Isotope patterns belonging to an n-plex are
usually coeluting, depending on the type of labeling, which can be exploited in the assembly of
n-plexes.
While mass measurements from modern high-resolution mass spectrometers, in combination
with the aforementioned higher-dimensional feature detection, can achieve very-high-mass pre-
cision, this does not automatically translate into high-mass accuracies, due to the presence of
systematic measurement errors. In Figure 3c, the peptide mass error prior to mass recalibration is
displayed as functions of m/z and of retention time. Systematic errors are typically nonlinear and
depend on multiple variables. In addition tom/z and retention time, the mass error can depend on
signal intensity and ion mobility index, if applicable. Nonlinear recalibration on multidimensional
parameters is difficult when it must rely on only a few calibration points, as is usually the case
if dedicated spike-in molecules are used. Hence, it is typically better in complex samples to use
the peptides from the sample itself as calibration points for multivariate recalibration, which is
achieved in MaxQuant by a two-level peptide identification strategy (25, 60, 61). The mass ac-
curacy increases by large factors resulting from the applications of these nonlinear recalibration
curves obtained in this way (Figure 3d).
Similar to the mass accuracy, the consistency of the retention times of peptide features can
also be increased by recalibration. Due to often unavoidable irreproducibility in chromatography,
retention times are usually not comparable between LC-MS runs, thereby limiting identification-
transfer and quantification between runs. Nonlinear shifts by several minutes are common.
Hence, algorithmic approaches were developed to align retention times between multiple runs
(Figure 3e). Typically, these retention time corrections need to be nonlinear (62). In MaxQuant,
this is achieved with a sample similarity–derived guide tree, which avoids the need for singling out
one LC-MS run as the master run (63) that all the other runs are aligned to. Ion mobilities can
be aligned between LC-MS runs with similar methods as retention times.
Once masses, retention times, and ion mobilities are recalibrated, one can transfer iden-
tifications between related LC-MS runs from peptide features identified by fragmentation to
unidentified peptide features by having same mass, charge, retention time, and ion mobility (64)
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(Figure 3f ). Following this strategy, the quantification profiles across many samples becomemore
complete, which partially removes the stochastic behavior of the data-dependent acquisition in
bottom-up proteomics. Determining and controlling false discovery rates (FDRs) for these kind
of matching approaches is challenging and the subject of current research. However, if samples
are similar, error rates caused by matching are in acceptably low ranges.
Peptide Identification
Peptide identification tools analyze the fragmentation spectra obtained by the mass spectrometer
with the aim of determining the sequence of the peptide. In the most popular approach, database
search engines (65–69) utilize a target database of theoretical fragmentation for identification
(Figure 4a). The database is generated from all protein sequences that are known or thought to
be produced according to the instructions in the genome of an organism. The protein sequences
are digested in silico into peptides according to a cleavage rule mirroring the protease used in the
experiment (e.g., trypsin, which cleaves after the occurrence of lysine or arginine in the protein
sequence). For each of these in silico peptides, the list of expected fragment masses is calculated
based on the backbone bond breakages expected for the fragmentation technique used in the exper-
iment. For a given measured fragmentation spectrum, the search engine calculates a match score
against all theoretical fragmentation spectrawithin a specifiedpeptidemass tolerance.Thehighest-
scoring peptide spectrum match (PSM) is taken as a candidate for the identity of the peptide.
Since the highest-scoring PSMmight still be a false positive, most workflows control the FDR us-
ing a target–decoy approach (70) (Figure 4b). In this approach, fragmentation spectra are searched
not only against the target database, but also against a decoy database, which is designed to produce
false-positive PSMs. Comparing the score distributions of target and decoy PSMs, posterior error
probabilities can be calculated and FDRs can be controlled. One procedure to generate decoy
sequences is to reverse the target sequences, providing peptides that do not occur in nature.
Additional peptide features besides the search engine score, such as the length of the peptide and
the number of missed cleavages, help distinguish true identifications from false positives, leading
to more high-confidence identifications. In MaxQuant, the posterior error probability, which is
the probability of a PSM being wrongly identified, is conditional on the score and additional
peptide properties (25). Other tools such as PeptideProphet (71, 72) and Percolator (73) use linear
discriminant analysis or support vectormachines (SVMs) with the same aim.Machine learningwas
used to predict intensity patterns in fragmentation spectra in order to support database scoring
and further improve identification (74), but it failed to improve upon the state of the art. In
contrast, the application of deep learning to de novo peptide identification did yield improvements
(75).
De novo peptide sequencing (Figure 4a) is another technique for identifying peptides from
fragmentation spectra. The peptide is identified using only information from the input spectrum
and the characteristics of the fragmentation method. Mass differences between certain peak pairs
correspond to amino acid masses, which are interpreted as consecutive ions in one of the expected
fragment series, for example, y or b ions for collision-induced dissociation. If thesemass differences
can be continued to awhole series fromN- toC-termini, the peptide is identifiedwithout reference
to a sequence database. An incomplete de novo amino acid series is called a sequence tag andmight
be completed on either of the termini with a sum of amino acid masses and PTMs. The many
existing tools for de novo peptide identification explore different algorithmic approaches, some
allowing for de novo sequencing errors and homology searches (76–79). An interesting approach
is a hybrid between database search and de novo sequencing (80); it requires only a little de novo
information and hence inherits high sensitivity from the database search approach.
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Figure 4 (Figure appears on preceding page)
Overview of peptide identification methods. (a) In the peptide database (DB) search engine approach, measured second-stage mass
spectrometry (MS2) spectra are scored against a list of theoretical spectra from an in silico digest of protein sequences. De novo peptide
identification allows reading the peptide sequence partially or completely out of the MS2 spectrum. (b) In the target–decoy approach,
true and decoy protein sequences are offered to estimate the false discovery rate (FDR). (c) Determining the localization probability for
a posttranslational modification on a peptide. (d ) Open search and dependent peptide search are methods for detecting modifications in
an unbiased way. Modifications still must be localized after open search. (e) Modifications found in a typical dependent peptide search.
Data from Reference 185 were used.
For a peptide that has been identified as having a certain sequence and carrying one or more
modifications, the positions of these modifications on the sequence might not be localizable
with complete certainty. Hence, a score needs to be calculated that quantifies for each poten-
tially modifiable amino acid in the peptide sequence the certainty of localization at a given locus
(Figure 4c). For instance, a peptide might contain several potentially phosphorylated serine, thre-
onine, and tyrosine residues, but from the peptide mass it is known that it is phosphorylated
only once. Then one needs to determine which of the sites are phosphorylated and use the spec-
tral evidence to derive each site’s probability that it is the one bearing the modification (81–85).
The most important spectral features for the calculation of localization probabilities are the site-
determining ions, which are fragments that are matched with one hypothetical localization but not
with the other. The exact way the localization score is calculated varies between different meth-
ods. In MaxQuant, the localization probability is calculated as a weighted average of exponential
Andromeda scores over all combinations of phosphorylation configurations (86).
The identification of modified amino acids, either as PTMs such as phosphorylation or as
modifications introduced during sample preparation, is usually done by adding these as variable
modifications into the database search.While this strategy is highly sensitive, allmodifications have
to be specified beforehand. The number of modifications that can be specified is limited due to the
combinatorial explosion of modified peptides species, leading to a large increase in database size.
There are two approaches overcoming these limitations: open search (87) and dependent peptide
search (88) (Figure 4d ). The open search approach does not extend the sequence database but
instead widens the precursor mass tolerance window for the MS1 precursor peptide molecule
to, for example, ±500 Da, while keeping the fragment mass tolerance low (87). Therefore, a
modified peptide with a mass within the tolerance window can still be matched to the correct
unmodified database sequence despite ∼50% of fragment ions being shifted by the modification.
The high number of candidate matches makes the open search computationally demanding, but
recent approachesmake use of fragment ion indexing to speed up the search significantly (89). The
dependent peptide search, also implemented inMaxQuant, is a generic approach to retrospectively
identify unassigned MS2 (second-stage MS) scans; it relies on the assumption that the sample
contains not only themodified dependent peptide, but also its unmodified base peptide counterpart
(88). Using any search algorithm will yield identifications, as well as unassigned MS2 spectra.
The search now queries all unassigned spectra against all identified spectra, while simultaneously
localizing the modification. The mass difference between the peptides is the putative mass of the
modification, which is used to generate a shifted ion series for each position in the peptide. The
highest-scoringmatchwill therefore determine the sequence of the peptide, as well as themass and
locus of the modification. Figure 4e shows the most frequent modifications found by dependent
peptide search in a typical data set.
There are a number of special topics in peptide identification, starting with dipeptides resulting
from cross-linked proteins (90, 91), which have the challenge of a vastly increased search space
due to pairing of peptides, for which several popular software packages are available (92–97).
In proteogenomics searches (98), peptides are identified based on customized protein sequence
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databases generated from genomic or transcriptomic information. Search spaces for proteoge-
nomics searches are typically larger than in conventional searches since they often involve three- or
six-frame translations of genomic sequences. Furthermore, these search spaces are heterogeneous,
since the sequence content ranges from clearly existing, manually validated protein sequences to
in silico–translated genomic regions without any prior evidence for their expression. Hence, extra
measures need to be taken in the identification process to account for this heterogeneity. Pro-
teomics of species without sequenced genome requires tools to integrate incomplete sequencing
data with homologous sequence data from closely related species (99).
Protein Inference and False Discovery Rate
Protein inference, that is, the assembly of peptides into a list of proteins, is a crucial step in a
computational proteomics workflow, since usually the peptides are only technical aids to study
proteins. (Readers are referred to Reference 100 for a review.) The relationship between peptides
and proteins is many-to-many, since upon digestion a protein gives rise to many peptides, but
a peptide can also originate from more than one protein. Furthermore, based on the identified
peptides, proteins that share common sequences might not be distinguishable from each other.
Hence, a redundancy grouping of protein sequences is necessary.
Peptides that are unique to a protein are more desirable than nonunique ones. On average,
longer peptides are more likely to be unique, and hence, more informative. As an order of mag-
nitude estimate, we calculate how often a random peptide of a given length would occur in the
human proteome, assuming it is randomly composed out of the 20 amino acids and has the same
size as the latest human UniProt release 2017_09, which contains 93,588 protein sequences com-
prising 37,118,756 amino acids in total. Peptides of length 5 should occur on average 12 times
in the proteome, meaning that their information content is nearly worthless. Peptides of length
6 should occur on average 0.6 times, making them only just potentially useful, but many of them
can still be expected to be nonunique. In this model, only peptides of length 7 or longer are on
average expected to be informative and useful. Although other factors like tryptic peptides and
paralog relationships between genes realistically should be considered, the conclusions hold true
of real data.
Many tools and algorithms for the protein assembly have been described in the literature. The
most frequently applied ones can be roughly subdivided into parsimonious and statistical models.
Parsimonious models (25, 101–104) apply Occam’s razor principle (105) to the protein inference
problem by finding a set of proteins that is as small as possible to explain the observed peptides.
Usually, fast greedy heuristics are used to find such a protein set. Statistical models (106, 107)
can assemble large amounts of weak peptide identifications to infer the existence of a protein.
However, for both types of models, it is worth considering a threshold on peptide identification
quality, for example, 1% FDR for PSMs. High-quality peptide identifications allow for solid
conclusions about the properties of the identified proteins, while weakly identified peptides can
compromise protein quantification accuracy. Ideally, the output of the protein inference step is a
list of protein groups. Each protein group contains a set of proteins that cannot be distinguished
from each other based on the observed peptides. Either the proteins in a protein group have equal
sets of identified peptides or the peptide set of one protein is a proper subset of that of another
protein, in which case, based on the peptide identifications, there is no evidence for the existence
of the latter protein, assuming that the former protein is in the sample.
The phenomenon of error expansion from peptide to protein identification in large data sets is
well known in the field (106, 108). Even if the FDR is thoroughly controlled at the PSM level, if
no additional measures are taken, the FDR on protein level can become arbitrarily large. Hence, it
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is highly important to use workflows that control FDR on the protein level (25, 106, 108, 109) to
limit the number of proteins falsely claimed to be present in the sample, particularly if the number
of identified proteins is a relevant outcome of the study.
Quantification
Proteomics becomes more powerful when done quantitatively, as compared to only browsing
through lists of identified proteins. Many responses to stimuli on the level of proteins are not
switching the expression of a protein on and off completely, but manifest themselves as changes in
cellular concentrations that might be small, yet important. Quantitative proteomics approaches
can be subdivided into absolute and relative quantification methods. In absolute quantification,
one wants to determine copy numbers or concentrations of proteins within a sample, while in
relative quantification, a quantitative ratio or relative change of protein concentrations between
samples is desired. Both absolute and relative quantification can be done either with the aid of
labels or label-free.
Figure 5 shows an overview of relative quantification methods. In label-free quantification,
the samples being compared are biochemically processed separately. The distinction between
metabolic and chemical labeling is not important from a computational perspective. Instead, the
main distinction is between MS1-level labeling, in which the peptide signals corresponding to
the multiple samples are compared and form multiplexed isotope patterns in the MS1 spectra,
and MS2-level or isobaric labeling, in which the multiplexed signals appear in the fragmentation
spectra.Hence, computationalmethods for relative quantification shouldbedistinguishedbetween
label-free, MS1-level labeling, and MS2-level labeling.
In label-free quantification, one faces particular challenges with normalization intensities be-
tween LC-MS runs and the compatibility of quantification with prefractionation. In MaxQuant,
the MaxLFQ algorithm (110) is implemented for relative label-free quantification. It uses signal
intensities of MS1 peptide features as input, optionally including the ones identified by matching
between runs, and produces as output relative protein abundance profiles over multiple samples.
MaxLFQ accounts for any peptide or protein prefractionation of the samples by applying a sophis-
ticated intensity normalization procedure to the feature intensities of each LC-MS run. A protein
intensity profile is constructed that best fits protein ratios determined in all pairwise comparisons
between samples. In each of these pairwise comparisons, only peptides that occur in both samples
are used, which makes the relative comparison very precise. Hence, MaxLFQ is more accurate
thanmerely summing up all peptide intensities belonging to a protein. By using a sample-similarity
network for the intensity normalization step, the algorithm scales well to large data sets and can
quantify hundreds of samples against each other.
Stable isotope labeling with sample multiplexing appearing on the level of MS1 spectra (55–
57, 111, 112) promises to be more accurate than label-free quantification since the coelution of
features in the same LC-MS run can be exploited. The ratio calculation can be performed along
the elution profile separately in each MS1 scan and separately for each isotopic peak. This results
in many estimates of the ratio, which can be summarized by taking the median. This robust ratio
estimate is less sensitive to contamination by other coeluting peptides. In this way, the ratios
between MS1-label channels are calculated in a more precise way, as compared to the label-free
approach, where feature intensities are calculated separately before their ratio is taken. During
MS1-label n-plex assembly, the isotope patterns of parts of the n-plex might be missing, leading
to an incomplete quantitative profile. Proper MS1 isotope patterns might be missing for peptides
arising from low-abundant proteins. In MaxQuant, the requantification algorithm tries to find
traces of these isotope patterns close to the noise level.
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Figure 5
Overview of relative quantification methods. Relative quantification of samples (colored squares) can be done in a label-free, metabolic, or
chemical labeling approach. For computational approaches, the distinction between MS1 labeling (b) and MS2 (isobaric) labeling (c) is
more crucial. In the label-free approach (a), the quantification is done for each peptide feature between extracted ion chromatograms in
different LC-MS runs. In MS1 label–based quantification (e.g., SILAC, dimethyl, NeuCode), multiple samples will appear as
differentially labeled isotope patterns in the MS1 spectra. For isobaric labeling (e.g., iTRAQ, TMT), the quantification signals appear
as reporter ions in the low-mass range of the MS2 spectra. Abbreviations: CTAP, cell type–specific labeling using amino acid
precursors; ICAT, isotope-coded affinity tags; iTRAQ, isobaric tags for relative and absolute quantification; LC, liquid
chromatography; MS, mass spectrometry, MS1, first-stage MS; MS2, second-stage MS; SILAC, stable isotope labeling with amino
acids in cell culture; TMT, tandem mass tags.
One can use one labeling channel as a common standard, as is done in Super-SILAC (113),
which allows quantifying unlabeled samples with the added accuracy of labeling by using ratios of
ratios to compare samples with each other. Computationally, these hybrid samples are analyzed
like MS1-labeled samples in the feature detection, but the downstream analysis proceeds nearly
as if they were label-free samples.
In isobaric labeling (114–116), peptides in different samples are labeledwith differentmolecules
per sample that have the same mass but that eject different reporter ions upon fragmentation. The
biggest advantage of isobaric labeling is its multiplexing capacity. Up to 11 samples can be mea-
sured simultaneously with the currently available tandem mass tag reagents. The downside is
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that the presence of coeluting peptides in the isolation window for fragmentation leads to ratio
compression (117). To be precise, cofragmentation makes ratios wrong in arbitrary and individual
ways. However, since it is often a valid assumption that most of the proteins are not changing
between samples, the cofragmented peptides are likely to have 1:1 ratios, thus compressing the
ratios of changing proteins. There are several experimental strategies to reduce or remove the
cofragmentation problem, such as gas-phase purification (118), MultiNotch MS3 (119), and use
of complementary ions (120). There are several computational methods that reduce ratio com-
pression. Reporter ions of low intensity are prone to carry more noise and be more affected by
cofragmentation signals. Hence, peptides with higher reporter ion intensities should be given
higher weights when calculating protein intensities. Another approach is to calculate the fraction
of precursor signal divided by the total MS1 signal observed in the isolation window (121, 122),
which can be used for filtering peptides used for quantification. To some extent, this quantity can
also be used to correct for ratio compression (123).
Approximate measures of absolute protein abundances can be obtained with simple computa-
tional prescriptions like the iBAQ or Top3 methods (124, 125). The problem that peptides of a
protein have vastly different flyability (a term used to cover the relative efficiencies of ionization,
transfer, and detection), making them not directly comparable for quantification, is solved by av-
eraging over many peptides or selecting the most intense ones, which enriches for high flyability.
For eukaryotic cells, one can add an absolute scale to these readouts with the proteomic ruler
approach (126), which uses the signal of histones, assuming that it is proportional to the amount
of DNA in the sample.
The quantification of peptides and PTMs differs from protein quantification in that only
a single or few features can be used for quantification, while on the protein level, accuracy is
achieved by accumulating quantitative information over many peptides. Hence, the variability of
PTM quantification data and the number of missing values is usually higher than it is for proteins.
For combined PTM-enriched and proteome data, computational methods exist for calculating
occupancies (86, 127), which are the percentages of proteins modified at a given PTM site.
DOWNSTREAM DATA ANALYSIS
Exploratory Statistics
Once proteins have been identified and quantified over many samples, one obtains a matrix with
proteins (or protein groups) as rows, samples as columns, and protein abundances or abundance
ratios in the matrix cells. Usually, the interpretation of this quantitative protein or PTM data
and the translation into significant biological or biomedical findings are the most important and
labor-intensive parts of a study. The Perseus platform (28) was developed to support the domain
expert in this data exploration. It is workflow based, modular, and extensible through a plugin
infrastructure.
There are some preparatory steps preceding most analyses, such as normalization of intensities
or ratios, data filtering, and potentially missing-value imputation (Figure 6a). A common task in
discovery proteomics is to identify proteins of biological interest and distinguish them from the
rest of the proteome. Statistical models are popular tools for identifying differentially expressed
proteins. Clustering methods, such as hierarchical clustering, are often used for finding expression
patterns of groups of proteins and for their visualization in a heat map. Principal component
analysis (PCA) is an alternativemethodof visualizing themain effects in the data and the relatedness
between samples. It also provides information on proteins responsible for a separation of sample
groups through the so-called loadings.
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The statistical tests t-test and ANOVA (analysis of variance, which is the generalization of the
t-test to more than two groups) are the basic versions of a series of statistical models that test for
significant changes between sample groups (128, 129). In more complex experimental designs,
one might want to test for the effects of two factors simultaneously (e.g., gender and treatment),
in which case two-way ANOVA can be used. ANOVA can be generalized to any number n of
factors, resulting in n-way ANOVA. After retrieving a list of significant proteins from ANOVA,
a post hoc test can be applied to pinpoint the sample groups within the experimental design
that were changing. If samples are related and independency assumptions are violated, so-called
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Figure 6 (Figure appears on preceding page)
Downstream analysis overview. (a) Putative workflow for downstream proteomics analysis. After data upload (Step 1) and preprocessing
(Step 2), common analyses include differential expression (Step 3A), principal component analysis (Step 3B), hierarchical clustering (Step
4A), annotation enrichment (Step 4B) and time series analysis (Step 4C). Data preprocessing (Step 2) may involve several steps including
data normalization and visual inspection of distributions of protein quantification values in histograms. Differential expression analysis
(Step 3A) reveals those proteins that are significantly changing their concentrations between two or more conditions. Principal
component analysis (Step 3B) highlights main trends in the data such as a separation between cellular conditions, as shown in the
example. Hierarchical clustering (Step 4A) is often done in conjunction with heat map visualization of expression changes and reveals
characteristic patterns relating groups of samples to clusters of proteins. Results are often validated using annotation enrichment
analysis (Step 4B). Time series analysis (Step 4C) can distinguish between characteristic temporal patterns such as phases of peaking
protein concentrations in a periodic process, as shown in the example. Adapted from Reference 28. (b) Support vector machines are a
powerful machine learning tool for classification. From training data they learn decision rules that can distinguish between classes of
samples based on their protein expression profiles. The decision rule is indicated here by a separating line between the two classes.
Support vectors are those samples that contribute most to defining the separating line. Adapted from Reference 28. (c) Applications for
machine learning in proteomics include finding predictive protein signatures and predicting the subcellular localization of proteins.
The colored clusters represent proteins that are localized in same organelles. Data from Reference 147 were used.
repeated measures ANOVA is a valid method of data analysis. For all of the methods above,
it is crucial to control false positives due to multiple hypothesis testing, since many tests are
done simultaneously. If only a moderate p-value cutoff is applied to define significant proteins,
the number of false positives will be inflated (130). Benjamini-Hochberg FDR control (131) or
permutation-based FDR estimates (132) are efficient methods to deal with this problem.
When an interesting group of proteins has been identified, for instance, by statistical testing,
clustering, or PCA, enrichment analysis can be performed to find biological processes, complexes,
or pathways common to these proteins. Fisher’s exact test checks for contingency between group
membership and the property of interest. It clarifies what is common to the cluster-member pro-
teins andmight indicate the functional role of the cluster. For this purpose, annotation sources like
gene ontology (133), pathway memberships (134), or curated protein complexes (135) are needed.
Biological processes under study often exhibit temporal changes, with proteins following an
expected pattern, for instance, as periodic changes in the cell cycle or circadian rhythm. Other
studies involve measuring a response to dose changes of stimuli. In these situations, methods can
be applied that detect concentration changes following a given model, such as periodic changes
with a given periodicity. For this case of periodic temporal changes, the analysis will assign an
amplitude of change and a peaking time to each protein (136).
Posttranslational Modifications
Quantitative PTM data can be represented as a matrix resembling proteome-expression data,
but with modified peptides or modification sites on the identified proteins as rows. Therefore,
PTM studies can be analyzed with methods similar to those used for protein expression. For
instance, after suitable normalization and filtering, hierarchical clustering or PCA can be applied to
determine dominant patterns of phosphorylation changes (86). As previously discussed, one needs
to be aware of the higher variance of PTM-level data compared to protein-level data. This requires
a higher number of replicates compared to protein-level data to achieve the same statistical power.
There are several public resources for obtaining PTM specific annotations. UniProt (40) pro-
vides comprehensive information on local protein properties at the PTM site or in its vicinity.
Specialized databases, such as PhosphoSitePlus (137), Signor (138), and Phospho.ELM (139),
cover mostly phosphorylation events. They include functional annotations, as well as kinase–
substrate interactions. This information can be used for enrichment analysis to gain information
about the processes involved in writing, reading, and erasing the studied PTMs. One can also
analyze PTMs in the context of signaling networks, as discussed below.
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Machine Learning
Machine learning has several applications in the downstream analysis of proteomics data
(Figure 6b,c). A very prominent one is the classification of patient-derived samples based on
their protein expression patterns (140–142). For artificial intelligence–based diagnosis, a super-
vised learning algorithm is first trained on samples derived from patient cohorts for which a
certain property is known, for instance, the cancer subtype. The trained algorithm is then used
to diagnose novel samples, that is, to predict the same property for samples where the property
is not known. The same supervised learning approach can be combined with feature selection
algorithms to derive predictive protein signatures. Each signature contains proteins that show a
distinct expression pattern and can be used for sample classification. Multivariate feature selection
methods can take the interdependence of proteins acting within networks into account and can
find patterns for which the discriminatory power is not apparent in the expression profiles of
single proteins. This makes machine learning–based feature selection a powerful alternative to
ANOVA-like methods to determine protein signatures, where a p-value is calculated for only one
protein at a time, independently from all the other proteins.
Machine learning approaches are most easily validated using cross-validation (143), which pro-
vides a measure of how well the prediction performance of a classification or regression model
will generalize to independent data not used for model training. Cross-validation helps avoid the
notorious problem of model overfitting and can be used to monitor prediction errors when ex-
tracting optimal protein sets from the output of feature selection algorithms. SVMs (144) often
perform particularly well in classification or regression of samples in omics spaces. This is not sur-
prising, since for most technologies, including proteomics, the number of features (biomolecules)
is typically much larger than the number of samples. SVMs were created to perform well in spaces
with exactly these properties. Deep learning (145, 146) is gaining traction in proteomics (75) and
will likely find more applications in the future.
Machine learning has also been successfully applied to the prediction of subcellular localization
with the dynamic organellar maps method (147, 148), which allows global mapping of protein
translocation events. First, one generates a database ofmarker proteinswith known localization and
absolute copy number information and characteristic fractionation profiles. Then, using SVMs, a
model is built for the prediction of cellular localization. This method has dynamic capabilities to
capture translocation events upon a stimulation. This enables a widely applicable proteome-wide
analysis of cellular protein movements without requiring process-specific reagents.
Network Biology
MS-based proteomics provides researchers with diverse tools for the study of biological net-
works (149). Enrichment protocols interrogate the interaction partners of a bait protein and
provide the basis for the assembly of large-scale protein–protein interaction (PPI) networks
(Figure 7a). Affinity enrichment/purification coupled to LC-MS is routinely used to quan-
tify hundreds of physical interaction partners. Since relying only on identification of proteins
in the pull-down leads to many false positives, it is crucial to distinguish background binders
from significantly enriched bona fide interactors. Statistical tests, such as the two-sample t-test,
can identify true interactors but require a control to compare against. This control sample ei-
ther can be a dedicated experiment lacking the bait protein or can be assembled from other
orthogonal experiments within the same study (150, 151). Due to its quantitative nature, this
approach can probe not only steady-state interactions, but also dynamic rewiring upon stim-
ulation by internal or external stimuli. If intensity-based quantification is used, the missing
values problem for enriched samples can be overcome by imputation. Alternative methods
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Figure 7
Network analysis. (a) Protein–protein interaction networks can be constructed by applying statistical testing to a series of pull-down
experiments with different bait proteins. The resulting network of proteins with significant enrichment to any of the bait proteins can
be visualized in tools such as Cytoscape. Adapted from Reference 28. (b) Signaling pathway reconstructed from phosphoproteomics
data derived from MCF7 cells after epidermal growth factor stimulation (160). The pie charts in the network visualize the measured
phosphorylation changes on each of the proteins. Proteins with unknown phosphorylation states are colored gray.
relying on spectral counting directly accommodate for the absence or presence of a protein
in a sample (152). Both approaches have been used to construct large-scale PPI networks
(151, 153).
Cells often achieve signal transduction through PTMs, which are enzymatically written, read,
and erased. The interpretation of PTMs in the context of these signaling networks is therefore nat-
ural. PTM specific networks, such as kinase–substrate interactions, can be obtained from curated
databases, such as PhosphoSitePlus (137). To increase coverage, kinase–substrate relationships
can also be predicted by machine learning and PPI network analysis (154). Logic models obtained
from, for example, the Signor database (138) can provide a mechanistic interpretation of phos-
phoproteomic data, indicating active kinases, as well as functional phosphorylation sites. Several
computational methods predict kinase activities from kinase–substrate interactions and phospho-
proteomics data. For a recent review and benchmark, readers are referred to References 155 and
156. Kinase–substrate enrichment analysis (157) uses parametric tests to compare the changes of
the substrates of one kinase to all other substrates. Cluster evaluation (158) clusters phosphoryla-
tion sites based on time series data, from which enrichments of kinase–substrate annotations are
calculated. Inference of kinase activities from phosphoproteomics (159) uses machine learning to
estimate the strength of kinase–substrate interactions, as well as kinase activities. Phosphopro-
teomic dissection using networks (PHOTON) (160) is a method using general PPI networks for
interpreting phosphorylation data within their signaling context. PHOTON identifies proteins
that significantly contribute to signaling and uses these proteins to reconstruct the most plausible
signaling pathway from the PPI network (Figure 7b).
For general-purpose network analysis, Cytoscape (161) has emerged as the de facto standard.
Through its plugin infrastructure, it provides a wealth of analyses and visualizations, often in-
tegrating expression-omics technologies with interaction networks. Cytoscape reads networks
from various standard formats and can extend them with interactions and pathways from var-
ious databases. Tools such as BiNGO (162) can identify significantly enriched gene ontology
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terms in these networks. Large-scale networks can be clustered into modules, either by topology
(MCODE; see Reference 163) or by differential expression (jActiveModules; see Reference 164).
Alternatively, network reconstruction tools, such as ANAT (165), identify a subset of interactions
connecting, for example, differentially expressed proteins to their signaling stimulus.
Multiomics Data Analysis
Analyzing data from two omics technologies applied to the same samples becomes straightfor-
ward if there is a near one-to-one match between the biomolecules measured in each of the two
omics spaces. For instance, when comparing the proteome and the transcriptome, the one-to-one
correspondence between transcript and protein sequences holds true with only little deviations
due to, for example, translation errors and postprocessing of the protein sequence. Thus, the
molecular correspondence is sufficiently valid to conceptually work with matching rows between
the two omics matrices. The problem reduces to mapping transcript to protein identifiers and to
dealing with the different depth in distinguishable splice variants, for which algorithmic solutions
exist (28). A similar molecular correspondence can be applied to the genome–proteome spaces for
correlating local genomic properties such as DNA copy number (166) or loss of heterozygosity
to protein expression if proteins matching to the same gene model are grouped together. Also,
ribosomal profiling data (167) can be brought into molecular correspondence with proteomics
data.
Once a correspondence between omics spaces has been established, one can perform pointwise
comparisons, as is done in the scatterplots in Figure 8a, in which protein abundances, messenger
RNA levels, and ribosomal profiling data are compared. Individual outliers in each of these plots
may hint at interesting biology. However, it is difficult to assign significance to individual data
points. Hence, researchers developed 2D annotation enrichment (168; Figure 8b) to answer the
question, Which classes of gene products show concordant and which show discordant behavior
between the different levels of gene expression? While transcriptional regulation is a dominant
factor in expression control, there are many known examples of posttranscriptional regulation
like microRNA-controlled inhibition of transcripts (169) and directed protein degradation (170),
which are detectable by this method.
Further examples of simultaneous multivariate analysis in two matched omics spaces are joint
time series analysis, which is exemplified in Figure 8c for circadian transcriptomics, and pro-
teomics data (136). Here, it was possible to derive time lags between peaks in transcript and
protein abundances as a proxy for the time lag between transcription and translation for individual
cycling transcripts and their associated proteins. Additionally, joint transcriptomics–proteomics
PCAperformed on the same data (Figure 8d ) indicates global similarities in transcript and protein
concentrations, but with a time delay.
When the input is time-resolved data for transcriptome and proteome, protein expression con-
trol analysis (PECA) (171, 172) computes the probability of regulation changes between adjacent
time intervals. PECA quantitatively dissects protein expression variation into the contributions of
mRNA and protein synthesis–degradation rate ratios.
Unlike in the previous examples, when combining proteomics with metabolomics, there is
not a one-to-one correspondence between molecules. In biochemical pathways, proteins are as-
sociated with reactions between metabolites as catalysts. The required mapping of biomolecules
is facilitated by the consensus human metabolic reconstruction Recon 2.2 (173), which has a
high potential for integrating and analyzing diverse data types. Recon 2.2 facilitates the integra-
tion of proteomics data with an updated curation of relationships between genes, proteins, and
reactions.
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Figure 8
Cross-omics data analysis. (a) Comparison of protein abundances, ribosomal profiling data, and mRNA expression. Proteins are
quantified with the iBAQ method (124), while RPKM (186) was used for the other two data types. Adapted from Reference 28.
(b) Output of the two-dimensional enrichment analysis applied to protein and mRNA abundances. Adapted from Reference 28.
(c) Side-by-side heat maps for daily rhythmic proteins and transcripts showing a cycling pattern. In the rows, samples are ordered by
time of extraction, and in the columns, proteins are ordered by time of their peak concentration. Adapted from Reference 136.
(d ) Principal component analysis performed jointly on transcriptomics data (red ) and proteomics data (blue) of two phases of circadian
mouse liver data. Labels next to data points denote time in hours. Both transcriptomics and proteomics data points arrange in a periodic
time series pattern in the first two principal components. Adapted from Reference 136. Abbreviations: ECM, extracellular matrix;
iBAQ, intensity-based absolute quantification; mRNA, messenger RNA; ncRNA, noncoding RNA; RPKM, reads per kilobase per
million mapped reads; rRNA, ribosomal RNA.
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DISCUSSION AND OUTLOOK
Computational proteomics has matured substantially and is keeping up well with the massive
amounts of data produced by modern mass spectrometers. Platforms for identification and quan-
tification of proteins can analyze the data in a reliable and automated way. Therefore, attention is
increasingly being shifted to the downstream part of the data analysis, in which the quantification
results are interpreted, hypotheses are tested, and novel biological and biomedical knowledge is
gained. We anticipate that future developments of computational proteomics tools will be partic-
ularly active in these areas, including network biology and cross-omics data analysis. In previous
work (28), we made the case for enabling the end users—the researchers from fundamental biol-
ogy, drug discovery, and medical sciences—to perform large parts of the data analysis themselves,
and this is increasingly happening.
Single-cell DNA and RNA sequencing (174) have shed new light onto the heterogeneity and
diversity of biological processes behind the cellular averages that are typically monitored in many
omics technologies. According to reports in the literature (175), single-cell proteomics is just
around the corner and will likely bear many new discoveries. Once it is scalable and sufficiently
deep in terms of proteome coverage, it might help define a highly resolved atlas of all cell types and
cell states in the human body (176). Certainly, novel computational tools will have to be developed
for the particular challenges of single-cell proteomics data, whichwill likely have unique challenges
in terms of normalization and handling of missing data.
There is still a large gap between the generation of large-scale proteomics data and themodeling
of signaling pathways and biochemical reactions. The curated knowledge of PTMs currently
available in public resources (134, 177) is still limited and needs to be expanded to support more
comprehensive analyses. New tools are emerging to reconstruct signaling pathways and translate
them into logic models (178). Hopefully, the path from large-scale time series data to kinetic
modeling (179, 180) will become more accessible for many interdisciplinary researchers, leading
to an improved mechanistic understanding of the biological processes under investigation based
on large-scale data.
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1.3 Interactomics
Since the invention of the tandem affinity purification (TAP) tag [Rigaut et al., 1999,
Puig et al., 2001], which enabled the purification of generic proteins, MS has been suc-
cessfully employed to identify interaction partners of many tagged proteins of interest.
Samples are subjected to MS analysis after two successive purification steps and inter-
actions are directly derived from the resulting list of identified proteins. Large-scale
studies uncovered the interactome of the prokaryote E. coli [Butland et al., 2005] and
the eukaryote yeast [Gavin et al., 2006], showing the competitiveness of the MS plat-
form compared to the established genomic yeast two-hybrid (Y2H) system [Uetz et al.,
2000] which had been used to generate PPI networks of even larger scale [Stelzl et al.,
2005].
With the advent of quantitative MS, the paradigm shifted away from relying on pu-
rification and identification [Schulze and Mann, 2004] towards enriching the sample
and subjecting the enriched sample to quantitative analysis [Keilhauer et al., 2015] (see
Figure 1.4). Several large scale human PPI networks have been assembled using a quan-
titative analysis of MS data, including [Hein et al., 2015], where proteins were tagged
with green fluorescent protein (GFP) using bacterial artificial chromosome (BAC) re-
combineering [Hubner et al., 2010], and the BioPlex project [Huttlin et al., 2015, 2017]
which employed FLAG-HA tags.
The central challenge in the analysis of quantitative pull-down experiments is dis-
tinguishing false-positive background binders from real interactors [Nesvizhskii et al.,
2007]. While initially simple fold-change cutoffs have been used, most studies now
employ statistical testing and apply a significance cutoff to determine interactors. A
popular choice is the t-test for comparing the means between a bait and a control pull-
down. One down side of the t-test is its sensitivity to proteins with low-variance and
small mean difference. Such proteins would be assigned a high p-value, despite the
expectations set by the experimental enrichment that true interactors should exhibit
a large effect size. In order to remove proteins with small effect size, either an addi-
tional fold-change cutoff can be applied [Kloet et al., 2016] or the t-test can be adjusted.
The s0-modified t-test [Tusher et al., 2001], initially developed for microarray analysis,
smoothly controls the contributions of the effect size on the adjusted p-value [Keilhauer
et al., 2015]. When testing multiple hypotheses, in this case one t-test for each pro-
tein in the dataset, a significance cutoff should not be applied directly to the p-values,
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Figure 1.4: The affinity-enrichment-MS workflow utilizes quantitative proteomics to
compare an enriched pull-down sample to a control sample. Adapted from [Hein et al.,
2013].
which will lead to inflated overall false-positive rates. Instead, a scheme to control the
false discovery rate (FDR) should be applied, such as the Benjamini-Hochberg correc-
tion [Benjamini and Hochberg, 1995]. A robust alternative, using permuted data to es-
timate the FDR, is implemented in the Perseus platform [Tyanova et al., 2016]. Alterna-
tives to the t-test include fitting a mixture model to capture the distributions of true and
false positives [Choi et al., 2011] or using a Naive Bayes classifier on semi-quantitative
features derived from the data, including co-occurrence patterns of proteins in multiple
bait pull downs [Huttlin et al., 2015].
1.3.1 Protein-protein interaction network databases
The networks generated by the community effort to uncover the interactomes of var-
ious organisms using genomic and proteomic technologies are stored in a zoo of PPI
data bases. Any researcher interested in studying the interactome accesses available
data through one of these databases. Each database has a different focus, such as a spe-
cific organism, the integration of multiple data sources or manual content curation. The
STRING [Szklarczyk et al., 2015] database is one of the most popular choices because
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of its easily accessible web interface and its inclusion of not only physical interactions
but also non-physical interactions, such as co-expression, gene fusion or literature co-
occurrence, and its wide coverage of organisms. Another PPI resource which addition-
ally provides large-scale genetic interactions is the BioGRID [Chatr-Aryamontri et al.,
2017]. Other databases, such as IntAct [Orchard et al., 2014] aggregate data from the
community and focus on standardized data access. Organism specific data bases, in-
cluding the Human Protein Reference Database (HPRD) [Keshava Prasad et al., 2009],
only report manually curated information on human proteins, but their interactive data
access, supplemented by additional tools for e.g. phosphorylation motif finding or,
pathway annotations make them a useful resource for small scale studies.
The popularity of manually curated interaction resources is mainly driven by the
large number of false-positive interactions plaguing large-scale databases. Via auto-
matic curation of interactions, some databases report confidence scores for each in-
teraction which distinguish well supported high confidence interaction from putative
low-confidence interactions [Szklarczyk et al., 2015]. A number of PPI databases are
specialized in aggregating and curating interaction networks and providing confidence
scores [Yosef et al., 2009, Alanis-Lobato et al., 2017]
Popular network resources that are rarely used for large-scale analysis but rather
for annotating and validating results include the KEGG [Kanehisa et al., 2016] and Re-
actome [Fabregat et al., 2016] pathway databases, and the CORUM [Ruepp et al., 2009]
database of mammalian protein complexes.
1.3.2 Analysis of protein-protein interaction networks
One can distinguish two different classes of analyses on PPI networks. The first being
concerned with understanding the topology of the interactome, the second utilizing
PPI networks to interpret other large-scale -omics data.
In order to understand the topology of a network, it is useful to examine the basic
properties of its nodes. Counting the number of neighbors of any node i gives rise to its
degree ki. In the same way a node degree distribution can be obtained for the network.
It has already been observed, that complex networks, such as cellular PPI networks,
often exhibit a specific power-law node degree distribution [Albert and Barabási, 2002].
If the node degree distribution matches the power-law
P(k) ∼ k−γ (1.1)
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Box 1.1: Graph notation
An undirected graph G is defined as a set of vertices V = {1, · · · , n} and edges
E = {(i, j) if i, j are connected}. If two vertices i and j are connected in the graph,
an edge (i, j) is added to E. Due to the undirected nature of the graph the edges
(i, j) and (j, i) are equivalent. Physical protein-protein interaction networks [Stelzl
et al., 2005] can be modelled as an undirected graph where the vertices are the
proteins and the edges represent their interaction.
In directed graphs the notation remains identical, but the existence of (i, j) does
not imply the existence of the opposite edge (j, i). Such networks are well suited
to model networks with directional flow of information, such as protein-DNA in-
teraction networks [Johnson et al., 2007], where transcription factors initiate tran-
scription on the DNA and not vice versa.
Simple graphs allow for only a single edge between each pair of nodes. The exten-
sion of a simple graph to allow for multiple edges per node is called a multigraph.
In this thesis multigraphs will use the same notation as simple graphs except of
edges being denoted as triplets (i, j, k) where i, j are the source and target nodes of
the interaction and k provides an unique identifier distinguishing the edge from
the other edges between the same nodes. Multigraphs can also be used to model a
graph containing different types of interactions [Bensimon et al., 2012, Szklarczyk
et al., 2015].
the network exhibits a so-called scale-free topology, which implies the existence a small
number of hub nodes with high degrees connecting a large number of peripheral nodes
with low degrees in a small-world network.
Extensions of the concept of node degrees to graphlet signatures, which more ac-
curately capture local topology, have been applied to various challenges, such as clus-
tering the network into modules [Milenkovic´ and Przulj, 2008], or aligning graphs be-
tween species with the aim of predicting novel interactions and transferring annota-
tions [Malod-Dognin and Pržulj, 2015].
Differential expression (DE) analysis of omics data can be integrated with PPI net-
works [Cline et al., 2007]. Rather than performing independent DE analysis on each of
the proteins, one can try to find differentially regulated local network modules by con-
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sidering a number of proteins simultaneously [Ideker et al., 2002]. Furthermore, any set
of proteins of interest can be extended with so-called subnetwork reconstruction meth-
ods [Yosef et al., 2011, Tuncbag et al., 2016]. Given a large-scale network a parsimonious
subnetwork connecting all proteins of interest is derived, potentially including proteins
which were not considered before. Several applications for the analysis of phosphopro-
teomic data are introduced in 1.4.1.
Given the size of large scale PPI networks (see Figure 1.5) the development of soft-
ware tools is essential for handling and analyzing such networks. The landscape of
software tools for the analysis of biological networks is diverse. Developer focussed
libraries implemented in programming languages such as R [R Core Team, 2018] and
Python [van Rossum, 1995] allow for the manipulation, analysis and visualization [Franz
et al., 2015] of generic networks. For the analysis of biological networks, the open-
source Cytoscape software [Shannon et al., 2003] has become one of the most popular
tools. On the one hand, it provides users with a graphical user interface and rich visual-
ization options and on the other hand, allows developers to extend Cytoscape through a
plugin system [Maere et al., 2005]. Commercial tools, such as IPA [Quiagen Inc.], focus
on providing higher quality annotations and expert knowledge stored in proprietary
databases.
1.4 Phosphoproteomics
An estimated third of eukaryotic proteins being phosphorylated [Cohen, 2000] makes
phosphorylation one of the key PTMs. In an active balance, kinases and phosphatases
rapidly and reversibly modify proteins in order to alter their function [Hunter, 1995].
While in signaling, phosphorylation often acts in an activating or deactivating man-
ner [Macek et al., 2009], it can modulate almost all protein functions, including localiza-
tion, half-life and interactions [Cohen, 2000]. Disruptions of phosphorylation-mediated
signaling leads to diseases, such as cancers and conversely makes kinases and phos-
phatases attractive drug targets [Ventura and Nebreda, 2006].
Since the detection of the first phosphorylation site on vitellin in 1906 by Levene and
Alsberg, phosphorylation sites have been studied one site at a time. However, only an
unbiased and comprehensive measurement of the phosphoproteome would allow the
understanding of the effects of protein phosphorylation at a systems level. MS provides
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Figure 1.5: Node-link visualization of a large cluster of proteins from a yeast PPI net-
work generated using the Y2H method [Uetz et al., 2000]. Protein nodes are colored
according to the phenotype observed when removed (red, lethal; green, non-lethal; or-
ange, slow growth; yellow, unknown). Adapted from [Jeong et al., 2001].
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an ideal platform to study PTMs such as phosphorylation which introduce a detectable
mass shift at their modification site. The main challenges are not only to measure the
phosphoproteome in a reproducible, high-throughput and deep-coverage manner, but
also to adapt and extend the subsequent statistical analysis.
Due to the low stoichiometry of phosphorylation [Riley and Coon, 2016], phospho-
peptides are hard to detect in regular proteomics experiments. Therefore, phosphopro-
teomic experiments are optimized to increase the coverage of phosphopeptides. First,
digestion can be improved by using additional restriction enzymes which alleviate is-
sues with suboptimal trypsin cleavage close to phosphorylated amino acids [Wis´niewski
and Mann, 2012]. Second, a phosphopeptide enrichment step greatly increases the
chances to detect low abundant phosphopeptides (see Figure 1.6). For smaller scale
experiments, antibodies targeting phosphorylated residues can be enriched for by im-
munoprecipitation (IP) [Grønborg et al., 2002]. TiO2 enrichment is better suited for
large-scale experiments. Here, the oxygen in the phosphoryl group interacts with the
metal oxid matrix [Thingholm et al., 2006]. Alternatively, immobilized metal affinity
chromatography (IMAC) [Villén and Gygi, 2008] exploits the affinity of the negatively
charged phosphate group on the peptide, to the positively charged metal cations in the
column. By utilizing extensive prefractionation the coverage of phosphopeptides can
be increased further. The downside to prefractionation is the increased amount of labor
and measurement time required for the analysis. Recent streamlined protocols in 96-
well format coupled with single-shot LC-MS enable high-throughput measurements of
a large number of phosphoproteomic samples [Humphrey et al., 2015, 2018]. For the
quantification of phosphoproteomics experiments, label-free as well as metabolic and
isobaric labeling have been employed successfully [Hogrebe et al., 2018].
Compared to the identification of unmodified peptides from MS2 spectra, the iden-
tification of the modified phosphopeptide and the localization of the modification on
the peptide sequence require special considerations [Potel et al., 2018, Sinitcyn et al.,
2018a]. In a database search framework, extending the sequence database with mod-
ified sequences allows for the identification of modified sequences. The mass shift on
parts of the fragment ion series alongside modification-specific neutral losses and di-
agnostic peaks are considered when generating theoretical spectra. A final localization
probability can be derived from the scores assigned to the theoretical fragment spec-
tra with the different possible localizations [Beausoleil et al., 2006, Cox et al., 2011].
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Figure 1.6: The phosphoproteomics workflow includes an additional phosphopeptide
enrichment step prior to MS analysis. Adapted from [Hein et al., 2013].
When complementary proteome data is available stoichiometry can be derived from
the measured intensities by calculating the ratios between the modified and unmodi-
fied peptide [Cox and Mann, 2008, Olsen et al., 2010, Sharma et al., 2014].
The identification of large numbers of phosphorylation sites has been successfully
used for evolutionary studies. Phosphorylation sites were found to be conserved when
occurring in structured regions of the protein, and rapidly evolving when located in
unstructured regions [Collins, 2009]. To study the regulatory effect of phosphoryla-
tion, a quantitative analysis of the up to 50,000 detected sites detected by MS is re-
quired [Sharma et al., 2014]. The first of the two core challenges in the analysis phos-
phoproteomic data is the increased variability inherent to peptide-level data. Protein-
level proteome analyses benefit from peptide to protein aggregation, leading to higher
confidence data [Sinitcyn et al., 2018a]. The second challenge is the translation of the
observed changes in phosphorylation patterns into mechanistic insights, since in gen-
eral, phosphorylation sites can exhibit excitatory, inhibitor or even combinatoric effects
on the function of the substrate [Macek et al., 2009].
While many phosphoproteomic studies still pursue analysis approaches taken from
proteome analysis, such as identifying differential expression or clustering on a phos-
phorylation site level [Olsen et al., 2010, Sharma et al., 2014], a number of tools have
been developed to specifically address the challenges of phosphoproteomic analysis.
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Figure 1.7: Kinase-substrate networks can be represented as either directed, site-specific
networks which naturally arise from kinase-substrate interactions or kinase motifs,
or as undirected protein-level interactions modeled after large-scale PPI networks.
Adapted from [Rudolph and Cox, 2018].
One core concept that is exploited by most of these analyses it the relationship between
kinases and their substrate, which allows to restate the aims of the analysis. Instead
of focusing or the individual phosphorylation sites, the aim is to identify regulated ki-
nases from large-scale phosphoproteomic data. Changes in the phosphorylation levels
of the substrates imply corresponding changes in the activity of the kinase.
1.4.1 Kinase-substrate networks and kinase activities
Prerequisite for a kinase-centric analysis of phosphoproteomic data is the assignment
of kinases to their specific substrates. To do so, phosphorylation events can be nat-
urally described as a directed interaction between a kinase and a specific site on the
substrate (Figure 1.7) forming a site-specific kinase-substrate network. Only a limited
number of such site-specific interactions are available in databases such as Phospho-
SitePlus [Hornbeck et al., 2015]. However, in order to obtain a comprehensive picture
on kinase activity, a high coverage of kinases and sites would be required.
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Due to the difficulties in uncovering novel interactions experimentally, a number of
computational tools address this issue. The statistical analysis of the peptide sequences
identified in large-scale phosphoproteomics experiments allows for the identification
of phosphorylation motifs which can serve as a proxy for a kinase [Schwartz and Gygi,
2005]. The NetPhorest tool [Miller et al., 2008] integrates motif finding with the phy-
logeny of kinases to pinpoint the kinase family of a phosphorylation site. Combined
with the network context modeling approach of NetworKIN [Linding et al., 2008], the
KinomeXplorer [Horn et al., 2014] platform, integrates both tools to predict human
kinase-substrate interactions, which can be used to supplement kinase-substrate net-
works from literature.
Most tools for the scoring of kinase activities from phosphoproteomic data have a
common approach. Using the kinase-substrate assignments from the network, an ac-
tivity score is calculated for each kinase/kinase family/motif from the observed phos-
phorylation changes on the assigned sites. The KSEA [Casado et al., 2013] method
includes a variety of scores, including a Z-score and its associated p-value, which per-
forms well for relative comparisons between conditions [Hernandez-Armenta et al.,
2017]. For comparisons within the same conditions KARP [Wilkes et al., 2017] ranks
the kinases based on their contribution to the total observed phosphorylation. Compu-
tationally more involved approaches try to optimize binding affinity between kinases
and substrates (IKAP [Mischnik et al., 2015]), or even derive an entire logic model from
a phosphoproteomic screen of kinase inhibitors [Terfve et al., 2015].
The requirement for site-specific interactions and the focus on deriving the enzy-
matic activity of kinases from the data limits the scope such methods. While the phos-
phorylation itself is mediated by the kinases, non-kinase proteins contribute to signal-
ing by enabling signal transduction through complex forming and scaffolding. The
PHOTON [Rudolph et al., 2016, Rudolph and Cox, 2018] method devises a more gen-
eral signaling functionality score which allows it to use large-scale PPI networks to
perform the analysis. The undirected, site-agnostic nature of such networks (Figure 1.7)
reduces the specificity of the approach, but dramatically increases the quality of the net-
work and the amount of data that can be utilized in the analysis. The PHOTON score
itself is calculated from the average phosphorylation changes observed on the neigh-
bors of any protein in the network. A permutation-based FDR approach determines
which proteins have significant signaling functionality scores.
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1.5 Co-expression analysis
Co-expression analysis is seeking to identify functional modules of genes or proteins
from omics experiments with large numbers of samples. First, a co-expression network
is constructed directly from the data, in which the node are connected by edges with
weights according to their co-expression. The extent of co-expression between genes
is most often measured using correlation [Langfelder and Horvath, 2008], or mutual
information [Margolin et al., 2006]. Finally, the clustering of the network reveals the
co-expression modules.
Choosing the appropriate co-expression metric is central to the analysis. Correla-
tion measures the linear dependence between a pair of genes, while mutual informa-
tion can capture non-linear relationships. On the other hand, the estimation of mutual
information from non-discrete data, such as protein expression measurements is more
challenging [Kraskov et al., 2004]. Biweight midcorrelation provides a robust alterna-
tive to Pearson’s correlation. For vectors x = (xa), a = 1, 2, . . . ,m and y it is defined
as
bicor(x, y) =
m
∑
a=1
x˜ay˜a (1.2)
x˜a =
(xa −med(x))w(x)a√
∑mb=1
[
(xb −med(x))w(x)b
]2 (1.3)
wa = (1− u2a)2 I(1− |ua|) (1.4)
ua =
xa −med(x)
9 mad(x)
(1.5)
Biweight midcorrelation was found to outperform Pearson-, Spearman correlation, and
mutual information measures for co-expression network construction in synthetic and
real data sets [Song et al., 2012].
A transformation of correlation coefficients ρij into the range [0, 1] is required in or-
der to obtain the adjacencies aij that form the co-expression network. A signed transfor-
mation retains the direction of the correlation, while the unsigned transformation does
not. Additionally, raising the adjacency measure to the power β acts as a soft-threshold
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on the network.
asignedij =
(
1+ ρij
2
)β
(1.6)
aunsignedij =|ρij|β (1.7)
The choice of β can be informed by looking at network properties, such as average con-
nectivity, or scale-freeness (see Equation 1.1) of the network. A scale-free fit index can
be derived from regressing on the log-transformed node-degree distribution [Zhang
and Horvath, 2005]. For higher powers of β, average connectivity will reduced while
the scale-free fit index should improve.
Once the co-expression network is constructed a cluster dendrogram can be calcu-
lated using hierarchical clustering. Instead of the often used euclidean distance, the
topological overlap distance 1− tij is applied. The topological overlap measure (TOM)
tij measures the distance between nodes in a network based on their first-degree neigh-
bors [Ravasz et al., 2002].
tij =

lij+aij
min{ki ,k j}+1−aij if i 6= j
1 if i = j
(1.8)
lij =∑
u
aiuauj (1.9)
ki =∑
u
aiu (1.10)
Modules can be extracted from the cluster dendrogram using a simple distance cut-
off, or using automated cluster detection by dynamic branch cutting [Langfelder and
Horvath, 2008]. Based on the guilt by association (GBA) principle [Oliver, 2000] mod-
ule members can be characterized and novel associations between members [Lee et al.,
2004] can be established. The biological relevance of the entire module can be assessed
using annotation enrichment analysis using Fisher’s exact test.
In order to make comparing modules and relating them to external traits, such as
phenotype or clinical data easier, each module can be represented by an module eigen-
gene [Zhang and Horvath, 2005]. The eigengene is derived from a principal component
analysis (PCA) of the quantitative profiles of all module members, and has a quantita-
tive profile that summarizes the module behavior. Subsequently, module to phenotype
links can be established by calculating the correlation between the eigengene and the
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observed phenotype. A heatmap of the correlations between the module eigengenes
and the phenotypes can provide a highly reduced view of large datasets.
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Chapter 2
Manuscripts
2.1 A network module for Perseus
We recently developed and published the popular Perseus software for the downstream
statistical analysis of proteomics data [Tyanova et al., 2016]. The following manuscript
introduces PerseusNet, the network module of Perseus. PerseusNet was devised to
fulfill the computational needs of proteomics researchers wishing to accomplish net-
work analysis of their data. While it is extensible through a new plugin application
programming interface, and hence any network analysis functionality can be imple-
mented, most tools needed for proteomics research and connecting it to generic net-
work analysis platforms are included in the software. Dedicated activities for ana-
lyzing AP-MS datasets and phospho-proteomics experiments in the context of kinase-
substrate networks belong to the basic infrastructure of PerseusNet. PerseusNet is ex-
tensible through a plug-in architecture in a multi-lingual way, integrating scripts in C#,
Python and R, which allows for the incorporation of a plethora of existing scripts and
programs from the network community.
My contribution was the implementation of PerseusNet, including the required
internal data structures and algorithms, as well as the activities that allow for load-
ing, processing, analysing and visualizing proteomics, phosphoproteomics and inter-
actomics data. I additionally designed and implemented a number of software mod-
ules (PluginInterop, perseuspy, PerseusR) which enable the interoperability between
Perseus and generic data science tools, as demonstrated by the integration of the
WGCNA [Langfelder and Horvath, 2008] and PHOTON [Rudolph et al., 2016] into
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ABSTRACT 
Proteomics data analysis strongly benefits from not studying single proteins in isolation but taking their 
multivariate interdependence into account. We introduce PerseusNet, the new Perseus network module for the 
biological analysis of proteomics data. Proteomics is commonly used to generate networks, e.g. with affinity 
purification experiments, but networks are also used to explore proteomics data. PerseusNet supports the 
biomedical researcher for both modes of data analysis with a multitude of activities. For affinity purification, a 
volcano plot-based statistical analysis method for network generation is featured which is scalable to large 
numbers of baits. For posttranslational modifications of proteins, such as phosphorylation, a collection of 
dedicated network analysis tools helps elucidating cellular signaling events. Co-expression network analysis of 
proteomics data adopts established tools from transcriptome co-expression analysis. PerseusNet is extensible 
through a plug-in architecture in a multi-lingual way, integrating analyses in C#, Python and R and is freely 
available at http://www.perseus-framework.org.
INTRODUCTION 
The study of complex systems1 is concerned with the 
question of how the relationship between the parts of 
a system give rise to its collective behavior. Complex 
systems often generate emergent properties2 which are 
not contained in an obvious way in its parts. Examples 
of such networks range over all disciplines of science, 
including the study of social media networks3, scientific 
collaboration networks4 and the human brain and its 
interconnected neurons as a particularly interesting 
one. The interactions between the components of a 
complex system define a network of connections 
consisting of nodes and edges. Much of the relevant 
content is concealed in the network constructed from 
these interactions and is not visible in the components 
themselves. For instance, the brain connectome5 is 
believed to make us who we are and not the cellular 
content of the brain6. Similarly, the observation of 
cellular concentrations of biomolecules without 
considering their interaction would provide a limited 
picture that ignores potential emergent properties of 
the biomolecular complex system. Hence it is 
mandatory to study biological systems, such as cellular 
concentrations of biomolecules, in the framework of 
network biology7. 
 
At a fundamental level, all network connections 
between the cellular biomolecules are biochemical 
reactions and their specification in biochemical 
pathways together with their subcellular spatial 
distribution would provide complete knowledge about 
the biological network state of the cell. This collective 
network of all biochemical reactions contains all 
metabolic reactions, the signaling cascades, gene 
regulatory networks and all complex-forming non-
covalent interactions between molecules, as for 
instance protein-protein interactions. Due to the 
limitations of experimental and computational methods 
to map out this interaction network, we often obtain 
only partial knowledge about the complete biochemical 
reaction network from experiments. Networks are 
however not limited to describing fundamental physico-
chemical interactions between biomolecules. For 
instance, in a gene co-expression network analysis8 one 
looks for similarity of expression patterns of gene 
products over many samples. Strongly correlated 
expression implies that these genes have some kind of 
non-physical interaction, e.g. they are part of the same 
transcriptional regulatory program or they share 
membership in the same pathway or protein complex. 
However, the exact relationship in terms of biochemical 
reactions remains unknown with these and other 
techniques. Hence, in these cases, networks describe a 
coarser grained level of detail, in which relationships 
between molecules are not necessarily biochemical 
reactions, but of a more general kind.   
 
Computational proteomics is a mature data science that 
copes well with the large amounts of data produced in 
mass spectrometry experiments9. Perseus is an 
established framework for the downstream 
bioinformatics analysis of quantitative proteomics 
data10,11. The initial version of Perseus provided a 
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comprehensive framework and set of activities to 
analyze data matrices originating from quantitative 
proteomics in a workflow environment. The main idea 
behind Perseus is to enable the researchers in 
biomedical sciences to perform the data analysis 
themselves. Here we describe how we extend this 
program to the analysis of biological networks in the 
context of proteomics. While cytoscape12 exists as the 
de-facto standard for network analysis and 
visualization, many proteomics-specific tasks for the 
generation and analysis of networks are lacking from 
this framework, as well as workflow navigation. 
PerseusNet fills this gap and enables non-
computational experts to perform complete network-
based analysis of their data. We explicitly do not want 
to re-invent existing methods and algorithms. Instead 
we designed an extensible framework that integrates 
with existing tools, like cytoscape, and interoperates 
with existing code and scripts from the network analysis 
community that were written in diverse languages, like 
Python and R. The data structures within Perseus that 
hold the networks were set up in a way that facilitates 
studying dynamic changes in networks and finding 
differential network properties over complex 
experimental designs. Side-by-side analysis of networks 
with data matrices in a common workflow environment 
allows for a seamless transition between matrix-centric 
and network-centric approaches. 
 
In the following we start with a general description of 
the new network framework in Perseus, including how 
it enables multilingual programming and usage of code 
resources from R and Python. Then we introduce the 
new volcano-plot based analysis workflow scalable to 
large affinity purification-mass spectrometry (AP-MS) 
datasets. We describe how general and more 
specifically, large-scale protein-protein interaction (PPI) 
networks are handled and curated in Perseus. A section 
on the analysis of posttranslational modification (PTM) 
induced networks, like kinase-substrate relationships 
for phospho-proteomics is next. Finally, we cover co-
expression analysis in Perseus and its applications to 
clinical proteomics. 
RESULTS 
WORKFLOW-BASED BIOLOGICAL NETWORK 
ANALYSIS  
PerseusNet was devised to fulfill the computational 
needs of proteomics researchers wishing to accomplish 
network analysis of their data. While it is extensible 
through a new plugin application programming 
interface (API), and hence any network analysis 
functionality can be implemented, most tools needed 
for proteomics research and connecting it to generic 
network analysis platforms are included in the software 
(Fig. 1). Dedicated activities for analyzing AP-MS 
datasets and phospho-proteomics experiments in the 
context of kinase-substrate networks belong to the 
basic infrastructure of PerseusNet. The most common 
standard data formats are supported as input. An 
extended multi-language plugin API allows leveraging 
many existing tools in the analysis workflow. As an 
important example, co-expression clustering tools are 
integrated in this way.   
 
To accommodate PerseusNet, we extended the Perseus 
framework with a new data type termed network 
collection (Fig. 2) that represents a set of one or more 
networks which are analyzed jointly in the workflow. 
Different networks within the same network collection 
can, for instance, represent networks derived from 
different individuals (patients), experimental conditions 
or biological replicates. All information in the network 
collection is organized in data tables, leveraging the 
existing augmented data matrix10 in Perseus. General 
information on the networks in the collection are stored 
in the networks table, where each row represents an 
individual network. Here, sample-related annotations, 
such as calculated global network properties, can be 
stored to enable their usage in analysis activities 
operating on a network collection. For instance, if the 
samples correspond to different patients, the networks 
table can hold patient-specific information as derived 
from patient records or questionnaires. These variables 
can then be used as independent or confounding 
factors in statistical analysis of the networks.  
  
The nodes and edges of each individual network are 
stored in a pair of separate tables. The nodes table 
further describes the entities in the network, while the 
edges table provides details on the connections 
between the entities. The entities in the nodes table can 
be annotated with local network properties, such as the 
node degree. In case the entities correspond to 
proteins, biologically meaningful annotations could 
include membership in gene ontology terms, pathways 
or protein complexes. Similarly, edges can be annotated 
in the edges table with properties of pairwise 
relationships between proteins, as for instance 
interaction confidence measures. All of these properties 
are then accessible to the network analysis tools. 
Furthermore, all mentioned tables can be sorted and 
searched, allowing all information to be browsed and 
inspected intuitively. Internally, a graph data structure 
for each network enables the efficient execution of 
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graph algorithms. We did not aim to include generic 
graphical representation of networks as node-link 
diagrams, since this can be achieved in other tools such 
as Cytoscape, for which we provide simple adaptors for 
the transfer of networks. However, several activities 
include specialized visualizations tailored to specific 
analyses. 
 
In Perseus, all data analysis steps are performed within 
a graphical workflow. (See Supplementary Fig. 1.)  
Enabled by the newly implemented network collection, 
the Perseus workflow is now capable of all import, 
processing, and analysis steps in the side-by-side 
analysis of expression matrices and networks. All data 
that is imported into Perseus is represented as a 
separate entity in the workflow. Any matrix or network 
undergoing a processing step is not modified in-place 
but rather becomes a new entity that gets connected to 
the original data in the workflow. By inspecting both, 
input and output data, every step in the analysis is 
traceable and easily understood. Certain processing 
steps allow for the transformation of matrices into 
networks and vice-versa, or the mapping of data 
between the two. As a result, any analysis performed in 
Perseus, potentially including several side-by-side 
processing steps of networks and matrices, always 
remains transparent to the user. 
MULTILINGUAL PLUG-IN ACTIVITIES  
The network collection data structure (Fig. 2) and the 
extended Perseus workflow provide the foundation for 
enabling various network analyses, many of which are 
available in Perseus. In general, networks either 
originate from external sources, or are created in a 
data-driven manner from within the workflow. To 
facilitate the import of external networks into the 
workflow, we implemented parsers for standard 
network formats, such as edge table (.tab|.txt|.csv), 
GraphML1 (.gml), Cytoscape’s simple interaction 
format2 (.sif) and D3js’s JSONgraph3 (.json) which 
enable loading interactions from most popular network 
databases, including STRING13, BioGRID14, IntAct15, 
CORUM16 and PhosphoSitePlus17. Furthermore, specific 
quantitative expression data, such as AP-MS drives the 
creation of novel protein-protein interaction networks, 
and phospho-proteomics datasets allow for a more 
detailed view or construction of kinase-substrate 
relationship networks. Specialized visualizations of such 
networks are provided (see later sections), which allow 
                                                          
1 http://graphml.graphdrawing.org/ 
2http://manual.cytoscape.org/en/stable/Supported_Networ
k_File_Formats.html 
3 http://jsongraphformat.info/ 
for an intuitive visual inspection of the results of the 
analysis. Perseus is not limited to physical interaction 
networks: co-expression clustering provides a powerful 
alternative to regular hierarchical clustering for 
expression proteomics studies. Finally, any network 
collection can be exported from the workflow in a plain 
text file format for sharing or use in any other external 
tools, such as Cytoscape. In order to accommodate 
these new capabilities in the Perseus plugin system, we 
extended the Perseus plugin API with new programming 
interfaces for the network collection and other 
associated data types, as well as the respective import, 
processing, and analysis interfaces. (See Supplementary 
Fig. 2.) This fully-featured API is available to all 
developers wishing to extend Perseus’ functionality 
with plugins. All analyses presented in this manuscript 
adhere to the new API. 
 
In-order to better leverage the existing network analysis 
ecosystem, we additionally implemented a new mode 
of interoperability between Perseus and external tools 
(Fig. 3). The PluginInterop project enables this 
functionality, and allows the user to run external tools 
from within the Perseus workflow, most prominently 
scripts written in the popular R and Python languages. 
Open-source companion libraries for R4 and Python5 
provide utilities for interfacing with Perseus. As a result, 
network analysis tools originally implemented in 
external tools can run from within the Perseus workflow 
with only minor adjustments. The implementations of 
the PHOTON and WGCNA plugins presented in the 
manuscript are based upon PluginInterop and its 
companion libraries. Instructions for interested 
developers on how to write scripts for Perseus or how 
to adapt existing tools can be found on the 
PluginInterop website6. In the following sections, we 
will present a number of network analyses which are 
now implemented in Perseus, with focus on their 
application to different types of proteomics data. 
AFFINITY ENRICHMENT MS INTERACTOMICS 
Affinity purification or enrichment coupled to MS 
analysis has become a powerful tool for interrogating 
PPIs18,19. It is able to provide not only a detailed view on 
proteins of interest, but it can also determine the basic 
building blocks for the assembly of large-scale protein-
protein interaction networks20,21. Historically, protein 
complex members were detected by subjecting the 
sample to a series of purification steps followed by MS 
4 PerseusR, https://github.com/jdrudolph/PerseusR 
5 perseuspy, https://github.com/jdrudolph/perseuspy 
6 https://github.com/jdrudolph/PluginInterop 
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identification. With the advent of quantitative MS, 
detecting even transient interactions has become 
possible by relying not only on the identification itself, 
but instead on quantitative information. The sample is 
not purified, but only enriched for the protein of 
interest and its interaction partners and then subjected 
to MS quantification22.  
 
Confidently identifying bona-fide interactions and 
distinguishing them from background binders, arising 
from off-target binding or contamination, requires data 
analysis of replicate case and control measurements. 
Compared to purely fold change-based methods, 
statistical tests provide a powerful way to compare case 
and control samples by calculating a test statistic and an 
associated p-value and limit the number of false-
positives. For visual inspection of the results, the 
(negative logarithm of the) p-value can be plotted 
against the size of the effect, i.e. the difference between 
the means of logarithmic abundances, in a so-called 
volcano plot. Since one statistical test is performed for 
each protein, which amounts to a large number of tests 
performed simultaneously, the significance level needs 
to be adjusted to avoid increased numbers of false 
positives due to the multiple hypothesis testing 
problem23. A popular strategy to adjust for multiple 
testing is to control the false discovery rate (FDR), which 
can be achieved by permutation-based methods. 
Furthermore, in the volcano plot method it is necessary 
to define the functional form of the curves that separate 
significant from non-significant hits, either by straight 
lines, or in a more sophisticated way, introduced in the 
significance analysis of microarrays (SAM) method24, by 
modifying the t-test statistic with the background 
variance parameter s0. This standard workflow is 
available in Perseus but becomes increasingly 
cumbersome for interaction screens with more than a 
handful of baits.  Parameter values for s0 and the FDR 
thresholds are often applied separately for each 
pulldown, inviting overfitting and cherry-picking, and 
also requiring results be subsequently combined 
manually. 
 
We implemented the interactive multi-volcano plot 
(Fig. 4a) to analyze interaction screens with arbitrarily 
many baits and conditions simultaneously. Given the 
experimental design of the dataset, defined by baits and 
conditions, the analysis is applied to each experiment. 
For sufficiently large datasets, instead of dedicated 
control samples, an internal control can be assembled 
from the dataset for each pulldown consisting of 
pulldowns of other, unrelated baits. The results can be 
inspected through an interactive user interface. All 
volcano plots are displayed in the overview panel. A 
multi-functional detail panel shows more information 
on selected plots and provides zoom, protein selection 
and labeling options. If a single plot is selected, the 
volcano plot is shown in the detail panel. When two 
plots are selected, the t-test differences between the 
selected experiments are plotted against each other, 
highlighting changes in the enrichment of proteins 
between experiments (Fig. 4b). Additionally, all data can 
be browsed in tabular form, making it easily searchable 
and allowing for rich styling options. Known interactors 
or gene ontology annotations matching the experiment 
can be used to highlight proteins in the plot and can 
serve as a positive control for the adjustment of test 
parameters. All test parameters are controlled on a 
global level, effectively preventing overfitting and 
cherry-picking parameter values. We integrated the 
multi-volcano analysis into the new network module. 
Results from protein-protein interaction screens can be 
exported as network objects into the Perseus workflow. 
A specialized node-link visualization based on the open-
source cytoscape.js library25,26 with multiple layers of 
information, allows for easy interpretation of the 
results (Fig. 4c). A protein-protein interaction network 
that was newly created in this way can be integrated 
with existing networks, or exported in various formats 
using the functions available through the network 
module. 
 
As an example application, we obtained pull-down 
experiments from reference27, covering three baits in 
two different cell types. The filtered data set contained 
2995 proteins. Using the new multi-volcano analysis 
(Fig. 4a), we obtained a PPI network with 134 nodes and 
140 edges. The results were comparable to the original 
publication with overlaps between 55% (Ring1b ESC) 
and 91% (Bap1 ESC) for Class A interactions. Differences 
can be explained by the slightly different methodology 
used in this manuscript. We used the s0-modified t-test 
with s0 set to 1.0, and FDRs of 0.01% and 0.2% for Class 
A and B, respectively, while the authors of reference27 
used individually chosen fold-change and p-value 
cutoffs for each experiment. Using the built-in 
visualization features, such as the enrichment between 
experiments, we identified several interactions that 
were conditional on the cell type (Fig. 4b). By annotating 
the newly created protein-interaction network with 
known complex interaction from CORUM and 
inspecting the resulting node-link network visualization 
(Fig. 4c), previously known and possibly novel 
interactions could be distinguished. 
 
Further confidence in the existence of an interaction 
between a protein identified in a pulldown and the bait 
can be obtained by correlation analysis. The correlation 
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of the intensity profiles over many pulldowns with the 
bait intensity profile is reported in the output tables 
together with the volcano plot-derived significance of 
the interaction. When assembling the interaction 
network a threshold is applied to this correlation in 
order to define an additional class of interactions (Class 
C), which might not have been found by volcano plot 
analysis (Classes A and B). This workflow is especially 
appealing for interaction screens with a large number of 
bait proteins. 
 
IMPORTING, CURATING AND PROBING LARGE-
SCALE PPI NETWORKS 
While protein interaction screens can uncover novel or 
condition-specific interactions, a wealth of detected 
and predicted interactions are already stored in 
protein-protein interaction databases28. Analyzing 
large-scale PPI networks jointly with other omics data 
has great promise. However, a major obstacle to 
performing systems-level analysis on these large-scale 
networks are lacking easy-to-use software solutions to 
transparently handle the processing and analysis of 
these networks. Many studies under-utilize the existing 
resources and mostly report the interactions of a single 
protein as an after-thought. In the following, we 
introduce the new network capabilities of Perseus to 
assemble, filter, and understand large-scale PPI 
networks, which lay the foundation for any network 
analysis. 
 
The first task is assembling a high confidence interaction 
network. Many databases, such as STRING13, BioGRID14 
or HIPPIE29, allow researchers to download all 
interactions in a tabular format, which can be easily 
loaded into Perseus, even with sizes of up to few 
millions of interactions. Supplementary information on 
the interactions such as, but not limited to, the 
interaction type or a measure of confidence, remain 
available at each step in the subsequent data analysis. 
With this information, generalized interaction 
networks, such as STRING can be filtered by interaction 
type to generate a physical interaction network. 
Confidence measures often integrate diverse 
knowledge into a single score, derived from how often, 
and by which experimental technique, an interaction 
was detected, combined with more abstract measures, 
such as co-expression and literature co-occurrence of 
the interaction partners13. There are two approaches 
for interaction confidence aware network analysis (Fig. 
5a). Applying a cutoff to the confidence score removes 
low-confidence interactions from the network, which is 
especially useful when applying methods that treat all 
interactions equally. The cutoff can be chosen according 
to the confidence score distribution and the targeted 
network size (Fig. 5b). Other methods operate on 
weighted networks and distinguish between 
interactions with high or low confidence. In this case the 
confidence scores can be used as an edge weight. In 
addition to static confidence scores, one can devise 
dynamic confidence scores from experimental data 
which reflect e.g. changes in abundance or localization 
of any of the interactors. 
 
A deeper understanding of the network requires a 
different perspective in addition to the interaction-
centric view. Any list of interactions can be converted 
into a network collection with a single click. A dedicated 
set of network-specific processing activities are now 
available. While processing the list of interactions the 
focus remains on the edges of the network. In the 
network view, the focus is shifted to the nodes. With 
the powerful identifier and data mapping mechanisms 
in Perseus, nodes are easily annotated with various 
annotations, such as gene ontology30 (GO), or 
quantitative proteomics data. Any annotation can be 
subsequently used to filter the nodes of the network. 
One could, for example, extract a subnetwork of 
proteins associated with a specific GO category and 
their interactions from the large-scale network. Using 
the data mapping from e.g. deep proteomes of specific 
cell-lines or tissues, condition-specific subnetworks can 
be created. 
 
Further understanding is gained by studying the 
intrinsic properties of networks. By calculating node 
degrees, corresponding to the number of neighbors of 
each node in the network, hub nodes can be 
distinguished from peripheral nodes. By analyzing the 
distribution of the node degrees in the network, global 
network properties, such as approximate scale-
freeness31 of the topology can be identified (Fig. 5c). 
Furthermore, intrinsic local network properties, like the 
node degree can be correlated with biological 
properties derived from protein annotations or 
experimental data. The proper construction of large-
scale interaction networks and understanding their 
basic properties are central to the successful application 
of more specialized analyses such as the integration of 
such networks with PTM data. 
NETWORK ANALYSIS OF PTM DATA 
The MS-based study of PTMs is nowadays possible on a 
global scale for several types of modifications. The best 
known example is MS-based phosphoproteomics32, 
which is a powerful tool for interrogating signaling 
events on a large scale. However, drawing conclusions 
directly from phosphorylation changes is challenging, 
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due to the mostly missing functional information on the 
inhibitory or excitatory action of a specific protein 
phosphorylation at a specific site. Network-based 
approaches for the analysis of phosphorylation data 
derive functional information on protein-level by 
interrogating the phosphorylation changes observed in 
the network neighborhood33–35. 
 
We implemented the popular kinase-substrate 
enrichment analysis34 (KSEA) tool for predicting kinase 
activities in Perseus. Site-specific kinase-substrate 
networks (Fig. 6a) assign kinases to the experimentally 
observed phosphorylation sites. The core of the analysis 
is the calculation of a series of scores (mean, 
enrichment, Z-score, p-value, q-value) for each kinase, 
based on the quantitative phosphorylation changes of 
its substrates. These predicted kinase activities can be 
analyzed further to find e.g. differentially activated 
kinases or pathways.  KSEA most often utilizes the 
curated kinase-substrate network from the 
PhosphoSitePlus database17,36,37. In order to extend the 
coverage of the network and thereby allow for the 
utilization of a larger fraction of the experimental data, 
the network can be supplemented with predicted 
kinase-substrate interactions from tools such as 
NetworKIN38,39, or with low-specificity interactions 
derived from kinase target sequence motifs. 
 
PHOTON33, now implemented in Perseus, is an 
alternative approach to KSEA that calculates more 
broadly defined signaling functionality scores for any 
protein, rather than activities for kinases only. A data-
annotated large-scale PPI network now serves as the 
input (Fig. 6a). The resulting signaling functionality 
scores for each experimental condition are based on the 
observed phosphorylation in the neighborhood of each 
proteins and are assigned a significance by a 
permutation-based FDR scheme. The scores can either 
be analyzed directly, to find proteins and pathways with 
e.g. differentially changing signaling functionality or 
utilized in a second step of the PHOTON pipeline, in 
which signaling pathways are automatically 
reconstructed from the large-scale network, that 
connect the proteins with significant signaling 
functionality. 
 
The Perseus network module allows for performing 
both KSEA, and PHOTON analysis on the same 
experimental data33 and a choice of networks17,29. Due 
to the differences in the utilized methodologies and the 
chosen networks, resulting scores will differ, but are 
                                                          
7 http://www.peterlangfelder.com/wgcna-resources-on-the-
web/ 
easily compared with the analyses and visualizations 
provided by Perseus (Fig. 6b). Both tools support the 
analysis of datasets with multiple conditions, effectively 
transforming the peptide-level phosphorylation data 
into protein-level scores. The entire well established 
toolset for the analysis of protein quantification data 
can be applied to these scores, including hierarchical 
clustering, enrichment analysis33 and time-series 
analysis40. 
 
We implemented an interactive visualization of kinase-
substrate networks directly in Perseus (Fig. 6c) using the 
cytoscape.js library25. The visualization allows for the 
joint visual inspection of the networks, e.g. 
subnetworks reconstructed by PHOTON, and the 
quantitative phosphorylation data. Browsing the 
quantitative phosphorylation in a reduced and highly 
structured network view while also considering the 
signaling functionality scores, allows for the generation 
of hypotheses that explain the signal transduction 
mechanistically. 
CO-EXPRESSION CLUSTERING AND CLINICAL 
DATA 
When performing co-expression analysis, the 
correlation matrix between the proteins in the dataset 
describes a fully connected, weighted network, in which 
the weight on each edge denotes the correlation 
between the two proteins (Fig. 7a). Hence, the actual 
network usually remains implicit.  A hierarchical 
clustering of the co-expression network can utilize the 
network neighborhood of each protein and integrate it 
into the similarity calculation41. The cluster dendrogram 
and the detected co-expression modules are then 
transferred back to the original data where their 
interpretation is equivalent to ordinary hierarchical 
clustering. In addition to the clustering, a representative 
expression profile for each of the clusters is generated, 
which is termed eigengene. This highly reduced view on 
the data can be correlated with clinical or phenotype 
data and clustered to gain a better understanding of the 
behavior of the detected cluster (Fig. 7b). The described 
co-expression analysis is available in Perseus through 
the R language interface provided by PluginInterop 
which interfaces directly with the established WGCNA 
library42. 
 
We applied the WGCNA co-expression analysis to parts 
of a cancer proteomics dataset43, following the 
recommended workflow7 from within Perseus. Bi-
weight midcorrelation, a robust alternative to Pearson 
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correlation, was chosen to calculate correlations 
between all pairs of proteins. In order to obtain a scale-
free co-expression network, a power parameter of 10 
was selected (Fig. 7c), leading to an approximately 
scale-free network with a scale-free fit index of 0.9. 
Hierarchical clustering of the co-expression network 
identified 30 modules (Fig. 7d). The representative 
expression profiles of each of the modules, as provided 
by the corresponding module eigengene, were 
correlated with the available clinical annotations. This 
high-level overview over the data was then visualized in 
a heatmap (Fig. 7e). Several modules showed high 
correlations with specific clinical annotations. The 
magenta module showed high correlation with the 
triple-negative subtype (TN) and was highly enriched for 
the ‘interferon-gamma-mediated signaling pathway’ 
GO category. The top module hub genes with kME > 0.8 
were GBP1, TAP1, TAPBP, HLA-A, TAP2, STAT1, and 
EML4. The purple module showed high correlation with 
Stage III, but and in depth look at the co-expression 
clustering heatmap revealed the module to be 
dominated by a single patient, limiting the validity of the 
module. 
SOFTWARE IMPLEMENTATION, DOWNLOAD AND 
MAINTENANCE 
The Perseus network module PerseusNet is 
implemented in the C# programming language using 
Visual Studio 2017, like the whole Perseus software. 
PerseusNet is distributed with Perseus by default and 
can be downloaded from http://www.perseus-
framework.org. The current version, which is described 
in this manuscript, is 1.6.2.3. The PluginInterop and 
PHOTON plugins are also included in the standard 
download. In the current release, it is recommended to 
use Windows as operating system, although Linux 
support is underway, realized in the same way as for the 
MaxQuant software44,45, by ensuring Mono 
compatibility. A plugin API enables external 
programmers to extend the functionality of PerseusNet 
and Perseus in general, by programming their own 
workflow activities. Plugin extensions by the user 
community will be linked from the plugin store at 
http://www.coxdocs.org/doku.php?id=perseus:user:pl
ugins:store upon request. Context-specific 
documentation is linked from each activity 
(Supplementary Fig. 3). Step-by-step guides for the 
integration of external tools, such as Python or R, that 
have to be installed and configured separately from the 
main Perseus software, are available online8. A help 
forum for Perseus and PerseusNet is available at 
https://groups.google.com/group/perseus-list. Bugs 
                                                          
8 https://github.com/jdrudolph/PluginInterop 
that are reproducible in the latest available software 
version should be reported at 
https://maxquant.myjetbrains.com/youtrack. 
DISCUSSION 
We introduced PerseusNet, the network analysis 
extension for the Perseus software. It enables 
proteomics researchers to perform most network 
analysis by themselves. PerseusNet is highly extensible 
through a plugin API and its extension to R and Python, 
which allows for the incorporation of a plethora of 
existing scripts and programs from the network 
community. We envision that large part of the future 
programming will not be done by local developers, but 
by the global community through the plugin API. 
Programmers can release their plugins under licenses of 
their choice.  
 
We have implemented powerful proteomics-specific 
activities for AP-MS network generation and PTM-
related network analysis, presumably the two main 
applications for networking in proteomics. We plan to 
extend PerseusNet in the near future by activities from 
other proteomics sub-domains, as interaction 
determination by protein correlation profiling46 and 
large scale network generation from cross-linking 
experiments on whole cell lysates47. 
ONLINE METHODS 
CREATING INTERACTION NETWORKS FROM PULL-
DOWN EXPERIMENTS 
We created an interaction network from a pull-down 
screen27 (Fig. 4). First, .RAW files were obtained from 
PRIDE (PXD003758) and processed with MaxQuant 
version 1.6.2.10. Mouse protein sequences were 
downloaded from UniProt (release 2017_07). 
Parameters ‘matching between runs’ and ‘LFQ’ were 
selected in addition to the default parameters. 
Downstream analysis of the ‘proteinGroups.txt’ output 
table was performed in Perseus. Columns for baits Eed, 
Ring1b, and Bap1 and their controls in the ESC and NPC 
cell lines were selected and log transformed. 
Quantitative profiles were filtered for missing values, 
and were filtered independently for each of the bait 
control pairs, retaining only proteins that were 
quantified in all three replicates of either the bait, or 
control, pull down. Missing values were imputed (width 
0.3, down shift 1.8) before combining the tables, 
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resulting in a total list of 2995 proteins on which the 
multi-volcano analysis was performed (Supplementary 
Table 1). The s0 and FDR parameters for Class A (s0=1, 
FDR=0.01%) and Class B (s0=1, FDR=0.2%) were chosen 
by visual inspection, aiming for a low number of 
significantly depleted proteins in any of the 
experiments. The interaction network was created by 
connecting significantly enriched prey proteins to their 
baits. Edges representing known protein complex 
interactions were annotated in the network. Due to 
missing mouse CORUM annotations for any of the baits, 
mouse CORUM annotations were obtained by mapping 
between mouse and human homologues as listed in the 
MGI48 database. The resulting annotated network was 
then visualized in Perseus. 
Approximately scale-free topology of the STRING 
interaction network 
In order to investigate the topology of a large scale 
interaction network (Fig. 5), we first downloaded the 
human STRING interaction network (v10.5) from the 
website. After filtering for high confidence interactions 
(>0.9), the scale-free fit index was calculated according 
to reference42. Node degrees were calculated and 
plotted against their frequency distribution on a log-log 
scale. The R^2 of a linear fit to the log-log space 
represents the scale-free fit index. 
NETWORK ANALYSIS OF A PHOSPHO-PROTEOMIC 
DATASET OF EGF STIMULATION 
Two separate analyses, PHOTON and KSEA, were 
performed on the same experimental dataset33 
(Supplementary Table 2) and compared (Fig. 6). Log2 
fold-changes for EGF from two replicates were 
averaged. For PHOTON analysis, we first generated a 
high-confidence PPI network. We downloaded all 
interactions from HIPPIE and filtered them for high 
confidence interactions (confidence > 0.72) and 
additionally removing high-degree nodes (degree < 
700). The experimental data was mapped from UniProt 
to Entrez GeneIDs and subsequently used to annotate 
the nodes of the network. We then performed PHOTON 
analysis with adjusted default parameters. Network 
reconstruction with ANAT was enabled with the 100 
highest scoring proteins and EGF anchor (GeneID 1950). 
Additionally, we increased the number of permutations 
to 100,000. The KSEA analysis was performed on the 
human site-specific kinase-substrate network from 
PhosphositePlus17. Data and network were matched 
based on UniProt identifiers. The resulting KSEA Z-
scores and PHOTON signaling functionality scores were 
plotted against each other in Perseus. Proteins 
annotated with the GO category ‘Epidermal growth 
factor receptor signaling pathway’ (GO:0007173), were 
highlighted in red. 
Co-expression analysis of a clinical proteomics dataset 
We applied the co-expression network analysis 
workflow to a clinical proteomics dataset (Fig. 7). 
Protein quantification data and clinical annotation were 
obtained from Yanovic et al.43. SILAC ratios were first 
transformed to log(light/heavy). The dataset was 
filtered for the 43 patients unique to Yanovich et al. 
Using global hierarchical clustering of the patients, 4 
outlier samples were identified and removed from the 
dataset. Additionally, proteins with less than 70% valid 
values were removed from the dataset and the resulting 
patient profiles were Z-scored (Supplementary Table 3). 
The power parameter for the co-expression analysis 
was selected using the ‘Soft-threshold’ activity. Using a 
signed network and the biweight midcorrelation, the 
power 10 was the lowest to a have scale-free fit index 
of more than 0.9 (Figure 7c). Proteins where then 
subjected to co-expression clustering (Figure 7d) and 30 
co-expression modules were identified. The eigengene 
of each co-expression module was correlated with the 
provided clinical data using Pearson correlation and 
clustered using hierarchical clustering (Figure 7e). 
PLUGININTEROP PROVIDES A CENTRAL ENTRY-
POINT FOR ALL EXTERNAL PLUGINS 
The PluginInterop project is written in the C# 
programming language and implements several Perseus 
plugin APIs. For users it provides a number of activities 
in Perseus for executing script files written in the Python 
and R languages. Upon selection of any of these 
activities, users will be prompted with a parameter 
window, allowing them to pass additional arguments to 
the script and requiring them to specify the executable 
that should be used for processing. Since Perseus does 
not include an installation of Python or R, users will have 
to install those and any other dependencies separately. 
PluginInterop aids the user by trying to automatically 
detect an existing installation and provide meaningful 
error messages in case of missing dependencies. 
Developers can additionally leverage the functionality 
implemented in PluginInterop as a basis for 
parametrized scripts. In general, developers are free to 
choose which external scripting language or program 
they would like to utilize. We found the R and Python 
scripting languages to be most useful, which is why we 
provide two companion libraries `perseuspy` and 
`PerseusR` to be used alongside PluginInterop. These 
libraries aid the communication between Perseus and 
the script. 
The communication between Perseus and external 
scripts is straightforward and is easily implemented for 
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any tools of choice. In short, Perseus will persist all 
necessary data to the hard-drive and call the specified 
tool with specific command-line arguments. The first 
arguments contain all the parameters specified by the 
user, per choice of the developer, either in an XML 
format, or simply separated by spaces. Secondly, the 
input data from the workflow is saved to a temporary 
location which is passed to the script. The final 
arguments specify the expected location of the output 
data. The external process can provide status and 
progress updates to the user, as well as detailed error 
reporting by printing to stdout/stderr and indicating 
success or failure through the exit code. Once the 
process exits, Perseus will parse the output data for its 
expected location and insert it to the workflow. Any 
step in the pipeline is customizable for advanced 
scenarios, such as custom data formats. 
 
The PluginInterop binary is automatically included in 
the latest Perseus version. The source code was 
published under the permissive, open-source MIT 
license, on Github9. The website also provides more 
information on how to develop plugins, including a 
video demonstration. The plugins presented in this 
manuscript are all developed on top of PluginInterop 
and the perseuspy and PerseusR companion libraries. 
LIBRARY SUPPORT FOR SCRIPTING LANGUAGES 
We implemented libraries in R and Python, which 
facilitate the interoperability of Perseus with external 
scripting languages. The main aim of these libraries is to 
map the data structures of Perseus to a counterpart 
native to the external language. Developers proficient 
in these languages will be more comfortable and 
productive with these native data structures. The 
largest benefit comes from the resulting integration 
with the existing data science ecosystem, all now 
available to Perseus plugin developers. 
The `perseuspy` module provides data mappings for the 
Python language. The Perseus expression matrix is 
mapped the ` DataFrame` object of the popular ` pandas` 
module, which is tightly integrated with `numpy`, the 
de-facto standard for numerical computations in 
Python. The Perseus network collection data-type maps 
to a list of networks from the `networkx` package. It 
features a variety of graph algorithms and interfaces 
well with other modules, due to its usage of standard 
Python dictionaries. `perseuspy` is distributed via The 
Python Package Index (PyPI), allowing for easy 
installation of the module for developers and users 
alike. The code of `persuspy` is published under the 
permissive, open-source MIT license, and available 
                                                          
9 https://github.com/jdrudolph/PluginInterop 
alongside usage examples and more information on 
https://github.com/jdrudolph/perseuspy. 
For the R language, we implemented the `PerseusR` 
package. It provides a mapping of the Perseus 
expression matrix to a custom wrapper class around the 
R `data.frame` object. The wrapping was necessary to 
represent Perseus-specific information such as 
annotation rows. Alternatively, developers can load 
data as a Bioconductor `expressionSet` object which 
enables the interface with the entire Bioconductors 
bioinformatics suite. Currently there is no support for 
network collections in `PerseusR`, but we plan to 
implement it in the near future. `PerseusR` is also 
published under the MIT license and its code is available 
on https://github.com/jdrudolph/PerseusR. Currently 
`PerseusR` is easily installed directly from the website. 
Due to the lengthy submission process, `PerseusR` will 
be uploaded to CRAN at a later point in time. 
IMPLEMENTATION OF PLUGINPHOTON 
We implemented a Perseus plugin for the PHOTON tool 
on top of the functionality provided by PluginInterop 
and perseuspy. PHOTON was previously capable to run 
only a single experiment at a time with a fixed human 
protein-protein interaction network. We expanded its 
implementation to allow for parallel processing of any 
number of experiments on any network. These changes 
make large datasets from any species directly amenable 
to PHOTON analysis. PluginPHOTON is published under 
the MIT licence, its code is available on 
https://github.com/jdrudolph/photon, and it is 
included in the latest Perseus release. 
IMPLEMENTATION OF PLUGINCOEXPRESSION 
We implemented parts of the WGCNA pipeline as a 
Perseus plugin. PluginCoExpression provides access to 
the WGCNA functions implemented in the R language 
via PluginInterop and PerseusR. 
Implementation of KSEA in Perseus 
KSEA analysis was implemented in Perseus and tested 
for correctness against the reference implementation. 
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FIGURES 
 
Figure 1 Schematic overview of the new network functionality in Perseus. PerseusNet implements a number of processing and 
analysis steps facilitated by the network collection data type. While including proteomics centric analyses, such as for the 
analysis of interaction screens, the network module also provides a number of general purpose tools, as, for instance, for 
network annotation, filtering, and topology determination. With the extension of the Perseus plugin API to networks and 
furthermore to other programing languages, it becomes possible to integrate existing network analysis tools in Perseus. 
Networks are easily imported to, and exported from Perseus, due to its support for standard formats. 
2.1. A NETWORKMODULE FOR PERSEUS 63
 
13 
 
 
Figure 2 Schematic representation of the network collection data type. User facing information is displayed in tabular form 
with tables listing the networks in the collection, as well as providing detailed information on the nodes and edges of each 
network. Internally an auxiliary graph data structure aids in the implementation of graph algorithms. Node- and edge-mapping 
provide the required cross-references between the tabular and graph representation. 
 
Figure 3 Schematic of the Perseus plugin system. Plugins written in C# are native to Perseus and implement their functionality 
directly on top of the APIs and data structures provided by the application framework. PluginInterop enables the execution of 
scripts in the Python and R languages, as well as other external programs. By communicating via the file system, data is 
transferred between Perseus and the external program. The companion libraries perseuspy and PerseusR enable developers 
to access the data science ecosystem in their language of choice. For custom GUI elements and an improved user experience 
of external tools, developers can implement a thin C# wrapper class that extends the generic functionality of PluginInterop. 
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Figure 4 AP-MS. a The Hawaii plot provides an overview over the entire dataset27 (Supplementary Table 1 and online methods) 
consisting of three baits in two conditions. Significant interactors are determined using a permutation-based FDR and the 
resulting Class A (solid line) and Class B (dashed lines) thresholds are displayed in the plot. Class A interactors are displayed in 
dark grey, other proteins are shown in light grey. b Enrichment plot comparing the Eed pull downs in ESC and NPC cell lines. 
Significant interactors in any of the two conditions are displayed in black, non-significant proteins are displayed in light grey. 
Proteins differentially enriched in one of the two conditions will be located far from the diagonal and can be identified visually. 
c Visualization of the resulting protein interaction network for both cell lines. Bait proteins are colored in green and their 
interactors are colored in blue. Thick lines represent Class A interactions, thinner lines Class B. Interactions which were already 
annotated in the human CORUM database are highlighted in red. 
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Figure 5 Handling large-scale protein interaction databases in Perseus. a Interactions in PPI databases are often annotated 
with confidence scores derived from various sources. Static confidence scores can combine experimental evidence and 
predictions of physical interaction as well as non-physical interactions between the proteins. Confidences can be adjusted 
dynamically based on condition-specific data to better represent the changed wiring. In any analysis a high-confidence network 
can be obtained by removing edges below a given hard threshold. Many analysis can directly utilize confidence scores as so-
called edge weights, thereby allowing for the inclusion of lower-confidence interactions. b Histogram of the combined 
confidence score from the human STRING PPI network. Superimposed in orange is the number of interactions in the filtered 
network if the edges with scores lower than the current value were removed. Filtering out low confidence edges leads to a 
significant reduction in the number of edges in the final network. c Log-log plot of the node degree against the degree 
frequency generated from the human STRING PPI network. The R^2 value of the linear fit (orange) to these data represents 
the scale-free fit index. 
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Figure 6 Network analysis of an EGF stimulation phospho-proteomics study. a Comparison of network topologies used for the 
analysis of phospho-proteomic data. Nodes in the network are represented as grey circles or pie-charts where each slice 
represents the observed phosphorylation changes at a specific site on the protein. Physical protein-protein interactions (left 
side) are present between all classes of proteins and are by definition undirected. In order to capture the enzymatic action of 
kinases more accurately, directed interactions (right side) from kinase to substrate are defined in a site-specific manner. b 
KSEA Z-score and PHOTON signaling functionality scores derived from phospho-proteomic data measured after EGF 
stimulation (Supplementary Table 2) only weakly correlate to each other (Pearson correlation 0.52). Kinases annotated in GO 
with the term ‘Epidermal growth factor receptor signaling pathway` are highlighted in red. Both methods assign high scores to 
central members of the expected pathway. c Signaling network reconstructed by PHOTON from the 100 highest scoring 
proteins anchored at EGF. The interactive visualization has an automatic layout and phosphorylation data overlay. 
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Figure 7 Co-expression network analysis on clinical data. a Any correlation matrix can be interpreted as a fully-connected 
network with edge weights corresponding to the correlation between the proteins. Hierarchical clustering of the correlation 
matrix can utilize a network-based distance function. b Co-expression clustering and identified co-expression modules 
annotate the original expression matrix. Phenotype data can be correlated with representative co-expression module profiles 
and provide a high-level interpretation of the modules. c Parameter selection of the power parameter for the Yanovich et al.43 
dataset (Supplementary Table 3 and Online Methods). The lowest power reaching close to a high scale-free fit index of 0.9 (red 
line) was selected. d Co-expression cluster dendrogram and assigned modules. e Correlation heat map between module 
eigengenes and clinical parameters.  
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2.2 Phosphoproteomics of cortical synapses
The following manuscript is the second in a series of two manuscripts studying the
effect of the circadian clock and sleep wake pressure on the transcriptome, proteome
and phosphoproteome of cortical synapses. It is the first report on the circadian regu-
lation of cortical synapses, which were previously studied only at the lower temporal
resolution of sleep and wake states [Wang et al., 2018, Diering et al., 2017].
In the first manuscript, the transcriptome and proteome of forebrain synaptosomes
was analyzed at three different times of day with state-of-the art technology. 70% of
transcripts were found to exhibit daily dynamics that correspond to the light to dark
and dark to light transitions. The transcripts peaking at each transition were found
to relate to synaptic function during the light to dark transition, and metabolism and
translation at the dark to light transition. The proteome data corroborated these find-
ings under wild-type conditions. Under sleep pressure, unlike the transcripts, none of
the detected proteins retained their daily dynamics. In conclusion, the circadian clock
was found to drive transcription, while protein synthesis was driven by the actual sleep
to wake transitions.
The second manuscript focusses on the phosphoproteomic characterization of the
daily dynamics of synaptosomes. A periodicity analysis of the more than 14,000 identi-
fied phosphopeptides found around 30% of the peptides to have an oscillatory behav-
ior. Most phosphopeptides peaked during the light to dark and dark to light transitions
and were found to be associated with synaptic transmission, cytoskeleton reorganiza-
tion and excitatory/inhibitory balance. In comparison, after sleep deprivation, 95% of
the phosphoproteome did not exhibit any time-of-day dependent dynamics. By ana-
lyzing the network of kinases and their substrates, we identified rhythmically active
kinases which were themselves controlled by temporal phosphorylation.
My contribution to the study was the analysis of the circadian phosphoproteome
by extending and applying the PHOTON algorithm [Rudolph et al., 2016]. The ex-
tension of PHOTON to handle multiple conditions and any PPI network [Rudolph
and Cox, 2018] allowed me to apply it to this dataset in combination with the mouse
STRING [Szklarczyk et al., 2017] interaction network, and calculate signaling function-
ality scores for all kinases. The results are presented in Figure 4 and described in the
results and methods sections.
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Abstract 
The circadian clock drives daily changes of physiology, including sleep-wake cycles, by regulating 
transcription, protein abundance and function. Circadian phosphorylation controls cellular processes in 
peripheral organs, but little is known about its role in brain function and synaptic activity. We applied 
advanced quantitative phosphoproteomics to mouse forebrain synaptoneurosomes isolated across 24h, 
accurately quantifying almost 8,000 phosphopeptides. Remarkably, half of the synaptic phosphoproteome, 
including numerous kinases, had large-amplitude rhythms peaking at rest-activity and activity-rest 
transitions. Bioinformatic analyses revealed global temporal control of synaptic function via 
phosphorylation, including synaptic transmission, cytoskeleton reorganization and excitatory/inhibitory 
balance. Remarkably, sleep deprivation abolished 98% of all phosphorylation cycles in synaptoneurosomes, 
indicating that rest-activity cycles rather than circadian signals are main drivers of synaptic 
phosphorylation, responding to both sleep and wake pressures.  
One Sentence Summary 
Sleep and wake pressure shape synaptic phosphorylation dynamics and function 
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Introduction  
Circadian clocks are endogenous oscillators present in virtually every mammalian cell. The molecular 
mechanism of the clock drives cycles of transcription, translation and protein activity to regulate daily 
changes in physiology and behavior. Mass spectrometry (MS) - based quantitative proteomics has 
importantly contributed to our understanding how circadian post-transcriptional mechanisms temporally 
shape metabolic processes in peripheral tissues (1, 2). Interestingly, circadian phosphorylation changes by 
far eclipse the regulation at the transcriptional and proteome levels in amplitude (3). Temporal 
characterization of proteome and phosphoproteome changes in the central nervous system, in contrast, has 
been challenging due to the sensitivity, dynamic range and throughput required to capture the regional, 
cellular and synaptic heterogeneity. However, recent advances in MS in combination with spatial isolation 
methods allow the deep characterization of proteomes from different brain regions and cell populations (4, 
5). In addition, high-throughput phosphoproteomic technologies are now suitable for the global 
characterization of phosphorylation signaling dynamics in different brain areas (6).  
Numerous synaptic features, like diffusion of receptors in membranes, channel conductance or cytoskeleton 
remodeling, depend on fast phosphorylation-based control mechanisms. In particular, synaptic plasticity 
and scaling have been linked to phosphorylation of receptors, scaffolding, cytoskeletal and other synaptic 
proteins (7, 8). Although quantitative phosphoproteomics has been applied to the synaptic compartment, 
technical limitations have so far precluded accurate quantification that would allow the precise 
characterization of global phosphorylation dynamics associated with synaptic function (7). It is thus 
unknown whether daily changes in synaptic activity are coupled to global dynamics of phosphorylation in 
synapses, and moreover, whether daily rhythms of phosphorylation temporally segregate synaptic 
processes. Two recent reports have addressed these technical limitations by either fractionating post-
synaptic density (9) or by mapping whole-brain phosphoproteomics to synaptic protein annotations (10). 
Both highlight a role for sleep pressure in driving synaptic phosphorylation changes associated with the 
kinase (SIK3) and downstream effectors (HOMER1a).  
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Here we apply state-of-the-art quantitative MS-based proteomics to characterize in vivo phosphorylation 
dynamics across the day in isolated synaptoneurosomes from mouse forebrain, resulting in by far the most 
comprehensive time-resolved phosphoproteome of synapses to date. Combination with in depth proteomics 
(see accompanying paper (11)) reveals that more than one fourth of the individual phosphorylation sites in 
synaptic proteins oscillate daily and independently of protein abundance. We bioinformatically analyze 
dynamic synaptic process and the regulatory protein classes modulated by phosphorylation.   
Temporally modulated phosphorylation networks gate synaptic processes at both dawn and dusk, 
suggesting a potential association with activity-rest cycles. To test this, we interfere with the sleep cycle 
and investigate the effect on the synaptic phosphoproteome. This leads to a dramatic ablation of global 
phosphorylation cycles, suggesting a dominant role of both sleep and wake pressure in synaptic 
phosphorylation dynamics.  
Results 
In-depth phosphoproteomic profiling of synaptoneurosomes  
To characterize daily dynamics of phosphorylation abundance specifically in synapses, we biochemically 
isolated synaptoneurosomes from mouse forebrains (11). Mice were kept in 12h:12h (light : dark) schedules 
and then sacrificed in biological quadruplicates at six time points, every 4 h, across 24 h (n=24 mice). We 
used a rapid method based on Percoll gradients to prepare synaptoneurosomes from forebrains, containing 
both pre- and post-synaptic components (12) and immediately flash-froze them to prevent de-
phosphorylation. To achieve sufficient throughput for our time-dependent experiments, we employed the 
EasyPhos method (13) to enrich phosphopeptides from only 1 mg of proteome homogenate for each 
synaptoneurosome preparation. Figure 1A depicts the MS-based quantitative phosphoproteomics workflow 
consisting of single runs on a high-resolution, high sensitivity quadrupole-Orbitrap HF-X mass 
spectrometer. Across all samples this resulted in a total of 10,439 unique phosphosites in 14,462 
phosphopeptides, mapping to more than 2,000 proteins (Fig. 1B and table S1). Comparing phosphorylated 
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amino acids in synapses to our previous circadian study in the liver (3) revealed similar proportions (83.6 
% pS, 15.7% pT, 0.6% pY; Fig. 1B). Phosphopeptide intensities between measurements were highly 
reproducible in both biological replicates and time points (Pearson r = 0.88 and 0.83, respectively; Fig. 
1C). Synaptic phosphopeptide intensities ranged over five orders of magnitude (fig. S1A), similar to what 
we found in liver, indicating that the synaptic compartment still has a wide quantitative range of 
phosphorylation levels. To indirectly evaluate our isolation method, we performed a Fisher’s exact test on 
the total phosphoproteome dataset. Of all keywords, the top two are “Synapse” and “Cell junction” (p < 
10e-40 for both) and the other highly enriched ones are also all relevant to synaptic function, even when 
analyzing every time point separately (Fig. 1D fig. S1B and S1C and see Methods). Our data show the 
power of combining high-throughput phosphoproteomics with biochemical isolation of synaptoneurosomes 
to deeply profile phosphorylation in this discrete neuronal compartment.  
 
Daily rhythms of the synaptic phosphoproteome  
Next we performed statistical cycling analysis in the circadian module of the Perseus software (2, 3, 14), to 
filter and cosine-fit the phosphopeptide intensities. A total of 2,202 (30.4%) of the 7,257 phosphopeptides 
accurately quantified in at least 50% of the samples oscillate in abundance with a rhythm of 24h (q-value 
< 0.05, see Methods, Fig. 2 A and B and table S2). We detected rhythmic phosphorylation for more than 
half of the synaptic phosphoproteins (838 out of the total 1,655, Fig. 2C). These rhythmic sites were 
localized with high probability to a single residue (mean 0.97) and their amino acid distribution was similar 
to the total dataset (Fig. 1C and fig. S2A). Cycling phosphopeptides had a similar intensity distribution as 
the total phosphoproteome (fig. S2B), implying that circadian phospho-regulation is not biased by 
abundance. Little is known about the magnitude of dynamic phosphorylation changes in the synaptic 
compartment and our data now revealed that these changes are substantial: the mean amplitude changes are 
more than three-fold, with hundreds of sites at more than 10-fold (Fig. 2D).  
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To assess to which extent these phosphorylation dynamics depend on protein abundance changes, we 
quantitatively compared the levels of phosphopeptides with the abundance of the corresponding protein. 
Almost 90% of proteins with cycling phosphopeptides were quantified at the protein level in our companion 
study (11), and of these only 5% significantly oscillate in abundance (q < 0.05, 24h period, Fig. 2E). Even 
the small fraction of rhythmic proteins with oscillating phosphorylation generally displays different phases 
across the day, and furthermore, multiple sites in the same protein generally behaved differently (Fig. 2F, 
fig. S2C). In the minor population of rhythmic proteins carrying cycling phosphorylation, the mean 
amplitudes at the phosphorylation level were ten-fold larger than those at the protein level (Fig. 2G). Our 
data clearly establish that protein phosphorylation in forebrain synaptoneurosomes is highly dynamic across 
the day and almost completely independent of protein abundance, suggesting another layer of synaptic 
functional regulation.  
Temporal compartmentalization of synaptic protein phosphorylation  
Our previous study in liver revealed that dynamic phosphorylation drives daily organ functions to an 
previously unappreciated degree (3). Examining the phosphorylation rhythms in the synaptic compartment 
showed that the phases of rhythmic phosphopeptides gathered in two distinct clusters. The larger one, at 
the light to dark transition when mice start to be active, contains two thirds of them, whereas the remaining 
largely clusters at the end of the night, preceding the resting phase (Fig. 3A). This phase distribution 
indicates a major rewiring of protein phosphorylation and presumably synaptic function at the activity-to-
rest and rest-to-activity transitions. In order to identify synaptic functions that are temporally 
compartmentalized by protein phosphorylation, we searched for statistically enriched protein annotations 
in each of the two defined phase clusters (Fisher’s exact test p<0.05, see Methods). At the end of the resting 
phase, our analysis found keywords representing Cell adhesion and Cell junction as well as Ion channels, 
Ion transporters, Hydrolases and Kinases highly enriched. In contrast, Cell projection, Cytoskeleton and 
Ubiquitin conjugation proteins are rhythmically phosphorylated in the cluster at the end of the activity phase 
(Fig. 3, B and C, table S3). This highlights the temporal regulatory nodes involved in the remodeling 
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processes that are known to occur at synapses (15). Proteins involved in Cell division and Mitosis were also 
overrepresented in the phosphorylation cluster at the end of the activity phase. Although far from the 
nucleus, the localization and function of some proteins with key roles in cell division, e.g. CDK5, are also 
important for synaptic activity (16), and such unexpected connections may be true for other proteins. We 
suggest that the combination of an in-depth, quantitative workflow with spatial isolation can enable the 
identification of phosphorylation events in proteins not traditionally associated with synaptic function.  
Synapses are hubs of kinases 
We next focused our attention on the major and specific enrichment of kinases, key regulators of almost all 
cellular process, at the end of the resting phase. Almost 500 phosphorylated peptides from a total of 128 
kinases from all major families. Thus a fifth of the total mouse kinome is not only present in the synaptic 
compartment but also detectable in a phosphorylated form (fig. S3A). More than half of these kinases show 
at least one rhythmic phosphorylation with the same overall phase distribution as the total cycling synaptic 
phosphoproteome (q < 0.05, Fig. 4A, fig. S3B, 3C and table S4). They belong to all major kinase families 
with a higher representation of AGC threonine/serine kinases (Fig. 4B and fig. S3D). All of the 66 kinases 
with rhythmic phosphorylation were also quantified at the protein level in this compartment (11), however, 
only four of them cycled in protein abundance (fig S3E). Therefore, phosphorylation, rather than protein 
abundance, regulates temporal kinase function at synapses across the day. 
Since site-specific phosphorylation does not always imply changes in activity, we set out to identify 
temporally activated kinases with an unbiased workflow that uses high-confidence protein-protein 
interaction networks and large-scale phosphorylation data to retrieve protein signaling functionality. This 
PHOTON pipeline assigns a score to each protein based on the phosphorylation status of their interacting 
proteins (17). As these scores reflect the changes in phosphorylation levels of their substrates/interactors, 
kinases that are activated rather than only phosphorylated should have PHOTON scores cycling across the 
24h, with the maximum score indicating the peak of kinase activity. From all synaptic kinases with rhythmic 
phosphorylation, this analysis resulted in rhythmic activity patterns for 13 of them (see Methods). Of these, 
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11 are active at the rest-activity transition, including protein kinase C (PRKCA, PRKCB, PRKCG) and 
Ca2+/calmodulin-dependent kinase 2 (CAMK2B, CAMK2G). Conversely, the tyrosine-protein kinase 
ABL2 and the serine/threonine-protein kinase DCLK1 showed the opposite behavior, peaking at the 
activity-rest transition (Fig 4, C and D). Interestingly, the kinases activated at the end of the rest phase are 
associated with excitatory synaptic activity (8) while those activated at the end of the activity phase are 
associated with inhibitory synaptic activity (18, 19). PHOTON scores were also used to predict temporally 
regulated synaptic processes by means of phosphorylation dynamics (see Methods). In line with our kinase 
activity results, we inferred that the triggering of inhibitory synaptic mechanism, involving GABA, happens 
at the end of the activity period, while glutamate-mediated synaptic excitatory activity was predominantly 
associated to the rest-activity transition (Fig. 4E). These data are consistent with the roles of these synaptic 
types in rest and activity, respectively (20, 21). While the existing network data are sufficient to associate 
rhythmic activity with a substantial subset of the kinases, more complete networks will likely establish 
activity changes for a much larger fraction of the cycling synaptic phosphoproteome in the future. Together 
the combination of predictive and experimental data places extensive temporal regulation of kinases activity 
at the core phospho-dependent functional processes at the synapse. 
Sleep deprivation abrogates synaptic phosphorylation rhythms 
We hypothesized that the sharp distribution of synaptic phosphorylation patterns concomitant with the 
activity transitions may reflect sleep pressure (a sleep homeostat) in addition or alternatively to circadian 
(time-of-day) mechanisms. To test their relative contribution, we subjected mice to 4h sleep deprivation 
(SD) by gentle handling (22) prior to each timepoint, and collected brains every 6h in 24h (n=4/time point; 
Fig. 5A). This protocol of SD across the 24h time course equalizes the sleep pressure to keep it constantly 
high (23). Synaptoneurosomes from forebrain were prepared from SD mice, and phosphopeptides enriched 
prior to MS analysis as above (Fig. 5A, see Methods). We accurately quantified 7,021 phosphopeptides in 
at least 50% of the measured samples, very similar values to those in the base-line experiment, with more 
than 90% overlap between them (fig. S4A). Strikingly, cycling analysis of the 6,526 phosphopeptides 
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revealed almost complete abrogation of rhythmic phosphorylation in the synaptic compartment of SD mice. 
Only 2.3% (47 phosphopeptides corresponding to 41 proteins) cycled in SD (period=24h, q < 0.05, see 
Methods, Fig. 5, B and C, fig. S4B-D, table S5). These few remaining cycling phosphopeptides oscillated 
with similar amplitudes and with comparable phases in both conditions (Fig. 6A-C). 
Since sleep pressure did not affect the pattern of the remaining rhythmic phosphopeptides, they appear to 
only be driven by the circadian clock. Of the corresponding 41 synaptic phosphoproteins, 31 form a protein 
interaction network with SHANK3, RTN4, MTAP1B, STX1, MYO5A and HSP90 at the core, much more 
than expected by chance (see Methods, fig. S5). They belong to interconnected cellular structures such as 
cytoskeleton, synaptic scaffolding, membrane, vesicle trafficking, and ubiquitin mechanisms, all important 
for synaptic integrity and function (24-26). Almost a third are cytoskeletal proteins with molecular motors 
such as MTAP1B and MYO5A and other microtubule associated proteins (MTAP4, KIF21A, STMN3, 
STMN1, ABI1). Furthermore, under SD rhythmic phosphorylation is also preserved on proteins involved 
in synaptic vesicle formation and exocytosis, which is essential for chemical neurotransmission (CHGB, 
STX1A, STXBP5). Cell adhesion (RTN4, PGRMC1, BASP1, NRCAM, CADM1) and scaffolding proteins 
(SHANK3, PICCOLO, BASSOON) are likewise unaffected, commensurate with the crucial role of these 
proteins in the regulation of synaptic integrity. Finally, the rhythmic phosphorylation of chaperone 
HSP90A, important in the synapse for trafficking of AMPA receptors (24), persisted. Thus only a very 
small number of phosphorylation sites in key synaptic components remain cycling under high sleep 
pressure, perhaps because of indispensable regulatory roles. Our results clearly establish that sleep 
deprivation severely affects synaptic phosphorylation across the day, leading to a dramatic loss in 
rhythmicity.   
Discussion  
Synaptic plasticity and function dynamically change across the day (27). It was already known that changes 
in synaptic activity are associated with the phosphorylation of several signaling proteins (8, 26). However, 
our large-scale quantitative phosphoproteomes of isolated synaptoneurosomes resulted in the first 
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comprehensive time-resolved map of synaptic phosphorylation across the entire activity and rest phases. 
We detected cycles on 30% of phosphorylation events in the synaptic compartment, a fraction far exceeding 
the 5% reported in total mouse hippocampus (28). The phosphoproteome is much more dynamic than the 
proteome (50% of proteins oscillating on at least one site vs. only 5% of oscillating proteins). Similar to 
our previous finding in the liver (3), mean fold-changes of the phosphoproteome are more than three-fold 
higher than in the proteome. At 7,000 accurately quantified phosphopeptides, the depth of our analysis 
allowed in depth bioinformatic analysis, retrieving many known but also highlighting novel temporally 
regulated processes at synapses. Overall, the phases of cycling phosphorylation fall into two main clusters 
at the boundaries of activity-rest transitions, implying a major role of synaptic phosphorylation in this 
process.  
Numerous kinases are expressed in the brain, and some of them have been also localized to the synaptic 
compartment (29). However, our study clearly now classifies the synapse as a major kinase hub. Indeed, 
we detect more than 100 phosphorylated kinases (20% of the total kinome) and found that 50% cycle on at 
least one phosphoresidue. Combining protein interaction network data with our quantitative 
phosphoproteome revealed that these phosphorylation changes regulate the activity of at least a subset of 
them.  
Together, our predictive and experimental data suggest phosphorylation-dependent temporal segregation 
of long-term potentiation (LTP) and long-term depression (LTD). Kinases with higher activity at the end 
of the rest period are involved in LTP, such as CAMK and PRKC, which function directly downstream of 
NMDARs receptor Ca2+ signaling (8). In contrast, ABL2 and DCLK1, two kinases modulating structural 
synaptic plasticity (18, 19) peak in activity at the transition to the rest period. Lack of ABL2 leads to 
elevated NMDAR synaptic currents (19), therefore ABL2 activation at the beginning of the resting phase 
may mediate synaptic downscaling. At the beginning of the active phase, GSK3b is phosphorylated on its 
inhibitory site S389. This blocks LTD and GABAR trafficking (30), further indicating a role of 
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phosphorylation in the temporal segregation of LTP and LTD. Figure 7 summarizes the complex 
phosphorylation pattern of many key components of these processes.  
Together, our data point towards an association of synaptic potentiation with wakefulness (activity) while 
synaptic downscaling with rest. This supports the general synaptic homeostasis hypothesis for sleep – that 
synaptic downscaling is a critical function of sleep (31) at the molecular level and provides starting points 
for a multitude of mechanistic investigations.  
To directly test the contribution of sleep and circadian cycles on phospho-dependent synaptic function, we 
sleep deprived mice at different times during the rest period. We observed that sleep pressure almost entirely 
abrogates global diurnal oscillation of phosphorylation in the synaptic compartment. This discovery 
establishes the importance of the homeostatic regulation of sleep over any other mechanism in generating 
daily rhythms of phosphorylation to modulate synaptic function.  
Independent studies examining phosphorylation and sleep pressure support our findings. A very recent 
analysis in total mouse brain showed that increasing hours of sleep deprivation resulted in increasing 
average phosphorylation levels of 80 synaptic proteins (10). Based on these results, we examined our data 
and found phosphorylations in all of those 80 proteins. Our data also show rhythms over the day in 69 of 
them, although our site-specific data reveal a more nuanced picture than a simple overall increase in 
phosphorylation. Nevertheless, the fact that two completely different experimental approaches find 
concordant regulation on a subset of synaptic proteins provides validation, whereas our rhythmic data 
support the hypothesis that these phosphorylation sites are indeed part of the signatures of sleep.  
Another recent phosphoproteomics study in the synaptic compartment showed that sleep regulates 
dephosphorylation of AMPA receptors in response to HOMER1a-dependent immediate early 
transcriptional signaling (9). Our data independently support these findings, extend them to several other 
neurotransmitter receptors and supply their diurnal rhythms of phosphorylation in response to sleep and 
activity pressure (Fig. 7).   
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Although the vast majority of protein phosphorylation appears to be regulated by sleep or wake states, a 
small number of circadian phosphorylations remain unchanged in amplitude and phase under sleep 
deprivation. These phosphorylations occur in a highly connected node of proteins involved in both synaptic 
vesicle trafficking (molecular motors, microtubule-associated proteins) and synaptic scaffold (SHANK3, 
PICCOLO, BASSOON), overall regulating excitatory synaptic strength, apparently irrespective of sleep-
wake pressure. The fact that circadian rhythmicity regulates cortical function is already well documented 
at both behavioral and molecular levels (32). Together with our data, this makes it likely that even as sleep-
wake pressures dynamically reconfigure synaptic structure and function, an underlying circadian 
rhythmicity continues at the molecular level, accounting for sleep-independent, circadian rhythms in 
cortical function. 
In conclusion, this study represents the first in vivo evidence of orchestration of thousands of 
phosphorylation events in synapses across the day. These extensive phosphorylation rhythms temporally 
segregate synaptic activity in response to activity changes. Our study demonstrates a central role for rest-
activity cycles in regulating phospho-dependent synaptic homeostasis in response to both sleep and wake 
pressure, potentially modulating inhibitory and excitatory synaptic plasticity. Interfering with rest-activity 
cycles almost completely abolished rhythms of phosphorylation in synaptic proteins, which may lead to 
dysfunctional synaptic plasticity associated with sleep deprivation.   
  
2.2. PHOSPHOPROTEOMICS OF CORTICAL SYNAPSES 81
 12 
References 
1. D. Mauvoisin et al., Circadian clock-dependent and -independent rhythmic proteomes implement 
distinct diurnal functions in mouse liver. Proceedings of the National Academy of Sciences of the 
United States of America 111, 167-172 (2014). 
2. M. S. Robles, J. Cox, M. Mann, In-vivo quantitative proteomics reveals a key contribution of post-
transcriptional mechanisms to the circadian regulation of liver metabolism. PLoS genetics 10, 
e1004047 (2014). 
3. M. S. Robles, S. J. Humphrey, M. Mann, Phosphorylation Is a Central Mechanism for Circadian 
Control of Metabolism and Physiology. Cell Metab,  (2016). 
4. F. Hosp, M. Mann, A Primer on Concepts and Applications of Proteomics in Neuroscience. Neuron 
96, 558-571 (2017). 
5. K. Sharma et al., Cell type- and brain region-resolved mouse brain proteome. Nature neuroscience 
18, 1819-1831 (2015). 
6. J. J. Liu et al., In vivo brain GPCR signaling elucidated by phosphoproteomics. Science 360,  (2018). 
7. D. C. Dieterich, M. R. Kreutz, Proteomics of the Synapse--A Quantitative Approach to Neuronal 
Plasticity. Molecular & cellular proteomics : MCP 15, 368-381 (2016). 
8. K. M. Woolfrey, M. L. Dell'Acqua, Coordination of Protein Phosphorylation and Dephosphorylation 
in Synaptic Plasticity. The Journal of biological chemistry 290, 28604-28612 (2015). 
9. G. H. Diering et al., Homer1a drives homeostatic scaling-down of excitatory synapses during sleep. 
Science 355, 511-515 (2017). 
10. Z. Wang et al., Quantitative phosphoproteomic analysis of the molecular substrates of sleep need. 
Nature,  (2018). 
11. S. B. Noya et al., The Cortical Synaptic Transcriptome is Organized by Clocks, but its Proteome is 
Driven by Sleep (2018). 
12. P. R. Dunkley, P. E. Jarvie, P. J. Robinson, A rapid Percoll gradient procedure for preparation of 
synaptosomes. Nature protocols 3, 1718-1728 (2008). 
13. S. J. Humphrey, S. B. Azimifar, M. Mann, High-throughput phosphoproteomics reveals in vivo 
insulin signaling dynamics. Nature biotechnology 33, 990-995 (2015). 
14. S. Tyanova et al., The Perseus computational platform for comprehensive analysis of (prote)omics 
data. Nat Methods 13, 731-740 (2016). 
15. V. M. Ho, J. A. Lee, K. C. Martin, The cell biology of synaptic plasticity. Science 334, 623-628 (2011). 
16. K. O. Lai, Z. Liang, E. Fei, H. Huang, N. Y. Ip, Cyclin-dependent Kinase 5 (Cdk5)-dependent 
Phosphorylation of p70 Ribosomal S6 Kinase 1 (S6K) Is Required for Dendritic Spine 
Morphogenesis. The Journal of biological chemistry 290, 14637-14646 (2015). 
17. J. D. Rudolph, M. de Graauw, B. van de Water, T. Geiger, R. Sharan, Elucidation of Signaling 
Pathways from Large-Scale Phosphoproteomic Data Using Protein Interaction Networks. Cell Syst 
3, 585-593 e583 (2016). 
18. E. Shin et al., Doublecortin-like kinase enhances dendritic remodelling and negatively regulates 
synapse maturation. Nature communications 4, 1440 (2013). 
19. X. Xiao, A. D. Levy, B. J. Rosenberg, M. J. Higley, A. J. Koleske, Disruption of Coordinated 
Presynaptic and Postsynaptic Maturation Underlies the Defects in Hippocampal Synapse Stability 
and Plasticity in Abl2/Arg-Deficient Mice. The Journal of neuroscience : the official journal of the 
Society for Neuroscience 36, 6778-6791 (2016). 
20. C. Cirelli, C. M. Gutierrez, G. Tononi, Extensive and divergent effects of sleep and wakefulness on 
brain gene expression. Neuron 41, 35-43 (2004). 
82 CHAPTER 2. MANUSCRIPTS
 13 
21. V. V. Vyazovskiy, C. Cirelli, M. Pfister-Genskow, U. Faraguna, G. Tononi, Molecular and 
electrophysiological evidence for net synaptic potentiation in wake and depression in sleep. 
Nature neuroscience 11, 200-208 (2008). 
22. I. Tobler, T. Deboer, M. Fischer, Sleep and sleep regulation in normal and prion protein-deficient 
mice. The Journal of neuroscience : the official journal of the Society for Neuroscience 17, 1869-
1879 (1997). 
23. S. Maret et al., Homer1a is a core brain molecular correlate of sleep loss. Proceedings of the 
National Academy of Sciences of the United States of America 104, 20090-20095 (2007). 
24. N. Z. Gerges et al., Independent functions of hsp90 in neurotransmitter release and in the 
continuous synaptic cycling of AMPA receptors. The Journal of neuroscience : the official journal 
of the Society for Neuroscience 24, 4758-4766 (2004). 
25. D. Ivanova, A. Dirks, A. Fejtova, Bassoon and piccolo regulate ubiquitination and link presynaptic 
molecular dynamics with activity-regulated gene expression. J Physiol 594, 5441-5448 (2016). 
26. J. Li et al., Long-term potentiation modulates synaptic phosphorylation networks and reshapes 
the structure of the postsynaptic interactome. Science signaling 9, rs8 (2016). 
27. G. Tononi, C. Cirelli, Sleep and the price of plasticity: from synaptic and cellular homeostasis to 
memory consolidation and integration. Neuron 81, 12-34 (2014). 
28. C. K. Chiang et al., Phosphoproteome Profiling Reveals Circadian Clock Regulation of 
Posttranslational Modifications in the Murine Hippocampus. Front Neurol 8, 110 (2017). 
29. L. L. Baltussen, F. Rosianu, S. K. Ultanir, Kinases in synaptic development and neurological 
diseases. Prog Neuropsychopharmacol Biol Psychiatry 84, 343-352 (2018). 
30. C. A. Bradley et al., A pivotal role of GSK-3 in synaptic plasticity. Front Mol Neurosci 5, 13 (2012). 
31. G. Tononi, C. Cirelli, Sleep function and synaptic homeostasis. Sleep Med Rev 10, 49-62 (2006). 
32. R. Iyer, T. A. Wang, M. U. Gillette, Circadian gating of neuronal functionality: a basis for iterative 
metaplasticity. Front Syst Neurosci 8, 164 (2014). 
33. J. A. Vizcaino et al., 2016 update of the PRIDE database and its related tools. Nucleic Acids Res 44, 
D447-456 (2016). 
34. P. R. Dunkley, P. E. Jarvie, P. J. Robinson, A rapid Percoll gradient procedure for preparation of 
synaptosomes. Nature protocols 3, 1718-1728 (2008). 
35. M. S. Robles, S. J. Humphrey, M. Mann, Phosphorylation Is a Central Mechanism for Circadian 
Control of Metabolism and Physiology. Cell Metab,  (2016). 
36. S. Tyanova, T. Temu, J. Cox, The MaxQuant computational platform for mass spectrometry-based 
shotgun proteomics. Nature protocols 11, 2301-2319 (2016). 
37. S. Tyanova et al., The Perseus computational platform for comprehensive analysis of (prote)omics 
data. Nat Methods 13, 731-740 (2016). 
38. M. S. Robles, J. Cox, M. Mann, In-vivo quantitative proteomics reveals a key contribution of post-
transcriptional mechanisms to the circadian regulation of liver metabolism. PLoS genetics 10, 
e1004047 (2014). 
 
Acknowledgments: We thank K. Mayr, I. Paron and G. Sowa for technical assistance with the 
MS measurements, B. Collins for critical reading of the manuscript and B. Splettstößer for 
technical help with experimental workflow. Funding: This work was supported by the Max-
Planck Society for the Advancement of Sciences and the German Research Foundation 
(DFG/Gottfried Wilhelm Leibniz Prize) funded this study. S.A.B. and S.B.N. were supported by 
the Swiss National Science Foundation, the Velux Foundation, the Human Frontiers Science 
Program, and the Zürich Clinical Research Priority Project “Sleep and Health” and are members 
2.2. PHOSPHOPROTEOMICS OF CORTICAL SYNAPSES 83
 14 
of the Neurosciences program within the Life Sciences Zürich Graduate School; Author 
contributions: S.B.N., M.S.R. and S.A.B. conceived and initiated the project and designed 
experiments; S.B.N., M.S.R. and F.B performed sample preparation and mass spectrometry 
experiments; M.S.R. and F.B. performed bioinformatic and data analysis with help from S.B.N. 
and T.B.; J.D.R. performed PHOTON analysis under supervision of J.C.; S.B.N., F.B., M.S.R., 
S.A.B. and M.M. wrote the manuscript with editing and input from T.B. and J.D.R. Data and 
materials availability: The mass spectrometry proteomics data have been deposited to the 
ProteomeXchange Consortium via the PRIDE (33) partner repository with the dataset identifier 
PXD010697. 
 
Supplementary Materials:  
Materials and Methods 
Figures S1-S5 
Tables S1-S5 
References # (34-38)   
84 CHAPTER 2. MANUSCRIPTS
 15 
 
Fig. 1 Phosphoproteome characterization of synaptoneurosomes isolated across the day from mouse 
forebrains.  
(A) Experimental workflow. (B) Number of identified phosphoproteins, phosphopeptides and phosphosites 
in all measured samples. Lower left: distribution of phosphorylated amino acids (Serine (pS), Threonine 
(pT) and Tyrosine (pY)). Lower right: number of phosphorylated residues from different classes according 
to localization probability -- Class I (probability > 75%), Class II (probability = 50 - 75%) and Class III 
(localization probability < 50%). (C) Heatmap representation of Pearson correlation coefficients calculated 
among phosphoproteomes. Inset: Example scatterplot of phosphopeptide intensities between two biological 
replicates of ZT0. (D) Scatterplot shows protein annotations (UniprotKB keywords) statistically enriched 
(Fisher’s exact test FDR < 0.02) in the total synaptoneurosome phosphoproteome compared to an in-silico 
mouse gene list.  
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Fig. 2 Daily rhythms of the synaptic phosphoproteome. 
(A) Pie chart showing the percentage of phosphopeptides oscillating daily in synaptoneurosomes. (B) Heat 
map with the intensities (log2 z-scored) of each cycling phosphopeptide (rows) across the measure samples 
(columns) ordered by peak of abundance. (C) Pie chart with the percentage of phosphoproteins oscillating 
daily in synaptoneurosomes. (D) Density plot showing the calculated amplitudes of rhythmic 
phosphopeptides in synaptoneurosomes. (E) Pie charts showing the percentage of cycling phosphopeptides 
from proteins quantified in our proteome study (left) and the fraction of cycling phosphopeptides from 
rhythmic proteins (right). (F) Rose plots representing the phase distribution of rhythmic phosphopeptides 
(left) and their corresponding oscillating proteins (right). (G) Density plots comparing the amplitudes of 
the rhythmic phosphopeptides and the corresponding oscillating proteins.  
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Fig. 3 Phosphorylation-dependent temporal control of synaptic functions.  
(A) Rose plot showing the distribution of phases from cycling phosphopeptides of the total 
phosphoproteome. (B) Scatter plot showing the significantly enriched (Fisher’s exact test p < 0.05) Uniprot 
Keywords protein annotations showing peak of phosphorylation cycles in the activity-rest transition (ZT18 
to ZT6). Size of geometric points is proportional to the number of cycling phosphoproteins in the annotation 
and color intensity to the total number of phosphosites. (C) As in B but for the phosphopeptide cluster in 
the transition of rest-activity (ZT6 to ZT18).   
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Fig. 4 Rhythmic phosphorylation and activation of synaptic kinases. 
(A) Rose plot with the phases of cycling phosphopeptides in kinases of synaptoneurosomes. Colors denote 
the clusters of activity-rest transition (ZT18-ZT6, orange) and rest-activity transition (ZT6-ZT18, purple). 
(B) Kinases with at least one phosphorylation cycling annotated to the major kinase families (52 out of the 
total 66 cycling) using http://www.kinhub.org. Tyrosine Kinases (TK), Tyrosine Kinase-Like (TKL), 
Homologs of the yeast STE7, STE11 and STE20 genes (STE), Casein/cell kinase 1 family (CK1), Protein 
Kinase A, G, C families (AGC), Calmodulin/Calcium regulated kinases and some non-calcium regulated 
families (CAMK), CDK, MAPK, GSK3 and CLK kinase families (CMGC). Atypical kinases are not 
shown. (C) Protein interaction network of PHOTON predicted cycling kinases (q <0.05) with rhythmic 
phosphorylations with their cycling phosphorylated interactors. Nodes are divided based on the number of 
cycling phosphorylations color coded based on the clusters in A. (D) Scatter plot showing the PHOTON 
predicted peak of activation of kinases from C color coded based on the transition clusters shown in A. 
Phases are represented in the X-axis and the q-value obtained in the cycling analysis of the PHOTON scores 
in the Y-axis. (E) Representation of the GO Molecular Function annotations statistically enriched in a phase 
dependent manner using the PHOTON scores (phase dependent enrichment test q < 0.05, see Methods). 
Color indicates the phase of the annotation based on the cluster colors of A. Size of circles is proportional 
to the number of cycling phosphoproteins in the annotation and color intensity to the p-value of the 
enrichment test.  
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Fig. 5 Sleep deprivation abrogates synaptic phosphorylation rhythms.  
(A) Experimental workflow used to profile the synaptoneurosome phosphoproteome under sleep 
deprivation across 24h. Sleep deprived (SD) animals were kept awake for 4h (green window) before being 
euthanized together with base line controls (BL). Blue and yellow indicate the light conditions during the 
protocol. Note that SD animals are awake regardless of the light conditions whereas BL mice rest during 
the light phase and are active in the dark. (B) Pie chart representing the fraction of cycling phosphopeptides 
(period=24h, q<0.05) in forebrain synaptoneurosomes from SD mice out of the 2,067 rhythmic in BL mice. 
(C) Pie chart representing the fraction of proteins with at least one cycling (period=24h, q<0.05) 
phosphopeptide in synaptoneurosomes of SD mice out of the 855 oscillating under BL conditions.  
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Fig. 6 Synaptic phosphoproteome cycling under sleep deprivation.  
(A) Heat maps of the intensities (z-scored log2) of the 47 cycling phosphopeptides in BL (left) and SD 
(right) synaptoneurosomes ordered by peak of abundance. (B) Density plot with the fold change of the 47 
phosphopeptides rhythmic in both conditions, calculated for BL (grey) and SD (green) conditions. (C) Rose 
plots showing the phase distribution in BL (left) and SD (right) for the 47 cycling phosphopeptides. 
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Fig. 7 Dynamic phosphorylation of synaptic plasticity mediators.  
Schematic map of an excitatory synapse showing rhythmic phosphorylated sites detected in proteins 
involved in long term depression and potentiation. Number in the circle represents the phosphorylated 
amino acid and the color refers to the peak of the phosphorylation cycle as in Fig. 3A (orange from ZT18 
to ZT6 and purple from ZT6 to ZT18). 
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2.3 MaxQuant goes Linux
MaxQuant [Cox and Mann, 2008] has been successfully used to analyze proteomics data
for 10 years. Rapidly increasing dataset sizes have made the use of large servers run-
ning Linux, rather than workstations, more appealing. By adapting MaxQuant, which
was initially written for the Windows-only .NET Framework, to the cross-platform
Mono framework we enable more people to run MaxQuant on the computational re-
sources available to them. I contributed to this joint lab effort by researching the re-
quired changes for the port of MaxQuant to Mono, and solving multiple user interface
bugs, such as wrong interface scaling on high resolution monitors.
Pavel Sinitcyn, Shivani Tiwary, Jan Daniel Rudolph, Petra Gutenbrunner, Christoph
Wichmann, S¸ule Yılmaz, Hamid Hamzeiy, Favio Salinas, and Jürgen Cox. MaxQuant
goes Linux. Nature methods, 15:401, June 2018b. ISSN 1548-7105. URL https://www.
nature.com/articles/s41592-018-0018-y
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MaxQuant goes Linux
To the Editor: We report a Linux version 
of MaxQuant1 (http://www.biochem.
mpg.de/5111795/maxquant), our popular 
software platform for the analysis of shotgun 
proteomics data.
One of our main intentions in developing 
MaxQuant was to ‘take the pain out of ’ 
quantifying large collections of protein 
profiles2. However, unlike, for instance, 
the Trans-Proteomic Pipeline3, the original 
version of MaxQuant could be run only on 
Microsoft Windows, and thus its use was 
restricted in high-performance computing 
environments, which very rarely use 
Windows as an operating system. When 
we began developing MaxQuant, Windows 
was the only operating system supported 
by vendor-provided raw data access 
libraries. Therefore, we wrote MaxQuant 
in the C# programming language on top 
of the Windows-only .NET framework. 
Windows support for cloud platforms is 
more expensive, and the operating system 
is harder to use and less scalable compared 
with Linux.
We recently carried out a major 
restructuring of the MaxQuant codebase, 
and we made it compatible with Mono 
(https://www.mono-project.com/), an 
alternative cross-platform implementation 
of the .NET framework. Furthermore, we 
now provide an entry point to MaxQuant 
from the command line without the 
need to start its graphical user interface, 
which allows execution from scripts 
or other processing tools. Meanwhile, 
Thermo Fisher Scientific has released 
its platform-independent and Mono-
compatible implementation of its raw data 
access library (http://planetorbitrap.com/
rawfilereader), and hopefully more vendors 
will follow soon. Together, this leads to a 
situation in which large-scale computing of 
proteomics data with MaxQuant becomes 
feasible on all common platforms.
When we parallelized the MaxQuant 
workflow over only a few central processing 
unit (CPU) cores, we hardly noticed 
a difference in performance between 
Linux and Windows (Fig. 1). However, 
in benchmarking of a highly parallelized 
MaxQuant run on 120 logical cores, we 
observed that the Linux version showed 
highly superior parallelization performance, 
with speed 64% faster than that observed 
under a Windows server operating system 
using identical hardware. MaxQuant uses 
operating system processes, rather than the 
intrinsic multi-threading mechanism of C#, 
to realize parallel execution, and it manages 
the load-balancing of an arbitrarily large set 
of raw data files over a specified number of 
processors by itself. We hypothesize that this 
allows Linux to optimize parallel execution 
to the high extent that we observed. A larger 
benchmark study is under way, in which 
we will investigate the dependence of the 
increased speed on hardware such  
as, for instance, the type of CPU and  
storage systems.
MaxQuant has already been adapted 
in several forms for cloud and high-
performance computing applications,  
as described, for instance, by  
Judson et al.4 and on the Chorus platform 
(https://chorusproject.org). We expect that 
the number of applications will increase 
with our Linux-compatible MaxQuant 
version. We envision that proteomics 
core facilities, for instance, will benefit 
from the combination of command-line 
access and Linux compatibility, which 
enables standardized high-throughput 
data analysis. The MaxQuant code base is 
identical for Windows and for Linux; thus 
there is only a single distributable running 
on both operating systems, which can be 
downloaded from http://www.maxquant.
org (version 1.6.1.0). MaxQuant is freeware, 
and contributions to new functionality 
are collaboration-based. The code of open 
source parts is available at https://github.
com/JurgenCox/compbio-base. ❐
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Fig. 1 | Benchmarking MaxQuant on Linux and 
Windows. We analyzed 300 LC-MS runs with 
MaxQuant using 120 logical cores in parallel, once 
with Ubuntu Linux (version 16.04.3) and once 
with Windows server 2012 R2 as the operating 
system. We used identical hardware in both 
cases: four Intel Xeon E7-4870 CPUs and 256 
GB of DDR3 RAM. The total running times are 
shown, and several long-running sub-workflows 
are highlighted. Percentages indicate the amount 
of time needed to complete the relevant process 
in Linux as a percentage of the total time required 
for the same process in Windows.
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Chapter 3
Discussion and Outlook
In this thesis I presented the Perseus network module for the analysis of various pro-
teomics data. It is aimed to enable researchers to not only generate novel PPI networks
from pull down screens, but also analyze already available large-scale networks side-
by-side with proteomics and phosphoproteomics data. Furthermore, previously hard-
to-use tools have become available by breaking the programming language barrier with
new interoperability infrastructure. Phosphoproteomic data can be transformed into
protein-level signaling functionality scores and a predicted signaling pathway. Co-
expression analysis uncovers the functional modules encoded in the data.
While MS-based proteomics has already proven to be competitive to the Y2H sys-
tem for the study of PPIs, several technological advancements could improve upon the
current state of the art. Pull-down screens rely on the endogenous tagging of a large
number of proteins. CRISPR-Cas9 technology could accelerate the generation of tagged
protein libraries [Lackner et al., 2015] especially in combination with smaller tags, such
as the split-GFP epitope tag [Kamiyama et al., 2016]. Alternatively, proximity labeling
has been successfully applied to identify proteins withing the same cellular compart-
ment or organell [Rhee et al., 2013, Roux et al., 2013]. Utilizing chemical cross linking
in combination with MS has already been used to get a more detailed view on the
interactions within a protein complex by identify distance constraints [Herzog et al.,
2012]. Rather than studying a single protein or complex, proteome-wide cross linking
and protein-correlation profiling promise to interrogate all protein binding simultane-
ously [Liu et al., 2015, Kristensen and Foster, 2014]. However, the coverage of such
studies is still very limited.
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Even in the presence of complete interaction networks the main challenge of inte-
grating such networks with other proteomics data, such as protein and phosphoryla-
tion site abundances, remains. Despite the establishment of a number of tools, includ-
ing the ones presented in this thesis, for the analysis of such data, researchers still con-
sider the classical analysis of protein lists separate from any network-based analyses.
Demystifying the large PPI databases that to-date remain hidden behind web interfaces
by allowing non-bioinformaticians to investigate and manipulate them in an intuitive
and transparent manner will be a main driver towards their wider spread use. Even
for researchers interested in only a single protein, studying not only which interaction
partners it has, but also calculating simple network measures, such as the proteins de-
gree compared to the degree distribution of the network can already provide functional
insights on the biology of the protein. A hub protein will have a high degree, while a
low degree implies peripheral location.
Many PPIs have been shown to be condition specific, such as dependent on phos-
phorylation [Tudor et al., 2015] or co-localization and highly dynamic. These charac-
teristics are rarely represented in PPI networks and databases. For most applications,
such as the calculation of signaling functionality scores from phosphoproteomic and
PPI data presented earlier, the network remains static in all measured conditions. The
large effort required to measure large-scale interactomes such as [Hein et al., 2013] pro-
hibits the generation of PPI networks for each of the myriad imaginable conditions. A
more practicable way would be to obtain a complete interactome of all potential PPIs
and filter out interaction in a condition-specific manner. Tissue-level resolution can
be obtained by retaining only interactions between proteins known to be expressed in
the tissue [Bossi and Lehner, 2009]. In the future, such methods could be extended by
utilizing the wealth of omics data and machine learning for the prediction of condition-
specific PPI networks [Will and Helms, 2016].
Tools for studying phosphoproteomic data in the context of physical interactions
usually score proteins from aggregated phosphorylation site information. Kinase ac-
tivity is often modeled as a function of the phosphorylation changes observed on the
substrates of the kinase [Hernandez-Armenta et al., 2017]. Such models have to rely on
the scarce site-specific kinase-substrate interactions reported in public databases [Horn-
beck et al., 2015], potentially supplemented by predictions [Horn et al., 2014]. For or-
ganisms other than human, the scarcity of the data affects analyses not only directly,
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but also limits the training data available for prediction tools. Overlaps in the kinase-
substrate assignments convolute the mechanistic interpretation of the data.
When kinase-substrate model assumptions are relaxed to accommodate higher qual-
ity undirected PPI networks the enzymatic interpretation of the scores is lost in return
for higher coverage [Rudolph et al., 2016]. Common to both models is the reliance on
first degree neighbors potentially losing the information encoded in the rest of the net-
work. Phosphatases which de-phosphorylate their substrates in a condition specific
manner are much less studied than kinases and not considered in any of the analyses
described.
In order to understand signaling on a mechanistic level, ultimately, the function of
phosphorylation patterns on proteins have to be understood. Master phosphorylation
sites that regulated the activity or localization of a protein have been identified by low-
throughput experiments. Additional phosphorylation sites appear to be ignored, sim-
ilar to the ’junk DNA’ hypothesis [Ohno, 1972]. While the ’junk DNA’ hypothesis has
been thoroughly debunked [Pennisi, 2012], large-scale characterization of phosphory-
lation sites has been limited to evolutionary conservation studies [Collins, 2009]. Going
forward, linking kinase or signaling scores to the phosphorylation patterns observed
on the protein itself, could provide an avenue for decoding the observed pattern.
In conclusion, this thesis provides a way forward for every researcher to leverage
the power of the joint analysis of expression-omics tables and interaction networks.
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Acronyms
BAC bacterial artificial chromosome
DDA data-dependent acquisision
DE differential expression
DIA data-independent acquisition
FDR false discovery rate
FTICR Fourier transform ion cyclotron
GBA guilt by association
GFP green fluorescent protein
HPLC high performance liquid chromatography
IMAC immobilized metal affinity chromatography
IP immunoprecipitation
LC liquid chromatography
MALDI matrix-assisted laser desorption/ionization
MS mass spectrometry
MS1 full scan
MS2 fragment scan
PCA principal component analysis
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PDI protein-DNA interaction
PPI protein-protein interaction
PTM post-translational modification
RP reversed-phase
SCX strong cation exchange
SILAC stable isotope labeling by amino acids in cell culture
TAP tandem affinity purification
TMT tandem mass tag
TOF time-of-flight
TOM topological overlap measure
Y2H yeast two-hybrid
Bibliography
D. J. Slamon, G. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich, and W. L. McGuire.
Human breast cancer: correlation of relapse and survival with amplification of the
HER-2/neu oncogene. Science, 235(4785):177–82, January 1987. ISSN 0036-8075. doi:
10.1126/SCIENCE.3798106. URL http://www.ncbi.nlm.nih.gov/pubmed/3798106.
G. W. Beadle and E. L. Tatum. Genetic Control of Biochemical Reactions in Neurospora.
Proceedings of the National Academy of Sciences, 27(11):499–506, November 1941. ISSN
0027-8424. URL http://www.ncbi.nlm.nih.gov/pubmed/16588492.
Albert László Barabási and Zoltán N. Oltvai. Network biology: Understanding the
cell’s functional organization. Nature Reviews Genetics, 5(2):101–113, 2004. ISSN 1471-
0056. doi: 10.1038/nrg1272.
Ariel Bensimon, Albert J. R. Heck, and Ruedi Aebersold. Mass Spectrometry–Based
Proteomics and Network Biology. Annual Review of Biochemistry, 81:379–405, 2012.
ISSN 1545-4509. doi: 10.1146/annurev-biochem-072909-100424.
Claus Jørgensen and Marie Locard-Paulet. Analysing signalling networks by mass
spectrometry. Amino Acids, 43(3):1061–1074, September 2012. ISSN 0939-4451. doi:
10.1007/s00726-012-1293-z.
Chunaram Choudhary and Matthias Mann. Decoding signalling networks by mass
spectrometry-based proteomics. Nature Reviews Molecular Cell Biology, 11(6):427–439,
June 2010. ISSN 1471-0072. doi: 10.1038/nrm2900. URL http://www.nature.com/
articles/nrm2900.
Réka Albert and Albert-László Barabási. Statistical mechanics of complex networks.
Reviews of Modern Physics, 74(1):47–97, January 2002. ISSN 0034-6861. doi: 10.1103/
RevModPhys.74.47.
101
102 BIBLIOGRAPHY
B. Alberts. The cell as a collection of protein machines: preparing the next generation
of molecular biologists. Cell, 92(3):291–4, February 1998. ISSN 0092-8674. URL http:
//www.ncbi.nlm.nih.gov/pubmed/9476889.
J. V. Olsen, M. Vermeulen, A. Santamaria, C. Kumar, M. L. Miller, L. J. Jensen, F. Gnad,
J. Cox, T. S. Jensen, E. A. Nigg, S. Brunak, and M. Mann. Quantitative phospho-
proteomics reveals widespread full phosphorylation site occupancy during mitosis.
Science Signaling, 3(104):ra3, 2010. doi: 10.1126/scisignal.2000475.
Maria S. Robles, Jürgen Cox, and Matthias Mann. In-Vivo Quantitative Proteomics Re-
veals a Key Contribution of Post-Transcriptional Mechanisms to the Circadian Regu-
lation of Liver Metabolism. PLoS Genetics, 10(1):e1004047, 2014. ISSN 1553-7390. doi:
10.1371/journal.pgen.1004047.
J. D. Jordan, E. M. Landau, and R. Iyengar. Signaling networks: the origins of cellular
multitasking. Cell, 103(2):193–200, October 2000. ISSN 0092-8674. URL http://www.
ncbi.nlm.nih.gov/pubmed/11057893.
Marco Y. Hein, Nina C. Hubner, Ina Poser, Jürgen Cox, Nagarjuna Nagaraj, Yusuke
Toyoda, Igor A. Gak, Ina Weisswange, Jörg Mansfeld, Frank Buchholz, Anthony A.
Hyman, and Matthias Mann. A Human Interactome in Three Quantitative Dimen-
sions Organized by Stoichiometries and Abundances. Cell, 163(3):712–723, October
2015. ISSN 1097-4172. doi: 10.1016/j.cell.2015.09.053. URL http://www.ncbi.nlm.
nih.gov/pubmed/26496610.
Susan L. Kloet, Matthew M. Makowski, H. Irem Baymaz, Lisa van Voorthuijsen, Ino D.
Karemaker, Alexandra Santanach, Pascal W. T. C. Jansen, Luciano Di Croce, and
Michiel Vermeulen. The dynamic interactome and genomic targets of Polycomb com-
plexes during stem-cell differentiation. Nature Structural & Molecular Biology, 23(7):
682–690, July 2016. doi: 10.1038/nsmb.3248. URL http://www.ncbi.nlm.nih.gov/
pubmed/27294783.
Marco Y. Hein, Kirti Sharma, Jürgen Cox, and Matthias Mann. Proteomic Analy-
sis of Cellular Systems. Handbook of Systems Biology, pages 3–25, January 2013.
doi: 10.1016/B978-0-12-385944-0.00001-0. URL https://www.sciencedirect.com/
science/article/pii/B9780123859440000010?via{%}3Dihub.
BIBLIOGRAPHY 103
Yaoyang Zhang, Bryan R. Fonslow, Bing Shan, Moon-Chang Baek, and John R. Yates III.
Protein analysis by shotgun/bottom-up proteomics. Chemical reviews, 113(4):2343–
2394, 2013.
A. Shevchenko, M. Wilm, O. Vorm, and M. Mann. Mass spectrometric sequencing of
proteins silver-stained polyacrylamide gels. Analytical Chemistry, 68(5):850–8, March
1996. ISSN 0003-2700. URL http://www.ncbi.nlm.nih.gov/pubmed/8779443.
Jacek R. Wis´niewski, Alexandre Zougman, Nagarjuna Nagaraj, and Matthias Mann.
Universal sample preparation method for proteome analysis. Nature Methods, 6(5):
359–362, May 2009. ISSN 1548-7091. doi: 10.1038/nmeth.1322. URL http://www.
nature.com/articles/nmeth.1322.
Nils A. Kulak, Garwin Pichler, Igor Paron, Nagarjuna Nagaraj, and Matthias Mann.
Minimal, encapsulated proteomic-sample processing applied to copy-number es-
timation in eukaryotic cells. Nature Methods, 11(3):319–324, March 2014. ISSN
1548-7091. doi: 10.1038/nmeth.2834. URL http://www.ncbi.nlm.nih.gov/pubmed/
24487582.
D. A. Wolters, M. P. Washburn, and J. R. Yates. An automated multidimensional protein
identification technology for shotgun proteomics. Analytical Chemistry, 73(23):5683–
5690, 2001. ISSN 0003-2700. doi: 10.1021/ac010617e.
James W. Jorgenson. Capillary Liquid Chromatography at Ultrahigh Pressures. Annual
Review of Analytical Chemistry, 3(1):129–150, June 2010. ISSN 1936-1327. doi: 10.1146/
annurev.anchem.1.031207.113014.
J. B. Fenn, M. Mann, C. K. Meng, S. F. Wong, and C. M. Whitehouse. Electrospray ion-
ization for mass spectrometry of large biomolecules. Science, 246(4926):64–71, 1989.
ISSN 0036-8075, 1095-9203. doi: 10.1126/science.2675315.
Michael. Karas and Franz. Hillenkamp. Laser desorption ionization of proteins with
molecular masses exceeding 10,000 daltons. Analytical Chemistry, 60(20):2299–2301,
October 1988. ISSN 0003-2700. doi: 10.1021/ac00171a028.
Michaela Scigelova, Martin Hornshaw, Anastassios Giannakopulos, and Alexander
Makarov. Fourier transform mass spectrometry. Molecular & Cellular Proteomics, 10
104 BIBLIOGRAPHY
(7):M111.009431, July 2011. ISSN 1535-9484. doi: 10.1074/mcp.M111.009431. URL
http://www.ncbi.nlm.nih.gov/pubmed/21742802.
Roman A Zubarev and Alexander Makarov. Orbitrap mass spectrometry. Analytical
chemistry, 85:5288–5296, June 2013. ISSN 1520-6882. doi: 10.1021/ac4001223.
Richard Alexander Scheltema, Jan-Peter Hauschild, Oliver Lange, Daniel Hornburg,
Eduard Denisov, Eugen Damoc, Andreas Kuehn, Alexander Makarov, and Matthias
Mann. The Q Exactive HF, a Benchtop mass spectrometer with a pre-filter, high-
performance quadrupole and an ultra-high-field Orbitrap analyzer. Molecular & Cel-
lular Proteomics, 13(12):3698–708, December 2014. ISSN 1535-9484. doi: 10.1074/mcp.
M114.043489. URL http://www.ncbi.nlm.nih.gov/pubmed/25360005.
Vivien Marx. Targeted proteomics. Nature Methods, 10(1):19–22, January 2013. ISSN
1548-7091. doi: 10.1038/nmeth.2285. URL http://www.nature.com/articles/
nmeth.2285.
Matthias Mann, Ronald C. Hendrickson, and Akhilesh Pandey. Analysis of Proteins
and Proteomes by Mass Spectrometry. Annual Review of Biochemistry, 70(1):437–473,
June 2001. ISSN 0066-4154. doi: 10.1146/annurev.biochem.70.1.437.
Ludovic C. Gillet, Pedro Navarro, Stephen Tate, Hannes Röst, Nathalie Selevsek, Lukas
Reiter, Ron Bonner, and Ruedi Aebersold. Targeted data extraction of the MS/MS
spectra generated by data-independent acquisition: a new concept for consistent and
accurate proteome analysis. Molecular & Cellular Proteomics, 11(6):O111.016717, June
2012. ISSN 1535-9484. doi: 10.1074/mcp.O111.016717. URL http://www.ncbi.nlm.
nih.gov/pubmed/22261725.
Jürgen Cox, Marco Y. Hein, Christion A. Luber, Igor Paron, Nagarjuna Nagaraj, and
Matthias Mann. Accurate proteome-wide label-free quantification by delayed nor-
malization and maximal peptide ratio extraction, termed MaxLFQ. Molecular & Cel-
lular Proteomics, 13(9):2513–2526, 2014. ISSN 1535-9484. doi: 10.1074/mcp.M113.
031591.
Shao-En Ong, Blagoy Blagoev, Irina Kratchmarova, Dan Bach Kristensen, Hanno Steen,
Akhilesh Pandey, and Matthias Mann. Stable isotope labeling by amino acids in
cell culture, SILAC, as a simple and accurate approach to expression proteomics.
BIBLIOGRAPHY 105
Molecular & Cellular Proteomics, 1(5):376–86, May 2002. ISSN 1535-9476. doi: 10.1074/
MCP.M200025-MCP200. URL http://www.ncbi.nlm.nih.gov/pubmed/12118079.
Blagoy Blagoev, Shao-En Ong, Irina Kratchmarova, and Matthias Mann. Tempo-
ral analysis of phosphotyrosine-dependent signaling networks by quantitative pro-
teomics. Nature Biotechnology, 22(9):1139–1145, September 2004. ISSN 1087-0156. doi:
10.1038/nbt1005. URL http://www.nature.com/articles/nbt1005.
Andrew Thompson, Jürgen Jurgen Schäfer, Karsten Kuhn, Stefan Kienle, Josef Schwarz,
Günter Gunter Schmidt, Thomas Neumann, and Christian Hamon. Tandem mass
tags: a novel quantificaiton strategy for comparative analysis of complex protein
mixtures by MS/MS. Analytical Chemistry, 75(8):1895–1904, 2003. ISSN 0003-2700.
doi: 10.1021/ac0262560.
Thilo Werner, Gavain Sweetman, Maria Fälth Savitski, Toby Mathieson, Marcus
Bantscheff, and Mikhail M. Savitski. Ion Coalescence of Neutron Encoded TMT 10-
Plex Reporter Ions. Analytical Chemistry, 86(7):3594–3601, April 2014. ISSN 0003-2700.
doi: 10.1021/ac500140s.
Mikhail M. Savitski, Toby Mathieson, Nico Zinn, Gavain Sweetman, Carola Doce, Is-
abelle Becher, Fiona Pachl, Bernhard Kuster, and Marcus Bantscheff. Measuring and
managing ratio compression for accurate iTRAQ/TMT quantification. Journal of Pro-
teome Research, 12(8):3586–3598, 2013. ISSN 1535-3893. doi: 10.1021/pr400098r.
Jeremy D. O’Connell, Joao A. Paulo, Jonathon J. O’Brien, and Steven P. Gygi. Proteome-
Wide Evaluation of Two Common Protein Quantification Methods. Journal of Pro-
teome Research, 17(5):1934–1942, May 2018. ISSN 1535-3893. doi: 10.1021/acs.
jproteome.8b00016. URL http://www.ncbi.nlm.nih.gov/pubmed/29635916.
Jürgen Cox and Matthias Mann. MaxQuant enables high peptide identification rates,
individualized p.p.b.-range mass accuracies and proteome-wide protein quantifica-
tion. Nature Biotechnology, 26(12):1367–1372, 2008. ISSN 1087-0156. doi: 10.1038/nbt.
1511. URL http://www.ncbi.nlm.nih.gov/pubmed/19029910.
Stefka Tyanova, Tikira Temu, Pavel Sinitcyn, Arthur Carlson, Marco Y. Hein, Tamar
Geiger, Matthias Mann, and Jürgen Cox. The Perseus computational platform for
comprehensive analysis of (prote)omics data. Nature Methods, 13(9):731–740, June
2016. ISSN 1548-7105. doi: 10.1038/nmeth.3901.
106 BIBLIOGRAPHY
Pavel Sinitcyn, Jan Daniel Rudolph, and Jürgen Cox. Computational Methods for Un-
derstanding Mass Spectrometry–Based Shotgun Proteomics Data. Annual Review of
Biomedical Data Science, 1(1):annurev–biodatasci–080917–013516, July 2018a. ISSN
2574-3414. doi: 10.1146/annurev-biodatasci-080917-013516.
G. Rigaut, A. Shevchenko, B. Rutz, M. Wilm, M. Mann, and B. Seraphin. A generic
protein purification method for protein complex characterization and proteome ex-
ploration. Nature Biotechnology, 17(10):1030–1032, October 1999. ISSN 1087-0156. doi:
10.1038/13732. URL http://www.nature.com/articles/nbt1099{_}1030.
Oscar Puig, Friederike Caspary, Guillaume Rigaut, Berthold Rutz, Emmanuelle Bou-
veret, Elisabeth Bragado-Nilsson, Matthias Wilm, and Bertrand Séraphin. The
tandem affinity purification (TAP) method: A general procedure of protein com-
plex purification. Methods, 24(3):218–229, July 2001. ISSN 1046-2023. doi: 10.
1006/meth.2001.1183. URL https://www.sciencedirect.com/science/article/
pii/S1046202301911831?via{%}3Dihub.
Gareth Butland, José Manuel Peregrin-Alvarez, Joyce Li, Wehong Yang, Xiaochun Yang,
Veronica Canadien, Andrei Starostine, Dawn Richards, Bryan Beattie, Nevan Krogan,
Michael Davey, John Parkinson, Jack Greenblatt, and Andrew Emili. Interaction net-
work containing conserved and essential protein complexes in Escherichia coli. Na-
ture, 433(7025):531–537, February 2005. ISSN 0028-0836. doi: 10.1038/nature03239.
URL http://www.ncbi.nlm.nih.gov/pubmed/15690043.
Anne Claude Gavin, Patrick Aloy, Paola Grandi, Roland Krause, Markus Boesche, Mar-
tina Marzioch, Christina Rau, Lars Juhl Jensen, Sonja Bastuck, Birgit Dümpelfeld,
Angela Edelmann, Marie Anne Heurtier, Verena Hoffman, Christian Hoefert, Karin
Klein, Manuela Hudak, Anne Marie Michon, Malgorzata Schelder, Markus Schirle,
Marita Remor, Tatjana Rudi, Sean Hooper, Andreas Bauer, Tewis Bouwmeester,
Georg Casari, Gerard Drewes, Gitte Neubauer, Jens M. Rick, Bernhard Kuster, Peer
Bork, Robert B. Russell, and Giulio Superti-Furga. Proteome survey reveals mod-
ularity of the yeast cell machinery. Nature, 440(7084):631–636, March 2006. ISSN
0028-0836. doi: 10.1038/nature04532. URL http://www.nature.com/articles/
nature04532.
Peter Uetz, Loic Glot, Gerard Cagney, Traci A. Mansfield, Richard S. Judson,
BIBLIOGRAPHY 107
James R. Knight, Daniel Lockshon, Vaibhav Narayan, Malthreyan Srinivasan, Pas-
cale Pochart, Alla Qureshi-Emlli, Ying Li, Brian Godwin, Diana Conover, Theodore
Kalbfleisch, Govindan Vijayadamodar, Meijia Yang, Mark Johnston, Stanley Fields,
and Jonathan M. Rothberg. A comprehensive analysis of protein-protein interac-
tions in Saccharomyces cerevisiae. Nature, 403(6770):623–627, February 2000. ISSN
0028-0836. doi: 10.1038/35001009. URL http://www.ncbi.nlm.nih.gov/pubmed/
10688190.
Ulrich Stelzl, Uwe Worm, Maciej Lalowski, Christian Haenig, Felix H. Brembeck,
Heike Goehler, Martin Stroedicke, Martina Zenkner, Anke Schoenherr, Susanne
Koeppen, Jan Timm, Sascha Mintzlaff, Claudia Abraham, Nicole Bock, Silvia Ki-
etzmann, Astrid Goedde, Engin Toksöz, Anja Droege, Sylvia Krobitsch, Bernhard
Korn, Walter Birchmeier, Hans Lehrach, and Erich E. Wanker. A human protein-
protein interaction network: A resource for annotating the proteome. Cell, 122(6):
957–968, September 2005. ISSN 0092-8674. doi: 10.1016/j.cell.2005.08.029. URL
https://www.sciencedirect.com/science/article/pii/S0092867405008664.
Waltraud X. Schulze and Matthias Mann. A Novel Proteomic Screen for Peptide-Protein
Interactions. Journal of Biological Chemistry, 279(11):10756–10764, March 2004. ISSN
0021-9258. doi: 10.1074/jbc.M309909200.
Eva C. Keilhauer, Marco Y. Hein, and Matthias Mann. Accurate protein complex re-
trieval by affinity enrichment mass spectrometry (AE-MS) rather than affinity pu-
rification mass spectrometry (AP-MS). Molecular & Cellular Proteomics, 14(1):120–
35, January 2015. ISSN 1535-9484. doi: 10.1074/mcp.M114.041012. URL http:
//www.ncbi.nlm.nih.gov/pubmed/25363814.
Nina C. Hubner, Alexander W. Bird, Jürgen Cox, Bianca Splettstoesser, Peter Bandilla,
Ina Poser, Anthony Hyman, and Matthias Mann. Quantitative proteomics combined
with BAC TransgeneOmics reveals in vivo protein interactions. Journal of Cell Biology,
189(4):739–754, May 2010. ISSN 0021-9525. doi: 10.1083/jcb.200911091. URL http:
//www.ncbi.nlm.nih.gov/pubmed/20479470.
Edward L. Huttlin, Lily Ting, Raphael J. Bruckner, Fana Gebreab, Melanie P. Gygi, John
Szpyt, Stanley Tam, Gabriela Zarraga, Greg Colby, Kurt Baltier, Rui Dong, Virginia
Guarani, Laura Pontano Vaites, Alban Ordureau, Ramin Rad, Brian K. Erickson, Mar-
108 BIBLIOGRAPHY
tin Wühr, Joel Chick, Bo Zhai, Deepak Kolippakkam, Julian Mintseris, Robert A.
Obar, Tim Harris, Spyros Artavanis-Tsakonas, Mathew E. Sowa, Pietro De Camilli,
Joao A. Paulo, J. Wade Harper, and Steven P. Gygi. The BioPlex Network: A System-
atic Exploration of the Human Interactome. Cell, 162(2):425–440, July 2015. ISSN
1097-4172. doi: 10.1016/j.cell.2015.06.043. URL http://www.ncbi.nlm.nih.gov/
pubmed/26186194.
Edward L. Huttlin, Raphael J. Bruckner, Joao A. Paulo, Joe R. Cannon, Lily Ting, Kurt
Baltier, Greg Colby, Fana Gebreab, Melanie P. Gygi, Hannah Parzen, John Szpyt, Stan-
ley Tam, Gabriela Zarraga, Laura Pontano-Vaites, Sharan Swarup, Anne E. White,
Devin K. Schweppe, Ramin Rad, Brian K. Erickson, Robert A. Obar, K. G. Guruhar-
sha, Kejie Li, Spyros Artavanis-Tsakonas, Steven P. Gygi, and J. Wade Harper. Archi-
tecture of the human interactome defines protein communities and disease networks.
Nature, 545(7655):505–509, May 2017. ISSN 1476-4687. doi: 10.1038/nature22366.
URL http://www.ncbi.nlm.nih.gov/pubmed/28514442.
Alexey I. Nesvizhskii, Olga Vitek, and Ruedi Aebersold. Analysis and validation of
proteomic data generated by tandem mass spectrometry. Nature Methods, 4(10):787–
797, October 2007. ISSN 1548-7091. doi: 10.1038/nmeth1088. URL http://www.ncbi.
nlm.nih.gov/pubmed/17901868.
V. G. Tusher, R. Tibshirani, and G. Chu. Significance analysis of microarrays applied to
the ionizing radiation response. Proceedings of the National Academy of Sciences, 98(9):
5116–5121, 2001. ISSN 0027-8424. doi: 10.1073/pnas.091062498.
Yoav Benjamini and Yosef Hochberg. Controlling the false discovery rate: a practical
and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series
B (Methodological), 57:289–300, 1995.
Hyungwon Choi, Brett Larsen, Zhen Yuan Lin, Ashton Breitkreutz, Dattatreya Mel-
lacheruvu, Damian Fermin, Zhaohui S. Qin, Mike Tyers, Anne Claude Gingras, and
Alexey I. Nesvizhskii. SAINT: Probabilistic scoring of affinity purificationg-mass
spectrometry data. Nature Methods, 8(1):70–73, January 2011. ISSN 1548-7091. doi:
10.1038/nmeth.1541. URL http://www.ncbi.nlm.nih.gov/pubmed/21131968.
Damian Szklarczyk, Andrea Franceschini, Stefan Wyder, Kristoffer Forslund, Davide
Heller, Jaime Huerta-Cepas, Milan Simonovic, Alexander Roth, Alberto Santos,
BIBLIOGRAPHY 109
Kalliopi P. Tsafou, Michael Kuhn, Peer Bork, Lars J. Jensen, and Christian Von Mer-
ing. STRING v10: Protein-protein interaction networks, integrated over the tree of
life. Nucleic Acids Research, 43(D1):D447–D452, January 2015. ISSN 1362-4962. doi:
10.1093/nar/gku1003. URL http://www.ncbi.nlm.nih.gov/pubmed/25352553.
Andrew Chatr-Aryamontri, Rose Oughtred, Lorrie Boucher, Jennifer Rust, Christie
Chang, Nadine K. Kolas, Lara O’Donnell, Sara Oster, Chandra Theesfeld, Adnane
Sellam, Chris Stark, Bobby Joe Breitkreutz, Kara Dolinski, and Mike Tyers. The Bi-
oGRID interaction database: 2017 update. Nucleic Acids Research, 45(D1):D369–D379,
2017. ISSN 1362-4962. doi: 10.1093/nar/gkw1102.
Sandra Orchard, Mais Ammari, Bruno Aranda, Lionel Breuza, Leonardo Briganti, Fiona
Broackes-Carter, Nancy H. Campbell, Gayatri Chavali, Carol Chen, Noemi Del-Toro,
Margaret Duesbury, Marine Dumousseau, Eugenia Galeota, Ursula Hinz, Marta Ian-
nuccelli, Sruthi Jagannathan, Rafael Jimenez, Jyoti Khadake, Astrid Lagreid, Luana
Licata, Ruth C. Lovering, Birgit Meldal, Anna N. Melidoni, Mila Milagros, Daniele
Peluso, Livia Perfetto, Pablo Porras, Arathi Raghunath, Sylvie Ricard-Blum, Bernd
Roechert, Andre Stutz, Michael Tognolli, Kim Van Roey, Gianni Cesareni, and Hen-
ning Hermjakob. The MIntAct project - IntAct as a common curation platform for 11
molecular interaction databases. Nucleic Acids Research, 42(D1), 2014. ISSN 0305-1048.
doi: 10.1093/nar/gkt1115.
T. S. Keshava Prasad, Renu Goel, Kumaran Kandasamy, Shivakumar Keerthiku-
mar, Sameer Kumar, Suresh Mathivanan, Deepthi Telikicherla, Rajesh Raju, Beema
Shafreen, Abhilash Venugopal, Lavanya Balakrishnan, Arivusudar Marimuthu,
Sutopa Banerjee, Devi S. Somanathan, Aimy Sebastian, Sandhya Rani, Somak
Ray, C. J. Harrys Kishore, Sashi Kanth, Mukhtar Ahmed, Manoj K. Kashyap,
Riaz Mohmood, Y. L. Ramachandra, V. Krishna, B. Abdul Rahiman, Sujatha Mo-
han, Prathibha Ranganathan, Subhashri Ramabadran, Raghothama Chaerkady, and
Akhilesh Pandey. Human Protein Reference Database–2009 update. Nucleic Acids
Research, 37(18988627):D767–D772, January 2009. ISSN 0305-1048. URL https:
//www.ncbi.nlm.nih.gov/pmc/PMC2686490/.
Nir Yosef, Lior Ungar, Einat Zalckvar, Adi Kimchi, Martin Kupiec, Eytan Ruppin,
and Roded Sharan. Toward accurate reconstruction of functional protein networks.
110 BIBLIOGRAPHY
Molecular Systems Biology, 5:248, 2009. ISSN 1744-4292. doi: 10.1038/msb.2009.3. URL
http://www.ncbi.nlm.nih.gov/pubmed/19293828.
Gregorio Alanis-Lobato, Miguel A. Andrade-Navarro, and Martin H. Schaefer. HIP-
PIE v2.0: Enhancing meaningfulness and reliability of protein-protein interaction
networks. Nucleic Acids Research, 45(D1):D408–D414, 2017. ISSN 1362-4962. doi:
10.1093/nar/gkw985.
Minoru Kanehisa, Yoko Sato, Masayuki Kawashima, Miho Furumichi, and Mao Tan-
abe. KEGG as a reference resource for gene and protein annotation. Nucleic Acids
Research, 44(D1):D457–D462, 2016. ISSN 1362-4962. doi: 10.1093/nar/gkv1070.
Antonio Fabregat, Konstantinos Sidiropoulos, Phani Garapati, Marc Gillespie, Kerstin
Hausmann, Robin Haw, Bijay Jassal, Steven Jupe, Florian Korninger, Sheldon McKay,
Lisa Matthews, Bruce May, Marija Milacic, Karen Rothfels, Veronica Shamovsky,
Marissa Webber, Joel Weiser, Mark Williams, Guanming Wu, Lincoln Stein, Henning
Hermjakob, and Peter D’Eustachio. The reactome pathway knowledgebase. Nucleic
Acids Research, 44(D1):D481–D487, 2016. ISSN 1362-4962. doi: 10.1093/nar/gkv1351.
Andreas Ruepp, Brigitte Waegele, Martin Lechner, Barbara Brauner, Irmtraud Dunger-
Kaltenbach, Gisela Fobo, Goar Frishman, Corinna Montrone, and H. Werner Mewes.
CORUM: The comprehensive resource of mammalian protein complexes-2009. Nu-
cleic Acids Research, 38(SUPPL.1), October 2009. ISSN 0305-1048. doi: 10.1093/nar/
gkp914.
David S. Johnson, Ali Mortazavi, Richard M. Myers, and Barbara Wold. Genome-wide
mapping of in vivo protein-DNA interactions. Science, 316(5830):1497–1502, June
2007. ISSN 0036-8075. doi: 10.1126/science.1141319. URL http://www.ncbi.nlm.
nih.gov/pubmed/17540862.
Tijana Milenkovic´ and Natasa Przulj. Uncovering biological network function via
graphlet degree signatures. Cancer Informatics, 6:257–73, 2008. ISSN 1176-9351. URL
http://www.ncbi.nlm.nih.gov/pubmed/19259413.
Noël Malod-Dognin and Nataša Pržulj. L-GRAAL: Lagrangian graphlet-based network
aligner. Bioinformatics, 31(13):2182–2189, July 2015. ISSN 1460-2059. doi: 10.1093/
bioinformatics/btv130.
BIBLIOGRAPHY 111
Melissa S. Cline, Michael Smoot, Ethan Cerami, Allan Kuchinsky, Nerius Landys, Chris
Workman, Rowan Christmas, Iliana Avila-Campilo, Michael Creech, Benjamin Gross,
Kristina Hanspers, Ruth Isserlin, Ryan Kelley, Sarah Killcoyne, Samad Lotia, Steven
Maere, John Morris, Keiichiro Ono, Vuk Pavlovic, Alexander R. Pico, Aditya Vailaya,
Peng-Liang Wang, Annette Adler, Bruce R. Conklin, Leroy Hood, Martin Kuiper,
Chris Sander, Ilya Schmulevich, Benno Schwikowski, Guy J. Warner, Trey Ideker,
and Gary D. Bader. Integration of biological networks and gene expression data
using Cytoscape. Nature protocols, 2(10):2366–82, 2007. ISSN 1750-2799. doi: 10.1038/
nprot.2007.324. URL http://www.ncbi.nlm.nih.gov/pubmed/17947979.
Trey Ideker, Owen Ozier, Benno Schwikowski, and Andrew F. Siegel. Discovering
regulatory and signalling circuits in molecular interaction networks. Bioinformatics,
18 Suppl 1:S233–40, 2002. ISSN 1367-4803. URL http://www.ncbi.nlm.nih.gov/
pubmed/12169552.
Nir Yosef, Einat Zalckvar, Assaf D. Rubinstein, Max Homilius, Nir Atias, Liram Vardi,
Igor Berman, Hadas Zur, Adi Kimchi, Eytan Ruppin, and Roded Sharan. ANAT: A
tool for constructing and analyzing functional protein networks. Science Signaling, 4
(196):pl1–pl1, 2011. ISSN 1945-0877. doi: 10.1126/scisignal.2001935.
Nurcan Tuncbag, Sara J. C. Gosline, Amanda Kedaigle, Anthony R. Soltis, Anthony Git-
ter, and Ernest Fraenkel. Network-Based Interpretation of Diverse High-Throughput
Datasets through the Omics Integrator Software Package. PLOS Computational Biol-
ogy, 12(4):e1004879, April 2016. ISSN 1553-7358. doi: 10.1371/journal.pcbi.1004879.
R Core Team. R: A Language and Environment for Statistical Computing, 2018. URL
https://www.r-project.org.
Guido van Rossum. Python tutorial. Technical report, Amsterdam, 1995.
Max Franz, Christian T. Lopes, Gerardo Huck, Yue Dong, Onur Sumer, and Gary D.
Bader. Cytoscape.js: A graph theory library for visualisation and analysis. Bioinfor-
matics, 32(2):309–311, September 2015. ISSN 1460-2059. doi: 10.1093/bioinformatics/
btv557.
Paul Shannon, Andrew Markiel, Owen Ozier, Nitin S. Baliga, Jonathan T. Wang, Daniel
Ramage, Nada Amin, Beno Schwikowski, and Trey Ideker. Cytoscape: A software
112 BIBLIOGRAPHY
Environment for integrated models of biomolecular interaction networks. Genome
Research, 13(11):2498–2504, 2003. ISSN 1088-9051. doi: 10.1101/gr.1239303.
Steven Maere, Karel Heymans, and Martin Kuiper. BiNGO: A Cytoscape plugin to as-
sess overrepresentation of Gene Ontology categories in Biological Networks. Bioinfor-
matics, 21(16):3448–3449, 2005. ISSN 1367-4803. doi: 10.1093/bioinformatics/bti551.
Quiagen Inc. IPA. URL https://www.qiagenbioinformatics.com/products/
ingenuitypathway-analysis.
H. Jeong, S. P. Mason, A. L. Barabási, and Z. N. Oltvai. Lethality and centrality in
protein networks. Nature, 411(6833):41–42, May 2001. ISSN 0028-0836. doi: 10.1038/
35075138. URL http://www.nature.com/articles/35075138.
P. Cohen. The regulation of protein function by multisite phosphorylation–a 25 year
update. Trends in biochemical sciences, 25(12):596–601, December 2000. ISSN 0968-
0004. URL http://www.ncbi.nlm.nih.gov/pubmed/11116185.
T. Hunter. Protein kinases and phosphatases: the yin and yang of protein phospho-
rylation and signaling. Cell, 80(2):225–36, January 1995. ISSN 0092-8674. URL
http://www.ncbi.nlm.nih.gov/pubmed/7834742.
Boris Macek, Matthias Mann, and Jesper V. Olsen. Global and Site-Specific Quantita-
tive Phosphoproteomics: Principles and Applications. Annual Review of Pharmacology
and Toxicology, 49(1):199–221, February 2009. ISSN 0362-1642. doi: 10.1146/annurev.
pharmtox.011008.145606.
Juan-José Ventura and Angel R. Nebreda. Protein kinases and phosphatases as ther-
apeutic targets in cancer. Clinical & translational oncology, 8(3):153–60, March 2006.
ISSN 1699-048X. URL http://www.ncbi.nlm.nih.gov/pubmed/16648114.
Nicholas M. Riley and Joshua J. Coon. Phosphoproteomics in the Age of Rapid and
Deep Proteome Profiling. Analytical Chemistry, 88(1):74–94, 2016. ISSN 1520-6882.
doi: 10.1021/acs.analchem.5b04123.
Jacek R. Wis´niewski and Matthias Mann. Consecutive Proteolytic Digestion in an En-
zyme Reactor Increases Depth of Proteomic and Phosphoproteomic Analysis. Analyt-
ical Chemistry, 84(6):2631–2637, March 2012. ISSN 0003-2700. doi: 10.1021/ac300006b.
BIBLIOGRAPHY 113
Mads Grønborg, Troels Zakarias Kristiansen, Allan Stensballe, Jens S. Andersen, Os-
amu Ohara, Matthias Mann, Ole Nørregaard Jensen, and Akhilesh Pandey. A
mass spectrometry-based proteomic approach for identification of serine/threonine-
phosphorylated proteins by enrichment with phospho-specific antibodies: identifica-
tion of a novel protein, Frigg, as a protein kinase A substrate. Molecular & Cellular Pro-
teomics, 1(7):517–27, July 2002. ISSN 1535-9476. doi: 10.1074/MCP.M200010-MCP200.
URL http://www.ncbi.nlm.nih.gov/pubmed/12239280.
Tine E. Thingholm, Thomas J. D. Jørgensen, Ole N. Jensen, and Martin R. Larsen.
Highly selective enrichment of phosphorylated peptides using titanium dioxide. Na-
ture Protocols, 1(4):1929–1935, November 2006. ISSN 1754-2189. doi: 10.1038/nprot.
2006.185.
Judit Villén and Steven P. Gygi. The SCX/IMAC enrichment approach for global phos-
phorylation analysis by mass spectrometry. Nature Protocols, 3(10):1630–1638, Octo-
ber 2008. ISSN 1754-2189. doi: 10.1038/nprot.2008.150. URL http://www.ncbi.nlm.
nih.gov/pubmed/18833199.
Sean J. Humphrey, S. Babak Azimifar, and Matthias Mann. High-throughput phospho-
proteomics reveals in vivo insulin signaling dynamics. Nature biotechnology, 33(9):
990–5, August 2015. ISSN 1546-1696. doi: 10.1038/nbt.3327.
Sean J. Humphrey, Ozge Karayel, David E. James, and Matthias Mann. High-
throughput and high-sensitivity phosphoproteomics with the EasyPhos platform.
Nature Protocols, 13(9):1897–1916, September 2018. ISSN 1754-2189. doi: 10.1038/
s41596-018-0014-9. URL http://www.ncbi.nlm.nih.gov/pubmed/30190555.
Alexander Hogrebe, Louise von Stechow, Dorte B. Bekker-Jensen, Brian T. Wein-
ert, Christian D. Kelstrup, and Jesper V. Olsen. Benchmarking common quantifi-
cation strategies for large-scale phosphoproteomics. Nature Communications, 9(1):
1045, December 2018. ISSN 2041-1723. doi: 10.1038/s41467-018-03309-6. URL
http://www.nature.com/articles/s41467-018-03309-6.
Clement M Potel, Simone Lemeer, and Albert J R Heck. Phosphopeptide fragmentation
and site localization by mass spectrometry; an update. Analytical chemistry, Novem-
ber 2018. ISSN 1520-6882. doi: 10.1021/acs.analchem.8b04746.
114 BIBLIOGRAPHY
S. A. Beausoleil, J. Villen, S. A. Gerber, J. Rush, and S. P. Gygi. A probability-based
approach for high-throughput protein phosphorylation analysis and site localization.
Nature Biotechnology, 24(10):1285–1292, 2006. doi: 10.1038/nbt1240.
Jürgen Cox, Annette Michalski, and Matthias Mann. Software lock mass by two-
dimensional minimization of peptide mass errors. Journal of the American Soci-
ety for Mass Spectrometry, 22(8):1373–1380, 2011. ISSN 1044-0305. doi: 10.1007/
s13361-011-0142-8.
Kirti Sharma, Rochelle C. J. D’Souza, Stefka Tyanova, Christoph Schaab, Jacek R.
Wis´niewski, Jürgen Cox, and Matthias Mann. Ultradeep Human Phosphoproteome
Reveals a Distinct Regulatory Nature of Tyr and Ser/Thr-Based Signaling. Cell Re-
ports, 8(5):1583–1594, 2014. ISSN 2211-1247. doi: 10.1016/j.celrep.2014.07.036.
M. O. Collins. Evolving Cell Signals. Science, 325(5948):1635–1636, September 2009.
ISSN 0036-8075. doi: 10.1126/science.1180331.
Jan Daniel Rudolph and Jürgen Cox. A network module for the Perseus software for
computational proteomics facilitates proteome interaction graph analysis. bioRxiv,
page 447268, October 2018. doi: 10.1101/447268. URL https://www.biorxiv.org/
content/early/2018/10/18/447268?rss=1.
Peter V. Hornbeck, Bin Zhang, Beth Murray, Jon M. Kornhauser, Vaughan Latham,
and Elzbieta Skrzypek. PhosphoSitePlus, 2014: Mutations, PTMs and recalibra-
tions. Nucleic Acids Research, 43(D1):D512–D520, January 2015. ISSN 1362-4962. doi:
10.1093/nar/gku1267. URL http://www.ncbi.nlm.nih.gov/pubmed/25514926.
Daniel Schwartz and Steven P. Gygi. An iterative statistical approach to the identifica-
tion of protein phosphorylation motifs from large-scale data sets. Nature Biotechnol-
ogy, 23(11):1391–1398, November 2005. ISSN 1087-0156. doi: 10.1038/nbt1146. URL
http://www.ncbi.nlm.nih.gov/pubmed/16273072.
Martin Lee Miller, Lars Juhl Jensen, Francesca Diella, Claus Jørgensen, Michele Tinti,
Lei Li, Marilyn Hsiung, Sirlester A. Parker, Jennifer Bordeaux, Thomas Sicheritz-
Ponten, Marina Olhovsky, Adrian Pasculescu, Jes Alexander, Stefan Knapp, Niko-
laj Blom, Peer Bork, Shawn Li, Gianni Cesareni, Tony Pawson, Benjamin E.
Turk, Michael B. Yaffe, Søren Brunak, and Rune Linding. Linear motif atlas for
BIBLIOGRAPHY 115
phosphorylation-dependent signaling. Science Signaling, 1(35):ra2–ra2, September
2008. ISSN 1945-0877. doi: 10.1126/scisignal.1159433.
Rune Linding, Lars Juhl Jensen, Adrian Pasculescu, Marina Olhovsky, Karen Colwill,
Peer Bork, Michael B. Yaffe, and Tony Pawson. NetworKIN: A resource for exploring
cellular phosphorylation networks. Nucleic Acids Research, 36(SUPPL. 1), 2008. ISSN
0305-1048. doi: 10.1093/nar/gkm902.
Heiko Horn, Erwin M. Schoof, Jinho Kim, Xavier Robin, Martin L. Miller, Francesca
Diella, Anita Palma, Gianni Cesareni, Lars Juhl Jensen, and Rune Linding. Ki-
nomeXplorer: An integrated platform for kinome biology studies. Nature Meth-
ods, 11(6):603–604, June 2014. ISSN 1548-7105. doi: 10.1038/nmeth.2968. URL
http://www.nature.com/articles/nmeth.2968.
Pedro Casado, Juan Carlos Rodriguez-Prados, Sabina C. Cosulich, Sylvie Guichard,
Bart Vanhaesebroeck, Simon Joel, and Pedro R. Cutillas. Kinase-substrate enrichment
analysis provides insights into the heterogeneity of signaling pathway activation in
leukemia cells. Science Signaling, 6(268):rs6–rs6, 2013. ISSN 1945-0877. doi: 10.1126/
scisignal.2003573.
Claudia Hernandez-Armenta, David Ochoa, Emanuel Gonçalves, Julio Saez-
Rodriguez, and Pedro Beltrao. Benchmarking substrate-based kinase activity in-
ference using phosphoproteomic data. Bioinformatics, 33(12):1845–1851, 2017. ISSN
1460-2059. doi: 10.1093/bioinformatics/btx082.
Edmund H. Wilkes, Pedro Casado, Vinothini Rajeeve, and Pedro R. Cutillas. Kinase
activity ranking using phosphoproteomics data (KARP) quantifies the contribution
of protein kinases to the regulation of cell viability. Molecular & Cellular Proteomics,
16(9):1694–1704, 2017. ISSN 1535-9476. doi: 10.1074/mcp.O116.064360.
Marcel Mischnik, Francesca Sacco, Jürgen Cox, Hans Christoph Schneider, Matthias
Schäfer, Manfred Hendlich, Daniel Crowther, Matthias Mann, and Thomas
Klabunde. IKAP: A heuristic framework for inference of kinase activities from
Phosphoproteomics data. Bioinformatics, 32(3):424–431, 2015. ISSN 1460-2059. doi:
10.1093/bioinformatics/btv699.
Camille D. A. Terfve, Edmund H. Wilkes, Pedro Casado, Pedro R. Cutillas, and Julio
Saez-Rodriguez. Large-scale models of signal propagation in human cells derived
116 BIBLIOGRAPHY
from discovery phosphoproteomic data. Nature Communications, 6:8033, 2015. ISSN
2041-1723. doi: 10.1038/ncomms9033.
Jan Daniel Rudolph, Marjo de Graauw, Bob van de Water, Tamar Geiger, and Roded
Sharan. Elucidation of Signaling Pathways from Large-Scale Phosphoproteomic
Data Using Protein Interaction Networks. Cell Systems, 3(6):585–593.e3, December
2016. ISSN 2405-4720. doi: 10.1016/j.cels.2016.11.005. URL https://linkinghub.
elsevier.com/retrieve/pii/S2405471216303696.
Peter Langfelder and Steve Horvath. WGCNA: an R package for weighted correlation
network analysis. BMC bioinformatics, 9(1):559, December 2008. ISSN 1471-2105. doi:
10.1186/1471-2105-9-559. URL http://www.ncbi.nlm.nih.gov/pubmed/19114008.
Adam A. Margolin, Ilya Nemenman, Katia Basso, Chris Wiggins, Gustavo Stolovitzky,
Riccardo Favera, and Andrea Califano. ARACNE: An Algorithm for the Reconstruc-
tion of Gene Regulatory Networks in a Mammalian Cellular Context. BMC Bioinfor-
matics, 7(Suppl 1):S7, 2006. ISSN 1471-2105. doi: 10.1186/1471-2105-7-S1-S7.
Alexander Kraskov, Harald Stögbauer, and Peter Grassberger. Estimating mutual in-
formation. Physical review. E, Statistical, nonlinear, and soft matter physics, 69:066138,
June 2004. ISSN 1539-3755. doi: 10.1103/PhysRevE.69.066138.
Lin Song, Peter Langfelder, and Steve Horvath. Comparison of co-expression measures:
mutual information, correlation, and model based indices. BMC Bioinformatics, 13(1):
328, December 2012. ISSN 1471-2105. doi: 10.1186/1471-2105-13-328.
Bin Zhang and Steve Horvath. A General Framework for Weighted Gene Co-
Expression Network Analysis. Statistical Applications in Genetics and Molecular Bi-
ology, 4(1):Article17, 2005. ISSN 1544-6115. doi: 10.2202/1544-6115.1128. URL
https://www.ncbi.nlm.nih.gov/pubmed/16646834.
E. Ravasz, A. L. Somera, D. A. Mongru, Z. N. Oltvai, and A. L. Barabási. Hierarchical
organization of modularity in metabolic networks. Science, 297(5586):1551–5, August
2002. ISSN 1095-9203. doi: 10.1126/science.1073374. URL http://www.ncbi.nlm.
nih.gov/pubmed/12202830.
Stephen Oliver. Guilt-by-association goes global. Nature, 403(6770):601–602, February
BIBLIOGRAPHY 117
2000. ISSN 0028-0836. doi: 10.1038/35001165. URL http://www.ncbi.nlm.nih.gov/
pubmed/10688178.
H. K. Lee, Amy K. Hsu, Jon Sajdak, Jie Qin, and Paul Pavlidis. Coexpression Analysis
of Human Genes Across Many Microarray Data Sets. Genome Research, 14(6):1085–
1094, May 2004. ISSN 1088-9051. doi: 10.1101/gr.1910904. URL http://www.ncbi.
nlm.nih.gov/pubmed/15173114.
Zhiqiang Wang, Jing Ma, Chika Miyoshi, Yuxin Li, Makito Sato, Yukino Ogawa,
Tingting Lou, Chengyuan Ma, Xue Gao, Chiyu Lee, Tomoyuki Fujiyama, Xiaojie
Yang, Shuang Zhou, Noriko Hotta-Hirashima, Daniela Klewe-Nebenius, Aya Ikkyu,
Miyo Kakizaki, Satomi Kanno, Liqin Cao, Satoru Takahashi, Junmin Peng, Yong-
hao Yu, Hiromasa Funato, Masashi Yanagisawa, and Qinghua Liu. Quantitative
phosphoproteomic analysis of the molecular substrates of sleep need. Nature, 558
(7710):435–439, June 2018. ISSN 0028-0836. doi: 10.1038/s41586-018-0218-8. URL
http://www.nature.com/articles/s41586-018-0218-8.
Graham H. Diering, Raja S. Nirujogi, Richard H. Roth, Paul F. Worley, Akhilesh Pandey,
and Richard L. Huganir. Homer1a drives homeostatic scaling-down of excitatory
synapses during sleep. Science, 355(6324):511–515, February 2017. ISSN 1095-
9203. doi: 10.1126/science.aai8355. URL http://www.ncbi.nlm.nih.gov/pubmed/
28154077.
Damian Szklarczyk, John H. Morris, Helen Cook, Michael Kuhn, Stefan Wyder, Mi-
lan Simonovic, Alberto Santos, Nadezhda T. Doncheva, Alexander Roth, Peer Bork,
Lars J. Jensen, and Christian Von Mering. The STRING database in 2017: Quality-
controlled protein-protein association networks, made broadly accessible. Nucleic
Acids Research, 45(D1):D362–D368, January 2017. ISSN 1362-4962. doi: 10.1093/nar/
gkw937.
Sara B. Noya, Franziska Brüning, Tanja Bange, Jan D. Rudolph, Jürgen Cox, Steven A.
Brown, Matthias Mann, and Maria S. Robles. Rest-activity cycles drive dynamics of
phosphorylation in cortical synapses. Submitted, 2018.
Pavel Sinitcyn, Shivani Tiwary, Jan Daniel Rudolph, Petra Gutenbrunner, Christoph
Wichmann, S¸ule Yılmaz, Hamid Hamzeiy, Favio Salinas, and Jürgen Cox. MaxQuant
118 BIBLIOGRAPHY
goes Linux. Nature methods, 15:401, June 2018b. ISSN 1548-7105. URL https://www.
nature.com/articles/s41592-018-0018-y.
Daniel H. Lackner, Alexia Carré, Paloma M. Guzzardo, Carina Banning, Ramu Man-
gena, Tom Henley, Sarah Oberndorfer, Bianca V. Gapp, Sebastian M. B. Nijman,
Thijn R. Brummelkamp, and Tilmann Bürckstümmer. A generic strategy for
CRISPR-Cas9-mediated gene tagging. Nature Communications, 6(1):10237, December
2015. ISSN 2041-1723. doi: 10.1038/ncomms10237. URL http://www.nature.com/
articles/ncomms10237.
Daichi Kamiyama, Sayaka Sekine, Benjamin Barsi-Rhyne, Jeffrey Hu, Baohui Chen,
Luke A. Gilbert, Hiroaki Ishikawa, Manuel D. Leonetti, Wallace F. Marshall,
Jonathan S. Weissman, and Bo Huang. Versatile protein tagging in cells with split
fluorescent protein. Nature Communications, 7:11046, March 2016. ISSN 2041-1723.
doi: 10.1038/ncomms11046.
Hyun Woo Rhee, Peng Zou, Namrata D. Udeshi, Jeffrey D. Martell, Vamsi K. Mootha,
Steven A. Carr, and Alice Y. Ting. Proteomic mapping of mitochondria in living cells
via spatially restricted enzymatic tagging. Science, 339(6125):1328–1331, March 2013.
ISSN 1095-9203. doi: 10.1126/science.1230593. URL http://www.ncbi.nlm.nih.gov/
pubmed/23371551.
Kyle J. Roux, Dae In Kim, and Brian Burke. BioID: A screen for protein-protein in-
teractions. In Current Protocols in Protein Science, volume 74, pages 19231–192314.
John Wiley & Sons, Inc., Hoboken, NJ, USA, November 2013. ISBN 0471140864. doi:
10.1002/0471140864.ps1923s74.
Franz Herzog, Abdullah Kahraman, Daniel Boehringer, Raymond Mak, Andreas
Bracher, Thomas Walzthoeni, Alexander Leitner, Martin Beck, Franz Ulrich Hartl,
Nenad Ban, Lars Malmström, and Ruedi Aebersold. Structural probing of a protein
phosphatase 2A network by chemical cross-linking and mass spectrometry. Science,
337(6100):1348–1352, September 2012. ISSN 1095-9203. doi: 10.1126/science.1221483.
Fan Liu, Dirk T. S. Rijkers, Harm Post, and Albert J. R. Heck. Proteome-wide profiling
of protein assemblies by cross-linking mass spectrometry. Nature Methods, 12(12):
1179–1184, April 2015. ISSN 1548-7105. doi: 10.1038/nmeth.3603.
BIBLIOGRAPHY 119
Anders R. Kristensen and Leonard J. Foster. Protein correlation profiling-SILAC to
study protein-protein interactions. Methods in Molecular Biology, 1188:263–270, 2014.
ISSN 1064-3745. doi: 10.1007/978-1-4939-1142-4_18.
Catalina O. Tudor, Karen E. Ross, Gang Li, K. Vijay-Shanker, Cathy H. Wu, and Ce-
cilia N. Arighi. Construction of phosphorylation interaction networks by text min-
ing of full-length articles using the eFIP system. Database, 2015, 2015. ISSN 1758-
0463. doi: 10.1093/database/bav020. URL http://www.ncbi.nlm.nih.gov/pubmed/
25833953.
Alice Bossi and Ben Lehner. Tissue specificity and the human protein interaction
network. Molecular Systems Biology, 5(1):260, January 2009. ISSN 1744-4292. doi:
10.1038/msb.2009.17. URL http://www.ncbi.nlm.nih.gov/pubmed/19357639.
Thorsten Will and Volkhard Helms. PPIXpress: construction of condition-specific pro-
tein interaction networks based on transcript expression. Bioinformatics, 32(4):571–
578, February 2016. ISSN 1367-4803. doi: 10.1093/bioinformatics/btv620.
S. Ohno. So much "junk" DNA in our genome. Brookhaven Symposia in Biology, 1972.
ISSN 0068-2799. doi: citeulike-article-id:3483106.
Elizabeth Pennisi. ENCODE project writes eulogy for junk DNA. Science, 2012. ISSN
1095-9203. doi: 10.1126/science.337.6099.1159.
120 BIBLIOGRAPHY
Acknowledgements
I would like to express my gratitude to the numerous people who made this thesis pos-
sible.
Matthias Mann for his supervision and for serving on my thesis advisory committee
alongside Professor Caroline Friedel and Jürgen Cox. Your advice was invaluable.
A very special thanks to Jürgen Cox for shaping my work while giving me the freedom
to pursue my interests. For, whenever I was stuck, breaking down seemingly impos-
sible problems into a number of simple steps. It was inspirational to learn the ins and
outs of computational mass spectrometry from the master himself. Thank you for the
opportunities to teach at the various workshops and summer schools, which forced me
to learn even more about all the topics surrounding my research.
Charo and Franziska for the fruitful collaboration.
The current and past Cox lab members which made the last years so much more enjoy-
able.
My gym buddies Shivani, Dan, and Peter for inspiring me to work(out) harder and
stick with it. I learned some life lessons with you in the basement.
Susi for all the joy and for believing in me.
My family for having my back. I love you guys!
121
